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resumo 
 
 
Os mecanismos de biogénese dos grânulos secretores e a secreção regulada 
das enzimas digestivas, nas células acinares do pâncreas, ainda não são 
totalmente compreendidos. Para esclarecer estes processos, que são de 
importância biológica e clínica (ex., pancreatite), é necessário um melhor 
conhecimento molecular dos componentes da membrana dos grânulos, as 
suas funções e interações. A aplicação da proteómica contribuiu largamente 
para a identificação de novas proteínas dos grânulos de zimogénio (ZG) mas 
ainda não foi acompanhada por uma melhor caracterização das suas funções. 
Este estudo teve como objectivos a) o isolamento e identificação de novas 
proteínas associadas à membrana dos ZG; b) a caracterização das 
propriedades bioquímicas e da função da lectina ZG16p, uma proteína 
associada a membrana dos ZG; c) explorar o potencial da ZG16p como uma 
nova ferramenta para marcar o compartimento endolisossomal. Inicialmente, 
efetuamos uma abordagem proteómica ao estudo das frações dos ZG, a qual 
nos levou à identificação de novas proteínas periféricas da ZGM com 
capacidade de se ligarem a proteoglicanos (Chymase e PpiB). Depois, 
começamos a desvendar as propriedades moleculares e (múltiplas) funções da 
lectina ZG16p. A ZG16p é uma proteína única nos mamíferos com capacidade 
de se ligar a glicanos e a proteoglicanos. Pela primeira vez, foi revelado que a 
ZG16p é extremamente resistente a proteases através do desenvolvimento de 
um ensaio de digestão com enterokinase. Adicionalmente, demonstrei que a 
ZG16p se liga a um complexo de elevado peso molecular (também resistente a 
proteases) e forma homodímeros muito estáveis. À luz destas descobertas, 
nós sugerimos que a ZG16p poderá actuar como um elo de ligação aos 
proteoglicanos, ajudando na formação e estabilização de uma rede/estrutura 
(matriz submembranar) ligada ao lúmen da ZGM, que desempenhará uma 
função importante durante a segregação e empacotamento dos zimogénios. A 
ZG16p poderá atuar como um elo de ligação entre a matriz e os zimogénios 
agregados devido à sua capacidade para formar dímeros. Adicionalmente, a 
resistência da ZG16p a protéases poderá ser de maior importância após a 
secreção, uma vez que é sabido que a ZG16p se liga a fungos patogénicos 
nos intestinos. Investiguei ainda, o papel dos domínios de ligação da ZG16p na 
sua segregação para os ZG em células AR42J, um modelo pancreático. A 
mutação pontual dos motivos de ligação a glicanos e a proteoglicanos não 
alterou a segregação da ZG16p para os ZG. Também demonstrei que quando 
a ZG16p se encontra no citoplasma liga-se ao compartimento endolisossomal. 
Como é sabido, a desregulação da autofagia devido ao funcionamento 
defeituoso dos lisossomas está associado à pancreatite, por isso iremos 
discutir o papel potencial da ZG16p nesta doença. 
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abstract 
 
The mechanisms of secretory granule biogenesis and regulated secretion of 
digestive enzymes in pancreatic acinar cells are still not well understood. To 
shed light on these processes, which are of biological and clinical importance 
(e.g., pancreatitis), a better molecular understanding of the components of the 
granule membrane, their functions and interactions is required. The application 
of proteomics has largely contributed to the identification of novel zymogen 
granule (ZG) proteins but was not yet accompanied by a better characterization 
of their functions. In this study we aimed at a) isolation and identification of 
novel membrane-associated ZG proteins; b) characterization of the biochemical 
properties and function  of the secretory lectin ZG16p, a membrane-associated 
protein; c) exploring the potential of ZG16p as a new tool to label the endo-
lysosomal compartment. First, we have performed a suborganellar proteomics 
approach by combining protein analysis by 2D-PAGE and identification by 
mass spectrometry, which has led to the identification of novel peripheral ZGM 
proteins with proteoglycan-binding properties (e.g., chymase, PpiB). Then, we 
have unveiled new molecular properties and (multiple) functions of the 
secretory lectin ZG16p. ZG16p is a unique mammalian lectin with glycan and 
proteoglycan binding properties. Here, I revealed for the first time that ZG16p is 
highly protease resistant by developing an enterokinase-digestion assay. In 
addition I revealed that ZG16p binds to a high molecular weight complex at the 
ZGM (which is also protease resistant) and forms highly stable dimers. In light 
of these findings I suggest that ZG16p is a key component of a predicted 
submembranous granule matrix attached to the luminal side of the ZGM that 
fulfils important functions during sorting and packaging of zymogens. ZG16p, 
may act as a linker between the matrix and aggregated zymogens due to dimer 
formation. Furthermore, ZG16p protease resistance might be of higher 
importance after secretion since it is known that ZG16p binds to pathogenic 
fungi in the gut. I have further investigated the role of ZG16p binding motifs in 
its targeting to ZG in AR42J cells, a pancreatic model system. Point mutations 
of the glycan and the proteoglycan binding motifs did not inhibit the targeting of 
ZG16p to ZG in AR42J cells. I have also demonstrated that when ZG16p is 
present in the cytoplasm it interacts with and modulates the endo-lysosomal 
compartment. Since it is known that impaired autophagy due to lysosomal 
malfunction is involved in the course of pancreatitis, a potential role of ZG16p in 
pancreatitis is discussed. 
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1. Introduction 
1.1. The exocrine pancreas 
The pancreas is a unique exocrine and endocrine organ located in the retroperitoneal 
region of the upper abdominal cavity. The cells of the pancreas are arranged into distinct 
lobules composed primarily by acinar cells (digestive enzyme-producing cells) of the 
exocrine pancreas, by the ductal structures that conduct the digestive enzymes to the 
duodenum and by distinct clusters of endocrine cells, the islets of Langerhans, that secrete 
hormones directly into the blood (e.g. insulin) (Figure 1). The majority of the pancreatic 
tissue mass, circa 90-95%, is present within the exocrine compartment of the organ (Lewis, 
2008). The acinar cell was the model system in which the fundamental details of the 
secretory pathway were first elucidated by Palade (Palade, 1975). This cell is highly 
polarised, with two distinct plasma membrane domains - a small apical domain, which 
accounts for less than 10% of the total surface area, and a much larger basolateral domain 
(Figure 1). Along with hepatocytes, the pancreatic acinar cells exhibit the highest rate of 
protein synthesis among cells in higher organisms. More than 90% of the newly synthesized 
proteins are targeted to the secretory pathway (Scheele et al., 1978) and are packaged into 
large secretory granules, also designated as zymogen granules (ZG) (Schrader, 2004), and 
further stored at the apical domain of the cell.  
Figure 1. Structure of the 
exocrine pancreas. The exocrine 
pancreas is organised in lobules 
that are constituted by acinar 
units, which consist of acinar 
cells surrounding a lumen. The 
polarity of the acinar cells is 
shown with the nucleus 
surrounded by ER in the basal 
domain and with the ZG in the 
apical domain. The contents of 
the ZG are secreted into the 
intercalated ducts that join to 
form the intralobular ducts, 
which merge into the main 
pancreatic duct. The bile duct 
comes into close contact with the 
termination of the main 
pancreatic duct and they empty 
into the duodenum together.  
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The ZG store digestive enzymes (endo- and exoproteases, lipases, glycosidases, and 
RNAse) that are mostly synthesized as inactive precursors (zymogens) which are only 
activated through limited proteolysis within the intestinal lumen. Stimulation of receptors in 
the basolateral membrane by secretagogues such as acetylcholine and cholecystokinin, 
generates a second messenger response that is dominated by the release of Ca2+ from 
intracellular stores (Kasai et al., 1993; Thorn et al., 1993), which in turn triggers granule 
fusion leading to the secretion of digestive enzymes into the lumen of the duct (Wasle and 
Edwardson, 2002). One of the main roles of pancreatic ducts is to provide a structural 
framework for acinar and islet cells and to convey digestive enzymes from acinar cells to the 
duodenum (Hegyi et al., 2011). Furthermore, the duct cells secrete fluid that helps in the 
transport of digestive enzymes, and secrete bicarbonate (HCO3-) that neutralizes gastric acid 
and provides an optimum pH environment for digestive enzymes in the duodenum. HCO3- 
is also a chaotropic ion that helps in the solubilisation of macromolecules preventing the 
aggregation of digestive enzymes and mucins (Lee et al., 2012). The human pancreas 
secretes 1-2 liters of pancreatic juice per day, a clear, alkaline, isotonic fluid rich in digestive 
enzymes secreted by the acinar cells (Lee and Muallem, 2008). The pancreatic duct system 
delivers the pancreatic juice into the duodenum, where conversion of trypsinogen to trypsin 
is mediated by proteolytic cleavage via enterokinase, a heterodimeric type II membrane 
protein of the brush border of duodenal enterocytes. Activated trypsin then proteolytically 
cleaves and activates the other zymogens (Zheng et al., 1999).  
 
1.2. Zymogen granule biogenesis and exocytosis in the exocrine 
pancreas 
The multiple enzymes characteristic of the pancreas are synthesized by ribosomes, 
associated with the membranes, and inserted into the lumen of the rough endoplasmic 
reticulum (ER). In the supranuclear region, the Golgi complex receives the products of the 
ER and processes them further (Bockman, 2008). Then, the selection/sorting of proteins to 
be packaged in ZG takes place at the trans-Golgi network (TGN) and might involve selective 
protein aggregation and protein-membrane interactions. Some of the ZG enzymes form 
protein complexes already within the lumen of the ER (Kleene et al., 1999a; Tooze et al., 
1989). The protein complexes progressively aggregate at the mildly acidic pH and high Ca2+ 
levels within the TGN and form dense core aggregates that are supposed to interact with the 
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TGN membrane (Figure 2) (Colomer et al., 1996; Dartsch et al., 1998; Freedman and 
Scheele, 1993; Gómez-Lázaro et al., 2010; Leblond et al., 1993). While the selective 
aggregation of ZG proteins has been well documented, their interaction with the TGN/ZG 
membrane is poorly understood at the molecular level, and neither a common sorting signal 
nor a sorting receptor has been identified so far.  
 
Figure 2. Zymogen granule biogenesis and exocytosis in the exocrine pancreas. ER – endoplasmic reticulum; 
TGN – Trans-Golgi Network; IG – Immature Granule; ZG – Zymogen Granules.  
Two models have been proposed to account for the sorting of regulated secreted 
proteins in exocrine and endocrine cells (Arvan and Castle, 1992, 1998). One is viewed as 
an active model for sorting (‘sorting by entry’), where membrane binding of secretory 
proteins is assumed to depend on a ‘sorting receptor’ within the TGN (e.g., a transmembrane 
protein), and entry into forming granules is restricted to receptor-mediated trafficking. The 
other model is a passive model (‘sorting by retention’), where aggregation of regulated 
secretory proteins is the primary sorting event. In this model, a receptor is not required and 
entry into the forming granule is not solely restricted to regulated secretory proteins. The 
non-secretory proteins fail to aggregate and are removed from the maturing granules in a 
clathrin-dependent process. In this case, the immature secretory granule can also be a site 
for sorting. However, the retention of the granule-specific membrane components is likely 
to involve their interaction with regulated secretory proteins (Gómez-Lázaro et al., 2010).  
Sorting during ZG biogenesis is also supposed to take place after the TGN, at the 
level of the ZG itself. Ultrastructural studies indicate that parts of the Golgi cisternae become 
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dilated and filled with electron-opaque material. These condensing vacuoles (CVs), the 
initial stage of ZG, then pinch off as immature granules, which mature into ZG by the 
selective removal of nonsecretory proteins (via a clathrin-mediated process called 
‘constitutive-like secretion’) and further condensation of the aggregated zymogens occurs, 
as well as a reduction in granule size (Arvan and Castle, 1992; Dahan et al., 2005; Gómez-
Lázaro et al., 2010; Klumperman et al., 1998).  
ZG are transported in a cytoskeleton-assisted fashion to the apical plasma membrane 
where they dock to the plasma membrane (Masedunskas et al., 2012). It is now accepted that 
docking and fusion requires specific heterotrimeric interactions between membrane-
associated SNARE proteins (soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors): syntaxin, SNAP25 (25 kDa synaptosome-associated protein) and VAMP (vesicle 
associated membrane protein). However, each step of the process (tethering, docking, 
priming and fusion) is assisted by specific accessory proteins (e.g., Rab27b, synaptotagmin-
like proteins). Ca2+-stimulated acinar secretion triggers an early rapid phase of exocytosis 
that is mediated by VAMP2-specific SNARE interactions and is likely controlled by the 
Ca2+-sensing protein syt1 and accessory protein complexin 2 (Messenger et al., 2014). 
Following a secretory stimulus, up to 30% of the cellular vesicle content is secreted over 
extended time periods of up to an hour (Valentijn et al., 1999; Williams, 2006). The apical 
plasma membrane takes a massive addition of membrane material from the ZG, however the 
overall size of this domain is maintained constant by a dynamic process of compensatory 
membrane endocytosis (Geron et al., 2013; Gómez-Lázaro et al., 2010; Massarwa et al., 
2009). Upon exocytosis of the ZG, the digestive enzymes are exposed to the alkaline pH of 
the acinar/ductal lumen, and the proteins are solubilized for their transit to the duodenum 
(Freedman et al., 1994). Once in the intestinal tract, granule proteins, in addition to digestion, 
are also supposed to fulfil regulatory and protective functions, for example, in host defence 
(Bach et al., 2006; Gómez-Lázaro et al., 2010; Szmola and Sahin-Tóth, 2007; Tateno et al., 
2012). 
 
1.3. Proteomics of pancreatic zymogen granules 
Proteomics workflows have been developed to reliably identify the protein 
complement of whole organelles, as well as for protein assignment to subcellular location 
(Drissi et al., 2013). Proteomics has been used to study the exocrine pancreas and its diseases 
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in various manners including understanding its physiology, identification of biomarkers of 
disease, and understanding the mechanism of disease (Williams, 2013). The exocrine 
pancreas served as the model that first established the role of intracellular compartments in 
the secretory pathway (Palade, 1975), and ZG have been used as a model system to study 
secretory-granule biogenesis and regulated secretion in general. The molecular mechanisms 
required for ZG formation at the TGN and for the packaging and sorting of cargo proteins, 
as well as for granule fusion and exocytosis, are still poorly defined. According to recent 
models, part of the molecular machinery required for digestive enzyme sorting, granule 
trafficking and exocytosis is supposed to be associated with the ZG membrane (ZGM). In 
addition to basic research interests, ZG also play important roles in pancreatic injury and 
disease (Gaisano and Gorelick, 2009; Thrower et al., 2010). Therefore, there is currently 
great interest in the identification and molecular characterization of ZG and ZGM 
components (Gómez-Lázaro et al., 2010).  
 
1.3.1. Isolation and subfractionation of zymogen granules 
Zymogen granules represent highly abundant organelles of the exocrine pancreas that 
can be easily isolated due to their large size and quantity. Isolated ZG can be lysed and 
further separated into a ZG content (ZGC) and membrane (ZGM) fraction. Isolation 
procedures for ZG from dog (Hokin, 1955), bovine and guinea pig pancreas (Greene et al., 
1963; Tartakoff et al., 1974), as well as for porcine (Rutten et al., 1975) and rat pancreas 
(Borta et al., 2010; Chen and Andrews, 2008; de Lisle et al., 1984; Pâquet et al., 1982; 
Rindler, 2006), have been described (Gómez-Lázaro et al., 2010). Subcellular fractionation 
is the most widely used method, which after tissue homogenization and differential 
centrifugation results in a relatively pure ZG fraction (≥90%). To achieve a higher degree of 
purity, sucrose or percoll gradient fractionation is often applied (Borta et al., 2010; Gómez-
Lázaro et al., 2010; de Lisle et al., 1984; Pâquet et al., 1982; Rindler, 2006).  
The efficiency of the isolation and the enrichment of ZG proteins as well as the 
presence of potential contaminations is often monitored by SDS-PAGE, immunobloting and 
enzyme activity measurements for marker proteins (e.g., amylase, GP2). In addition, the 
organelle integrity and the presence of contaminating subcellular structures in the ZG 
fractions, which include mitochondria, ER and large lysosomes are verified by electron 
microscopy (Gómez-Lázaro et al., 2010). Intact ZG can be gently lysed at pH 8, which 
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corresponds to the physiological conditions at which the ZGC proteins become soluble in 
the pancreatic duct, after exocytosis. Then, the ZGC and membrane subfractions can be 
obtained by centrifugation. The isolated membranes have been treated with potassium 
bromide and/or carbonate at pH 11 to liberate membrane-associated proteins from 
transmembrane and membrane-anchored proteins (Figure 3) (Chen and Andrews, 2008; 
Chen et al., 2006; Hoops and Rindler, 1991; Schmidt et al., 2000). However, some ZGC 
proteins are still found in the ZGM fraction and vice versa. This may be due to the 
observation that some ZGC proteins exist in a soluble and membrane-associated pool (Borta 
et al., 2010; Chen et al., 2006, 2008; Rindler, 1992; Schmidt et al., 2000). Furthermore, some 
ZGM proteins are enzymatically cleaved and released in a soluble form (e.g., GP-2, a major 
glycosylphosphatidylinositol [GPI]-anchored ZGM glycoprotein) (Gómez-Lázaro et al., 
2010; Rindler and Hoops, 1990).  
 
Figure 3. Subfractionation of zymogen granules (ZG). Isolated ZG can be lysed at pH 8 by freezing and 
thawing. The content (ZGC) and membrane (ZGM) subfractions are obtained by centrifugation. After treating 
the isolated membranes with carbonate at pH 11.5, a subfraction with integral membrane proteins 
(ZGMwashed) and a subfraction with membrane-associated proteins (Wash) is obtained by ultracentrifugation.  
 
1.3.2. Separation of zymogens 
Introduced by George Scheele, bidimensional (2D) separation of proteins in slab gels 
using isoelectric focusing (IEF) in the first dimension and SDS-PAGE in the second 
dimension (Scheele, 1975) was used for the analysis of the complex mixture of soluble 
proteins secreted by the exocrine pancreas. For the first time it was possible to analyse 
simultaneously the major exportable proteins in subcellular fractions, obtained after 
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homogenization, and in extracellular fluids (e.g., pancreatic juice [PJ] or incubation medium) 
contributing to the determination of the intracellular transport of pulse-labeled proteins along 
the secretory pathway (Scheele et al., 1978). In combination with the development of 
pancreatic lobules as an in vitro model of biological response (Scheele, 1975; Scheele and 
Palade, 1975) and, thus, the efficient study of protein synthesis, 2D-SDS-PAGE has 
furthermore provided valuable insights into the differential regulation of gene expression in 
the rat pancreas in response to hormones (Adler et al., 1983; Schick et al., 1984a) and 
different nutrients (Kern et al., 1987; Schick et al., 1984b). In addition, 2D-SDS-PAGE has 
been used to identify many of the abundant ZG proteins (Bieger and Scheele, 1980; Borta et 
al., 2010; Kleene et al., 1999a; Scheele et al., 1981). In the 1980s, guinea pig and human 
exocrine pancreatic proteins were the most thoroughly described systems analysed by 2D-
SDS-PAGE. Owing to limited resolution and sensitivity, however, a relatively simple 
protein composition for the ZGM was proposed. The recent improvements in organellar 
proteomics revealed a more-complex picture of the components of the ZGM (Chen et al., 
2006, 2008; Rindler et al., 2007). Alternative procedures besides the traditional 2D-SDS-
PAGE, such as double SDS-PAGE, have demonstrated their capacity to resolve membrane 
proteins (Faust et al., 2008), but the main developments were due to the application of 
nongel-based techniques, such as high-performance liquid chromatography (HPLC) with 
improved capacity to resolve membrane and membrane-associated proteins, mostly applied 
after in-solution digestion (Chen et al., 2006, 2008; Rindler et al., 2007; Sun and Jiang, 
2013).  
 
1.3.3. Identification of ZG proteins by mass spectrometry 
Mass spectrometry (MS) is an analytical technique aiming at the study in the gas 
phase of ionised molecules, in order to determine their molecular weight (m/z ratio), 
characterize their structure and determine their abundance (Silva et al., 2013). The technical 
innovations in MS, protein-identification methods and database annotation over the last 20 
years have allowed scientists to rapidly and systematically detect thousands of proteins in 
complex biological samples (Aebersold and Mann, 2003; Han et al., 2008; Kim et al., 2014; 
Wilhelm et al., 2014). In this respect, MS has become the method of choice for the analysis 
of complex protein samples (Aebersold and Mann, 2003; Lane, 2005), where the 
development of ‘soft’ ionization methods is the main responsible for its success in the 
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proteomics field. Presently, two ionization techniques, namely electrospray ionization (ESI) 
(Fenn et al., 1989) and MALDI (Karas and Hillenkamp, 1988; Tanaka et al., 1988), are 
playing a significant role in MS-based peptide analysis (Fröhlich and Arnold, 2006; Han et 
al., 2008).  
Until recently, the major ZG proteins have been identified by the purification of 
proteins, N-terminal peptide sequencing techniques and the specific immunolocalization of 
granule components. The introduction of mass spectrometry in the proteomic study of ZG 
resulted in a better characterization of the ZG proteome, and contributed mainly to the 
discovery of additional ZGM proteins (Berkane et al., 2007; Chen et al., 2006; Rindler et al., 
2007; Sun and Jiang, 2013) and ZGM associated proteins (Borta et al., 2010). The 
combination of 2D-SDS-PAGE and 2D-LC allowed, for the first time, the separation and 
subsequent identification by mass spectrometry of a total of 101 proteins from purified ZGM 
(Chen et al., 2006). The separation of rat ZG proteins by combining 1D-SDS-PAGE with 
LC resulted in the identification of a total of 371 proteins by MS (Rindler et al., 2007). More 
recently, the combination of FASP (filter-aided sample preparation), that combines the 
advantages of complete sample solubilisation with in-solution digestion, and 2D-LC-
MS/MS allowed the identification of 800 proteins in mouse ZG by MS (Sun and Jiang, 
2013).  
 
1.4. Proteoglycans and zymogen granules 
Sulfated proteoglycans have previously been identified as constituents of pancreatic 
zymogen granules and in the fluid of pancreatic ductal system (Berg and Young, 1971; 
Reggio and Palade, 1978; Tartakoff et al., 1975). Furthermore, Scheele et al. (1994) reported 
that in acinar cells of the rat pancreas more than 90% of sulfated-labeled proteoglycans were 
associated with the ZGM, and could be released by treatment of ZGM with sodium carbonate 
at pH 11.2 (Scheele et al., 1994). In addition, a reticular network on the inner surface of 
ZGM had been observed by freeze-fracture and deep-etching studies several years ago 
(Cabana et al., 1981). GP-2 was described to be associated with fibrillar material in lysates 
of ZG, in the acinar lumen and in pancreatic juice (Beaudoin et al., 1991; Grondin et al., 
1992). Based on these findings, Scheele and co-workers postulated the existence of a 
submembranous granule matrix at the luminal surface of ZGM and presented further 
evidence that during granule exocytosis the release of the putative matrix is mediated by the 
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alkaline pH present in the acinar lumen and the activation of phosphatidylinositol-specific 
phospholipase C (PI-PLC) (Freedman et al., 1998a). The release of the hypothetical matrix 
is supposed to be a prerequisite for the efficient recycling of granule membranes via 
endocytosis (Freedman et al., 1998a, 1998b; Schrader, 2004). The submembranous matrix 
model predicts the presence of high molecular weight components (e.g., a proteoglycan 
scaffold and associated (glyco)proteins) attached to the luminal side of the granule 
membrane. This scaffold is supposed to fulfil important functions during the sorting and 
packaging of secretory proteins (Scheele et al., 1994; Schrader, 2004). The glycoconjugate 
scaffold underneath the ZGM is suggested to serve as the backbone of a complex membrane 
matrix, and a bridge between the ZGM and the zymogens. 
Moreover, sulfated proteoglycans were found to be associated with lipid 
microdomains in the ZGM (Kalus et al., 2002; Schmidt et al., 2001). These lipid 
microdomains and associated proteins (e.g., GP2) were involved in the attachment of the 
matrix proteoglycans to the granule membrane (Schmidt et al., 2001). Recently, Kumazawa-
Inoue and colleagues isolated heparin sulfate proteoglycans from rat pancreatic zymogen 
granules and characterized the glycosaminoglycan (GAG) chains but the identification of 
the core protein was unsuccessful (Kumazawa-Inoue et al., 2012). Sulfated proteoglycans 
are present in multiple intracellular compartments, such as endosomes, lysosomes, nucleus 
and especially in storage organelles of immunosecretory, neurosecretory cells (Gallagher, 
1989; Gallagher et al., 1986; Kolset and Gallagher, 1990; Prydz and Dalen, 2000). The 
negatively charged proteoglycans in secretory granules of haemopoietic cells and mast cells 
are involved in the binding of small positively charged molecules, such as histamine 
(Rönnberg et al., 2012). 
Since specific membrane receptors or sorting signals have not yet been identified in 
exocrine cells, the concept of the submembranous matrix offers an interesting alternative to 
understand the packaging and sorting of a complex mixture of proteins in an exocrine 
system. Furthermore, the submembranous matrix might have protective and mechanical 
properties, e.g., to maintain membrane curvature, granule shape and stability (Schrader, 
2004).  
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1.5. Lectins in the Pancreas  
1.5.1. Lectins 
Lectins are carbohydrate-binding proteins, excluding sugar-specific antibodies, 
receptors of free mono- or disaccharides for transport or chemotaxis and enzymes modifying 
the bound carbohydrate (Gabius et al., 2002). Some of the well-characterized roles of lectins 
are in cell-cell communication, host-pathogen interactions, tissue development, metastasis 
and embryogenesis (Raval et al., 2004).  
Lectins were first found and described in plants, but in subsequent years multiple 
lectins were isolated from microorganisms and animals (Sharon and Lis, 2004) and now they 
can be classified in more than forty families (Tateno, 2010; Tateno et al., 2012). 
Interestingly, plant and animal lectins show no primary structural homology, yet they share 
similarities in their tertiary structures (Ghazarian et al., 2011; Sharon and Lis, 2004), 
suggesting that animal and plant lectin genes may have co-evolved, thus highlighting the 
importance of lectin-carbohydrate interactions in living systems (Ghazarian et al., 2011; 
Gorelik et al., 2001).  
Structural studies conducted on animal lectins suggested that the carbohydrate 
binding activity of most lectins was generated by limited amino acid residues designated as 
the carbohydrate recognition domain (CRD) (Ghazarian et al., 2011; Sharon and Lis, 2004). 
Several highly conserved CRD amino acid sequences have been identified, thus allowing 
investigators to categorize the majority of these lectins into structurally related families and 
superfamilies (Sharon and Lis, 2004).  
Several lectins have been associated with the pancreatic ZG (Parikh et al., 2012; 
Rindler et al., 2007; Sun and Jiang, 2013), but I will focus on a group of unusual pancreatic 
secretory proteins with carbohydrate-binding activities. Among them are a multifunctional 
family of secreted lectins containing CTL (C-type lectin) domains (Reg family) with known 
anti-inflammatory, antiapoptotic, and mitogenic action in multiple physiologic and disease 
contexts (Iovanna and Dagorn, 2005; Parikh et al., 2012) and the lectin ZG16p, a mannose-
binding Jacalin-related lectin (mJRL), and the main subject of this dissertation. 
Protein analysis of ZG (and pancreatic secretions) resulted in the identification of 
several unique proteins with carbohydrate-binding properties. Among them are the secretory 
lectin ZG16p and the structurally different C-type lectins regenerating gene (Reg) family. 
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The latter are supposed to exert anti-inflammatory, anti-apoptotic, proliferative, free radical 
scavenging and antibacterial effects (Iovanna and Dagorn, 2005; Moniaux et al., 2011), 
whereas the activity of ZG16p is largely unknown. Interestingly their expression is not 
restricted to the pancreas thus pointing to multifunctional properties and a broader 
(patho)physiological importance (Laurine et al., 2003). As lectins have been shown to be 
involved in various protein trafficking/sorting processes and in the maintenance of 
membrane polarisation (Delacour et al., 2009), the biochemical and functional analysis of 
the unusual secretory lectins is of great biological importance.  
 
1.5.2. The regenerating gene family  
The Reg family encodes a group of secreted proteins, RegI to RegIV, and each 
member has an N-terminal signal peptide linked to a conserved sequence motif homologous 
to the carbohydrate recognition domain (CRD) of C-type lectin (Cash et al., 2006; Ho et al., 
2010). C-type lectins are the most abundant of all animal lectins, and the CTL superfamily 
is grouped into three families: selectins, collectins and endocytic lectins (Kerrigan and 
Brown, 2009; Sharon and Lis, 2004). A majority of CTLs are large, asymmetric, have one 
or more CRDs and exist as Ca2+ dependent proteins found in secreted or bound forms 
(Ghazarian et al., 2011; Gorelik et al., 2001; Sharon and Lis, 2004). The Reg proteins were 
discovered independently during pancreatitis and pancreatic islet regeneration (de Caro et 
al., 1979; Keim et al., 1984), but there is evidence of participation of Reg proteins in the 
proliferation and differentiation of many cell types. Currently, they are associated with 
various pathologies, including diabetes, pancreatitis, gastrointestinal cancer (Parikh et al., 
2012), Alzheimer or Creutzfeldt-Jakob disease (Duplan et al., 2001; Laurine et al., 2003). 
These findings have led to the emergence of key roles for Reg proteins as anti-inflammatory, 
antiapoptotic, and mitogenic agents in multiple physiologic and disease contexts (Parikh et 
al., 2012).  
Despite the initial association with the pancreas, most Reg proteins are expressed in 
multiple organs under normal and pathological conditions. At least one of the REG1α, 
REG1β, and REG3β is detected in human fetal and adult pancreas, brain, stomach, intestine, 
and pituitary gland (Bartoli et al., 1998). The latest addition to the Reg group, RegIV, was 
initially found to be significantly upregulated during mucosal injury due to active Crohn’s 
disease or ulcerative colitis (Hartupee et al., 2001). It is overexpressed in colorectal 
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carcinomas (Violette et al., 2003) and is prominently expressed in the human gastrointestinal 
tract. RegIV expression is also linked to pancreatic cancer and malignancies of the stomach, 
intestine, colon, rectum, gallbladder, and urogenital tract (Hayashi et al., 2009; Nanakin et 
al., 2007; Oue et al., 2005; Tamura et al., 2009; Violette et al., 2003). But the expression 
patterns and relevance to diseases and/or tissue homeostasis of the Reg family remain 
unclear (Parikh et al., 2012). In addition, some of the Reg family members were associated 
with antibacterial activity, suggesting an extracellular function in host defence after 
secretion. RegI was found to bind and aggregate several bacterial strains, including Gram-
positive and Gram-negative aerobic and anaerobic bacteria (Iovanna et al., 1993). Recently, 
mouse RegIIIγ and human RegIII were shown to be direct antibacterial proteins that bind to 
Gram-positive bacteria via interactions with peptidoglycan carbohydrate in a calcium-
independent manner (Ho et al., 2010; Lehotzky et al., 2010). RegIV protein adopts a typical 
fold of C-type lectin but binds mannan, a polymer of mannose residues, with two calcium-
independent sites (Ho et al., 2010). These proteins may play a vital role in maintaining host-
bacterial homeostasis in the mammalian gut, which reveals a previously undiscovered 
biological function for animal lectins, and represent an evolutionarily primitive form of 
lectin-mediated innate immunity (Ho et al., 2010).  
 
1.5.3. The secretory lectin ZG16p 
1.5.3.1. Discovery and localization in ZG 
Zymogen Granule protein 16 was first identified by immunoscreening of a rat 
pancreatic cDNA expression library with a polyspecific antiserum raised against purified 
ZGM (Cronshagen et al., 1994). It was considered to be a secretory lectin due to its sequence 
homology with the plant lectin Jacalin (Cronshagen et al., 1994). Most recently, the tertiary 
structure of ZG16p was solved by crystallography and it was shown to possess a Jacalin-
related β-prism fold, the first to be reported among mammalian lectins (Kanagawa et al., 
2011). After ZG16p discovery, Kleene and colleagues have shown that it is mainly 
associated with the luminal side of ZGM and that it is almost completely removed after 
bicarbonate treatment at pH 11.5 (Kleene et al., 1999b). Later, it was shown that ZG16p was 
found in cholesterol-glycosphingolipid-enriched microdomains together with GP2, syncollin 
and sulfated proteoglycans (Kalus et al., 2002; Schmidt et al., 2001). Furthermore, the 
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association of ZG16p with the luminal side of the zymogen granule membrane was 
confirmed by proteomics in several publications (Borta et al., 2010; Chen et al., 2006, 2008; 
Rindler et al., 2007).  
Full length ZG16p has 167 amino acids (aa) where the first 16 aa represent a signal 
peptide that targets the protein to the ER (Cronshagen et al., 1994; Kanagawa et al., 2011) 
and it doesn’t have any transmembrane domains (Borta et al., 2010; Cronshagen et al., 1994; 
Kanagawa et al., 2011, 2014). Residues 36-159 are classified as the jacalin-related domain 
based on sequence alignment in the Pfam database (http://pfam.xfam.org/protein/Q8CJD3).  
 
1.5.3.2. 3D structure and binding motifs 
The crystal structure of ZG16p was recently solved (Kanagawa et al., 2011) revealing 
a β-prism fold with 3 β-sheets, each consisting of 3-4 β-strands forming three Greek motifs 
(PDB: 3APA), similar to jacalin related mannose-binding type lectins (mJRL) (Kanagawa 
et al., 2011). Jacalin-related lectins (JRLs) derive their name from Jacalin, the first member 
to be identified from the seeds of jackfruit (Bunn-Moreno and Campos-Neto, 1981; Raval et 
al., 2004). They are further divided into two subgroups based on the sugar-binding 
specificities: galactose-binding-type (gJRLs) and mannose-binding-type (mJRLs) (Van 
Damme et al., 1996; Nakamura-Tsuruta et al., 2008; Tateno et al., 2012). Most JRLs 
identified so far belong to mJRL, which consists of the intact subunit of about 150 amino 
acids (Tateno et al., 2012). The gJRL subfamily consists of a short β-chain (2 KDa) and a 
long chain (13 KDa) as a result of post-translational processing (Nakamura-Tsuruta et al., 
2008) and is a much smaller subgroup, in which only a few members have been identified, 
such as Jacalin (Sastry et al., 1986; Tateno et al., 2012). While gJRLs have been extensively 
used as tools to detect mucin-type O-glycans, (Nakamura-Tsuruta et al., 2008), an mJRL 
(BanLec) isolated from the fruit of bananas was recently shown to be a potent inhibitor of 
HIV-1 infection. BanLec inhibits entry of the virus into the cell by binding to the high 
mannose structures found on the heavily glycosylated envelope protein gp120 (Swanson et 
al., 2010; Tateno et al., 2012). The structural similarities between ZG16p and the mJRLs 
suggested that it possesses the same mannose-binding mode through three conserved 
exposed loops (GG loop, recognition loop and binding loop) at the top of the β-prism I fold. 
The binding loop is a common carbohydrate recognition domain (CRD), a glycine and an 
aspartic acid separated by a 3-amino-acid spacer (GXXXD) (Figure 4). This domain is 
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conserved in the majority of β-prism fold lectins (Kumazawa-Inoue et al., 2012; Raval et al., 
2004; Sharma et al., 2007). In addition, it was shown by a glycoconjugate microarray, that 
ZG16p binds to polyvalent mannose via the carbohydrate recognition domain and, by frontal 
affinity chromatography, that ZG16p binds to high-density mannose and yeast mannan. It 
was further demonstrated that ZG16p binds to pathogenic Candida and Malassezia species 
heavily coated with mannan (Tateno et al., 2012). More recently, Kanagawa and colleagues 
characterized by crystallography the binding of ZG16p with α-O-methyl-mannose and 
concluded that ZG16p and mJRLs have the same mannose-binding mode (Kanagawa et al., 
2014). On both cases mutation of the amino acid D151 abolished the binding of the 
carbohydrate recognition domain (GXXXD) to mannose-related probes (Kanagawa et al., 
2014; Tateno et al., 2012). Interestingly, analysis of the crystal structures of BanLec (a 
mJRL) with carbohydrate ligands revealed that BanLec possesses two carbohydrate-binding 
sites including the signature motifs GG and GXXXD (Kumazawa-Inoue et al., 2012; 
Meagher et al., 2005; Singh et al., 2005), while ZG16p has only one mannose-binding site 
(Kanagawa et al., 2011, 2014). On the other hand, BanLec does not bind 
glycosaminoglycans (GAG) probably due to its negatively charged surface potential 
(Kanagawa et al., 2014). 
 
Figure 4. Tertiary structure and the carbohydrate recognition domain (CRD) of ZG16p. (A) 3D model obtained 
from Protein Database Bank (3APA). β-strands are coloured in yellow and a short α-helix is coloured in purple. 
A glycerol molecule is bound to the CRD at the top of ZG16p molecule. (B) Close-up view of the CRD of 
ZG16p.  
Previously, ZG16p was suggested to bind to sulfated proteoglycans (Kanagawa et 
al., 2011; Kleene et al., 1999b; Schmidt et al., 2001; Schrader, 2004) but the characterization 
A 
B 
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of the proteoglycan binding sites was only accomplished recently by Kumazawa-Inoue and 
colleagues (Kumazawa-Inoue et al., 2012). ZG16p binds to proteoglycans through two 
positively charged basic patches, constituted by lysine and arginine residues on the surface 
of the protein, that interact with the negatively charged side chains of sulfated proteoglycans 
(Kanagawa et al., 2011; Kleene et al., 1999b; Kumazawa-Inoue et al., 2012). Point mutation 
of those sites (K33A, K36A, R37A and R55A, R58A) abolished the binding to heparin 
(Kumazawa-Inoue et al., 2012) (Figure 5). 
 
Figure 5. Localization of the amino acids at the surface of ZG16p subjected to point mutation. (A and B) 
Amino acids coloured in green and blue correspond to the proteoglycan binding motif (PGM) and the amino 
acid coloured in red is part of the carbohydrate recognition domain. (C) Surface model of ZG16p coloured 
according to the electrostatic surface potential (blue – positive, red – negative). Yellow circle shows 
localization of the PGM and the arrow points to CRD.  
ZG16p is likely a unique lectin with dual specificity to sulfated glycosaminoglycans 
(proteoglycan binding motif) and to polyvalent mannose and short chain α-manno-
oligosaccharides (carbohydrate recognition domain) (Figure 6) (Kanagawa et al., 2011, 
2014; Kumazawa-Inoue et al., 2012; Tateno et al., 2012). Furthermore, the mannose binding 
site does not compete with the proteoglycan binding site on ZG16p (Kanagawa et al., 2014). 
 
 
Figure 6. Domains of ZG16p. SP – Signal Peptide, PGM – ProteoGlycan binding Motif, CRD – Carbohydrate 
Recognition Domain. 
 
1.5.3.3. ZG16 gene expression profile 
ZG16p was first identified in the zymogen granules of the rat pancreas (Cronshagen 
et al., 1994) and it was shown that the expression of ZG16 mRNA in the pancreas was up-
regulated by a hormonal treatment with cholecystokinin (CCK) or cerulein (Cronshagen et 
al., 1994). Both peptide hormones are known to evoke a complete release of zymogen 
A B C 
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granules and to up-regulate expression and transport of most secretory enzymes (Cronshagen 
et al., 1994; Steinhilber et al., 1988; Vasiloudes et al., 1991; Wang and Cui, 2007). 
Furthermore, expression of ZG16 mRNA levels in a rat acinar carcinoma cell line (AR42J) 
treated with dexamethasone resulted in a 12-fold increase (Cronshagen et al., 1994). 
Treatment with the glucocorticoid dexamethasone induces both the differentiation of AR42J 
cells into acinar-like cells and the de novo formation of electron-opaque secretory granules, 
which contain the major pancreatic zymogens (Logsdon et al., 1985). In parallel, the 
presence of ZG16 mRNA was tested on several tissues by Northern blot and it was detected 
in pancreas, duodenum, colon and stomach (Cronshagen et al., 1994).  
Interestingly, gene expression profiling in very diverse studies revealed new insights 
into the up or down regulation of ZG16 mRNA across different tissues. Implants of 
biomaterials into the rat stomach strikingly lead to the transient expression of several genes 
encoding pancreatic enzymes and ZG16 in the gastric wall (Löbler et al., 2002). The 
comparison of gene expression in response to treatment with known liver toxicants or 
inducers between rat liver slices and primary hepatocytes (in vitro) and rat liver (in vivo) 
also showed the regulation of ZG16 mRNA in the liver. In this case, treatment with ANIT 
(α-napthylisothiocyanate), an insecticide that gives rise to cholangiolitic hepatitis with 
necrosis of the bile duct epithelial cells and hepatic parenchymal cells (Fukumoto et al., 
1980; Jessen et al., 2003), induced over a two fold increase of ZG16 mRNA on all tested 
systems (Jessen et al., 2003). In a study aiming at the identification of regulated genes in the 
lesion area as well as in the axotomized neurons following lesion of a central nervous system 
(CNS) fibre tract, ZG16 mRNA was in the 2.3% of the 1185 genes studied that showed 
significant changes (3 fold for ZG16 mRNA) in the lesion site, when compared with the 
control (Küry et al., 2004). This study also indicates, for the first time, the expression of 
ZG16 mRNA in the rat brain, while previously it was only associated with the digestive 
system. The gene expression profiling in the ileum in a rat ileal-augmented bladder model 
revealed that ZG16 mRNA was over two fold down-regulated in 1 and 3 months after 
surgery (Miyake et al., 2004). In a rat model for colon cancer induced by azoxymethane 
(AOM) it was evaluated the effect of lifetime ingestion of casein (control), soy and whey 
proteins on the gene expression profile of colons. ZG16p was determined to be over four 
fold down-regulated in rats fed with whey protein and no changes were observed when fed 
with soy protein (Xiao et al., 2005). Human ZG16 (hZG16) was shown, by Northern blot, to 
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be expressed in adult liver and colon and, by RT-PCR, in adult pancreas. But more 
significantly, hZG16 was down-regulated in hepatocellular carcinoma (Zhou et al., 2007). 
In a tissue screening of expression of human ZG16 mRNA by real-time PCR, ZG16 was 
strongly detected in liver, pancreas and small intestine (Tateno et al., 2012). A treatment of 
mice with supraphysiological doses of cerulein inducing acute pancreatitis, led to a rapid 
down regulation (12 h) of ZG16p mRNA in mouse pancreas with recovery of mRNA levels 
within 3 days (Neuschwander-Tetri et al., 2004). These studies reveal that ZG16 mRNA is 
found not only in the pancreas or intestine but several other organs like the stomach, liver or 
brain under normal or disease states. However, a more careful investigation of ZG16 
expression in different tissues (in health and disease) is necessary, in order to better 
understand the relevance of ZG16 expression under (patho)physiological conditions.  
 
1.5.3.4. ZG16 protein expression in different tissues 
ZG16p was first identified in the pancreas and as outlined above it was shown to be 
associated with the ZGM (see Chapter 1.5.3.1). Additionally, there is evidence at the protein 
level (western blot, dot blot, immunohistochemistry and immunocytochemistry and MS 
identification) of ZG16p expression in different tissues from different species. Initially, 
Cronshagen and colleagues reported by immunohistochemistry the expression of ZG16p in 
pancreas, mucus-producing goblet cells and at the luminal surface of the duodenum and 
colon (Cronshagen et al., 1994). Later, ZG16p was found by dot blot analysis in human 
intestine and colon, and by immunohistochemistry in human liver (Zhou et al., 2007). More 
recently, Tateno and colleagues showed by immunohistochemistry the localization of 
ZG16p in human serum and in mucus-secreting cells of the digestive system: in acinar cells 
of pancreas, goblet cells of the small bowel, colon, appendix and rectum and in the 
serosanguineous acinar cells of the parotid gland (Tateno et al., 2012). ZG16p was first found 
to be part of the mucus proteome of the mouse colon (Johansson et al., 2008) and later to be 
part of the mucus proteome through all gastrointestinal tract (GIT) (Rodríguez-Piñeiro et al., 
2013). The mouse GIT is protected by mucus that covers the epithelial surface from stomach 
to colon (Ermund et al., 2013; Rodríguez-Piñeiro et al., 2013). The stomach is covered by a 
two-layered mucus with an inner mucus layer that is adherent to the epithelium but fully 
penetrable, the colon is also constituted by two layers (an inner layer attached to the 
epithelium, impenetrable and devoid of bacteria and an outer layer, looser in structure and 
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colonized by bacteria), while the small intestine is covered by a loosely attached mucus layer 
(Ermund et al., 2013; Larsson et al., 2013; Rodríguez-Piñeiro et al., 2013). Muc5ac is one 
of the most abundant proteins of the mucus layer in the stomach, while Muc2 is most 
abundant in the intestine mucus samples (Rodríguez-Piñeiro et al., 2013). ZG16p was found 
as part of the mucus proteome in all sites of the GIT and, interestingly, both ZG16p and 
Muc2 were both shown, by mass spectrometry and immunohistochemistry, to increase 
quantitatively from the stomach to the colon, where MUC2 is the most abundant mucin and 
ZG16p is in the top 10 of most abundant proteins of the mucus proteome (Rodríguez-Piñeiro 
et al., 2013). Additionally, sulfation of mucin O-glycans shows a similar pattern, increasing 
from the stomach to the colon. Lastly, both Muc2 and ZG16p were found to be highly 
expressed in the mucus-producing goblet cells (Cronshagen et al., 1994; Rodríguez-Piñeiro 
et al., 2013). Altogether, these results indicate a close relation between the proteoglycan 
Muc2 and ZG16p. 
Finally, the publication of the first draft of the Human proteome (Kim et al., 2014; 
Wilhelm et al., 2014) allowed access to a high coverage map (over 92% of human protein-
coding genes) (Wilhelm et al., 2014) of proteins expressed in several human tissues and body 
fluids. ZG16p was successfully identified in several tissues by both publications but the 
expression patterns differ from each other and from other published data (e.g., pancreatic 
expression is not described on both drafts). In one publication, ZG16p was found in adult 
colon and rectum (Kim et al., 2014), and in the other, ZG16p was found in colon, colonic 
epithelial cells, ileum epithelial cells, rectum, proximal fluid (coronary sinus), urine and 
stomach (Wilhelm et al., 2014). With a different approach, the Human Protein Atlas aims at 
a systematic exploration of the human proteome using antibody-based proteomics, and 
detected ZG16p in duodenum, small intestine, appendix, colon and rectum. As also indicated 
by the analysis of the ZG16 gene expression, this further shows that the expression of the 
lectin ZG16p is not limited to the pancreas thus pointing to multifunctional properties and a 
broader (patho)physiological importance, resembling the Reg proteins, a distinct family of 
pancreatic lectins.  
 
1.5.3.5. Proposed functions of ZG16p 
ZG16p is predominantly associated with the luminal surface of ZGM, and can be 
removed in conjunction with proteoglycans/GAGs by carbonate-, chondroitinase- or 
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heparitinase-treatment (Kleene et al., 1999b; Kumazawa-Inoue et al., 2012; Schmidt et al., 
2000; Schrader, 2004). Thus, it was suggested to represent a component of the 
submembranous granule matrix (see Chapter 1.4), where it interacts with sulfated 
proteoglycans. Interestingly, ZG16p has also been found to associate with cholesterol-
glycosphingolipid-enriched microdomains in the ZGM together with GP-2 and sulfated 
proteoglycans (Schmidt et al., 2001). However, the ZGM association of ZG16p was not 
influenced in GP-2 knock-out mice (Yu et al., 2004). In line with this, a function as a 
linker/helper protein in the binding of aggregated zymogens to the granule membrane has 
been proposed from in vitro studies (Kleene et al., 1999b). Pretreatment of ZGM with anti-
ZG16p antibody in an in vitro condensation-sorting assay (Dartsch et al., 1998) inhibited the 
binding of aggregated content proteins to the membrane by about 50% whereas pretreatment 
with anti-amylase antibody had no significant effect (Kleene et al., 1999b) . Furthermore, 
ZG16p was found to bind to heparin sulfate proteoglycans, present in the ZG, by recognizing 
their glycosaminoglycan chains through two positive patches constituted by basic amino 
acids on the surface of ZG16p (Kumazawa-Inoue et al., 2012). The recent structural data on 
ZG16p (Kanagawa et al., 2011, 2014; Kumazawa-Inoue et al., 2012; Tateno et al., 2012) 
resulted in the identification of a carbohydrate recognition domain (Kanagawa et al., 2011, 
2014; Tateno et al., 2012) and two proteoglycan binding sites (Kumazawa-Inoue et al., 
2012). Importantly, both carbohydrate and proteoglycan binding sites are independent from 
each other (Kanagawa et al., 2014), suggesting that ZG16p could aid in the formation of the 
submembranous matrix by functioning as a linker between the GAG chains and contribute 
to the sorting and packaging of zymogens during ZG biogenesis (Dartsch et al., 1998; Kalus 
et al., 2002; Kleene et al., 1999b; Kumazawa-Inoue et al., 2012; Leblond et al., 1993; 
Schrader, 2004). 
In addition, the recent association of ZG16p with the mucus proteome and more 
specifically with expression of Muc2 (a sulphated proteoglycan and the main component of 
the mucus in the intestine) suggests that ZG16p might also have a function after secretion 
(e.g., in host defence). Quantitatively, ZG16p was shown to increase from the stomach to 
the colon (Rodríguez-Piñeiro et al., 2013) and it is known that the small intestine is designed 
to limit the growth and transport of bacteria distally, whereas the large intestine harbours the 
commensal bacteria (Johansson et al., 2013). Interestingly, the large intestine shows higher 
amounts of both Muc2 and ZG16p (Rodríguez-Piñeiro et al., 2013) in the mucus layer. 
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Furthermore, it was demonstrated that ZG16p binds to pathogenic Candida and Malassezia 
species heavily coated with mannan through its carbohydrate recognition domain (Tateno et 
al., 2012). The leading cause of candidiasis, Candida albicans, resides as a commensal of 
the mucosa and the intestinal tract (Arendorf and Walker, 1980; Tateno et al., 2012). 
Thévenod and co-workers proposed an additional function for ZG16p in the 
regulation of a K+ conductance in zymogen granules (Braun and Thévenod, 2000). In an 
approach to identify a ZGM protein involved in the regulation of an ATP-sensitive K+ and 
Cl- conductance they used a dihydropyridine derivative in photoaffinity labeling 
experiments. To their surprise, they labeled and purified ZG16p as a high-affinity 
dihydropyridine binding protein of rat ZGM. They suggested a regulatory role for ZG16p in 
the direct coupling between granule fusion to the plasma membrane and the activation of 
channels in the ZGM (Thévenod, 2002). It had already been proposed that anion-cation 
channels might promote “flushing out” of the granule content (i.e., enzymes or mucins) 
during exocytosis in pancreatic acinar cells and in intestinal goblet cells (Guo et al., 1997; 
de Lisle and Hopfer, 1986). It is speculated that a similar mechanism may take place after 
an initial, fusion pore-mediated granule swelling by the granule matrix, including ZG16p 
(Thévenod, 2002; Thévenod et al., 1994). This intriguing possibility remains to be 
elucidated. 
Taken together this suggests that ZG16p might have multiple functions at different 
locations, highlighted by its expression in different tissues, and points to a broader 
(patho)physiological importance.  
 
1.6. Pancreatic diseases 
Under physiological conditions, the pancreatic acinar cells are subjected to high 
levels of stress, mostly due to the high rate of protein synthesis and secretion. To prevent 
autodigestion, the pancreatic acinar cells normally synthesize proteolytic enzymes in the 
inactive zymogen form, but if prematurely activated those enzymes are capable of damaging 
the cells and consequently the pancreas itself. Pancreatic damage can be acute or chronic. 
Acute damage is associated with the generation of an inflammatory response, which can be 
mild and localized to the pancreas (acute pancreatitis), or severe and systemic. The systemic 
inflammation resulting from pancreatic disease can lead to multiple organ failure and 
mortality (Logsdon and Ji, 2013). Chronic damage to the pancreas results in chronic 
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pancreatitis with acinar cell destruction and replacement with fibrosis or fat, which if 
extensive, leads to exocrine insufficiency. It also increases the probability of genetic 
instability and thus the risk of developing pancreatic cancer, especially pancreatic ductal 
adenocarcinoma (PDAC) (Logsdon and Ji, 2013). The rate of pancreatic cancer in patients 
with chronic pancreatitis is greater than that in age-matched controls (Lowenfels et al., 
1993), and the risk is especially high in patients with prolonged pancreatic inflammation due 
to hereditary pancreatitis (Lowenfels et al., 1997; Whitcomb and Beger, 2008). Currently, 
no effective treatments beyond surgery exist for either PDAC or pancreatitis, two diseases 
associated with severe pain (Logsdon and Ji, 2013).  
 
1.6.1. New insights in the study of pancreatitis. The role of autophagy in 
pancreatitis 
Chronic pancreatitis is a progressive inflammatory disorder in which the pancreatic 
secretory parenchyma is destroyed and replaced by fibrous tissue, eventually leading to 
malnutrition and diabetes. Traditionally, chronic pancreatitis has been classified as 
fundamentally different from acute pancreatitis, which is usually characterised by restoration 
of normal pancreatic histology after full clinical recovery (Sarles, 1986). However, acute, 
recurrent acute, and chronic pancreatitis are now regarded as a disease continuum (Braganza 
et al., 2011; Mitchell et al., 2003; Whitcomb, 2004). Pathologic responses arising from the 
pancreatic acinar cell appear to have a central role in initiating acute pancreatitis. Activation 
of zymogens within the acinar cell and an inhibition of secretion are critical, but poorly 
understood, early pancreatitis events. Additionally, stimulation of acinar cell autophagy has 
been a recognized feature of acute pancreatitis for years, although its role remains to be 
clarified (Gorelick and Thrower, 2009). Mice deficient in the ability to form 
autophagosomes are resistant to acute pancreatitis (Hashimoto et al., 2008), suggesting that 
formation of autophagosomes is also an important step to develop pancreatitis (Feng et al., 
2012). It is thought that autophagy might have multiple roles in acute pancreatitis. For 
example, distinct autophagic events could modulate zymogen activation (leading to 
pancreatitis) vs the degradation of active zymogens in the acinar cell (protecting from 
pancreatitis) (Gorelick and Thrower, 2009). 
Recent studies have suggested that impaired autophagic flux due to deficient 
lysosomal degradation is an important mechanism that contributes to intra-acinar trypsin 
 22 
 
activation and pancreatitis (Feng et al., 2012; Fortunato and Kroemer, 2009; Gukovsky and 
Gukovskaya, 2010; Mareninova et al., 2009). Autophagy encompasses several intracellular 
pathways of lysosome-driven degradation and recycling of organelles and long-lived 
proteins (Gukovskaya and Gukovsky, 2012). Impaired autophagy mediates two key 
pathological responses of pancreatitis: accumulation of vacuoles in acinar cells and the 
abnormal, intra-acinar activation of digestive enzymes such as trypsinogen (Gukovsky et al., 
2011). The lysosomal function is impaired in pancreatitis through at least two mechanisms, 
which both cause retarded autophagic flux: (1) deficient lysosomal proteolytic activity and 
(2) pathologic alterations in lysosomal membrane proteins, such as LAMPs. For example, 
LAMP-2 genetic ablation causes autophagy impairment in pancreas (Tanaka et al., 2000), 
with accumulation of large autolysosomes containing poorly degraded material. The 
decreased activity of proteolytic activity is a result from impaired maturation of hydrolases 
and consequent defective activation. The delivery of hydrolases to the lysosome is a 
multistep process controlled by the Golgi and the endosomal system (Gukovskaya and 
Gukovsky, 2012). During trafficking, cathepsins undergo proteolytic processing 
(maturation) to become active enzymes: first, in endosomes, this process generates an 
intermediate, “single-chain” form of cathepsins, and then, mainly in the lysosome, a fully 
mature “double-chain” active form. Therefore, the lysosomal/autophagic dysfunction may 
be a manifestation of a more general phenomenon, indicating disordering of endo-lysosomal 
traffic in pancreatitis (Gukovskaya and Gukovsky, 2012).  
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2. Objectives 
To understand the molecular machinery required for granule biogenesis, sorting and 
secretion in exocrine cells, a better molecular characterization of the components of the 
ZGM is required. Clearly, these components have a central function in granule formation at 
the TGN, in protein sorting, apical exocytosis and membrane fusion as well as regulation of 
exocytosis. The disturbance of these regulated processes (incorrect compartmentalization, 
premature activation of the zymogens, uncontrolled and unspecific fusions) can cause 
pathological changes of the pancreas, e.g. during acute pancreatitis. The identification of 
membrane components of ZG, their molecular characterization and the unravelling of their 
functions in granule biogenesis and regulated secretion are therefore highly relevant for both 
cell biologists and clinical research developments.  
We favour a model, in which a predicted submembranous matrix composed of high 
molecular weight components and associated proteins attached to the luminal side of the 
ZGM fulfils important functions during the sorting and packaging of secretory proteins. 
Furthermore, the submembranous matrix might have protective and mechanical properties, 
e. g., to maintain membrane curvature, granule shape and stability (Borta et al., 2010; 
Schrader, 2004). Since specific membrane receptors or sorting signals have not yet been 
identified in exocrine cells, the concept of the submembranous matrix offers an interesting 
alternative to understand the packaging and sorting of zymogens in ZG. Once in the intestinal 
tract matrix proteins such as ZG16p, syncollin, or GP2 are also supposed to fulfil important 
protective functions, e.g. in host defence (Bach et al., 2006; Hase et al., 2009; Tateno et al., 
2012). Our main goal is to understand the molecular machinery required for granule 
biogenesis, using the pancreatic acinar cell as a model system, with the specific aims:  
 
a) Isolation and identification of membrane-associated proteins of the predicted 
submembranous granule matrix. 
b) Characterization of the biochemical properties and function (by mutational analyses) of 
the secretory lectin ZG16p, a membrane-associated protein. 
c) Explore the potential of ZG16p as a new tool for labelling the endo-lysosomal 
compartment.  
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3. Material and Methods 
3.1. Frequently used buffers and solutions 
 
Blocking solution for immunofluorescence:  
1% (w/v) BSA in PBS   
Blocking solution for immunoblots:  
5% (w/v) milk powder in PBS   
Cell culture medium for COS-7, AR42J and HepG2 cells: 
DMEM, high glucose (4.5 g/l) with L-glutamine; 10% (v/v) FBS; 100 U/ml Penicillin; 100 
µg/ml Streptomycin 
Equilibration buffer (2D-GE) 
6 M urea, 75 mM Tris-HCl pH 8.8, 34.5% Glycerol (87%), 2% SDS, 0.002% bromophenol 
blue and 1.5 mM DTT 
Fixative for immunofluorescence:  
4% (w/v) Paraformaldehyde in PBS, pH 7.4   
HBS – HEPES buffered saline, pH 7.15, for electroporation:  
5 g/l HEPES; 8 g/l Sodium chloride; 0.37 g/l Potassium chloride; 0.1 g/l Sodium phosphate 
dibasic; 1.08 g/l D(+)Glucose  
LB medium:  
2.5% (w/v) LB-Broth Miller   
LB plates:  
2.5% (w/v) LB-Broth Miller; 1% (w/v) Agar   
Mounting medium for immunofluorescence:  
3 volumes Mowiol stock; 1 volume n-propylgallat stock  
Mowiol stock:  
12 g Mowiol 4-88; 40 ml PBS, 20 ml Glycerol 
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n-propylgallate stock (antifading):  
2.5% (w/v) Propylgallate in PBS; 50% (v/v) Glycerol  
PBS – phosphate buffered saline, pH 7.35:  
140 mM Sodium chloride; 2.5 mM Potassium chloride; 6.5 mM Sodium phosphate dibasic; 
1.5 mM Potassium phosphate dibasic  
Permeabilization for immunofluorescence:  
0.2% (v/v) Triton X-100 in PBS  
Protease inhibitor mix (final concentrations):  
0.1 mM PMSF; 0.01 mM FOY 305; 0.25% (v/v) Trasylol 
Rehydration Buffer (2D-PAGE) 
8 M Urea; 2 M Thiourea; 1% CHAPS; 12.9 mM DTT; 0.1% Pharmalyte 3-10 (IPG buffer); 
0.01% Bromophenol Blue 
SDS loading buffer (Laemmli 1970):  
60 mM Tris, pH 6.8; 2% (w/v) SDS; 10% (v/v) Glycerol; 0.005% (w/v) Bromophenol blue; 
20 mM DTT; 5% (v/v) β-Mercaptoethanol (fresh)   
SDS-PAGE running buffer:  
25 mM Tris-HCl; 190 mM Glycine; 0.1% (w/v) SDS   
Semidry blotting buffer:  
48 mm Tris-HCl; 39 mM Glycine; 0.4% (w/v) SDS; 20% (v/v) Methanol   
TAE – Tris-Acetate-EDTA (50x), pH 8.0:  
40 mM Tris; 20 mM Acetic acid; 1 mM EDTA  
Tris buffer separation gel (pH 8.8):  
2 M Tris-HCl  
Tris buffer stacking gel (pH 6.8):  
1 M Tris-HCl 
Zymogen Granule homogenization buffer:  
0.25 M sucrose; 5 mM 2-N-morpholino-ethanesulfonic acid (MES), pH 6.25; 0.1 mM 
MgSO4; 10µM Foy 305; 2.5 mM Trasylol; 0.1 mM phenylmethylsulfonyl ﬂuoride (PMSF). 
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3.2. Lists of antibodies, plasmids and primers used 
Table 1. List of primary antibodies and corresponding dilutions 
Antibody Source / Reference 
Dilution 
IMF WB 
Amylase (rabbit pc) Sigma-Aldrich 1:200 1:2000 
BiP (mouse mc) BD Biosciences  1:1000 
Calnexin (rabbit pc) Stressgen  1:1000 
Carboxypeptidase A (rabbit 
pc) 
Rockland, Immunochemicals 1:800 1:5000 
Chymase (goat pc)  
LB Schwarz, Virginia Commonwealth 
University  
 1:1000 
CEL (chicken pc)  Borta, Aroso et al. 2010  1:88 
Chymotrypsin (sheep pc)  Eigene Herstellung, Marburg 1:400 1:2000 
EEA1 (rabbit pc) Abcam 1:500  
GFP (rabbit pc) Invitrogen, Molecular Probes  1:2000 
GP2 (4AS9 mouse mc)   A. Lowe, Stanford University, USA  1:2000 
Myc (mouse mc)  Santa Cruz Biotechnology 1:200  
p115 (mouse mc)  BD Biosciences 1:200  
PDI R-707 (rabbit pc)  
HD Sölling, Max-Planck Institute for 
Biophysical Chemistry 
1:500  
PpiB (rabbit pc)  Abcam 1:100 1:1000 
RNaseA (rabbit pc)   Sigma-Aldrich 1:1000  
TGN38 (guinea pig-pc) H. F. Kern (ref 1995) 1:100  
Tryptase β1 (mouse pc) R&D Systems  1:1000 
ZG16p N1d1 (rabbit pc)  Cronshagen, Voland et al. 1994 1:200 1:2000 
Abbreviations: pc, polyclonal; mc, monoclonal; IMF, immunofluorescence; WB, Western blot 
 
Table 2. List of secondary antibodies and corresponding dilutions 
Antibody Source 
Dilution 
IMF WB 
TRITC Donkey anti Mouse Dianova 1:200  
TRITC Donkey anti Rabbit Dianova 1:200  
TRITC Donkey anti Sheep Dianova 1:400  
Alexa 488 Goat anti Mouse Invitrogen 1:400  
Alexa 488 Goat anti Rabbit Invitrogen 1:400  
HRP Rabbit anti Chicken  Sigma-Aldrich  1:2000 
HRP Donkey anti Goat Dianova  1:2000 
HRP Goat anti Mouse  Bio Rad  1:5000 
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Antibody Source 
Dilution 
IMF WB 
HRP Goat anti Rabbit  Bio Rad  1:5000 
Abbreviations: pc, polyclonal; mc, monoclonal; IMF, immunofluorescence; WB, Western blot 
 
Table 3. Plasmids used in this study 
Name Source 
pDsRed2-ER Clontech 
pET-28b Novagen 
pCMV-Tag 3A Stratagene 
pcDNA3 Invitrogen 
pEGFP-C1 Clontech 
Lamp1-GFP 
 Steve Caplan, University of  
Nebraska, USA 
 
Table 4. Plasmids cloned during this study 
Name Vector Primer Template 
H-ZG16dSP pET-28b UpHis-Zg16 & ZG16down Myc-ZG16dSP 
HMyc-ZG16dSP pET-28b 
UpHisMycZG16 & 
ZG16down 
Myc-ZG16dSP 
ER-Myc-ZG16dSP pDsRed2-ER ER-Myc-Up & ZG16down Myc-ZG16dSP 
ER-Myc-ZG16dSP_K pDsRed2-ER 
K33A.K36A.R37Afw & 
K33A.K36A.R37Arv 
ER-Myc-ZG16dSP 
ER-Myc-ZG16dSP_R pDsRed2-ER 
R55A.R58Afw & 
R55A.R58Arv 
ER-Myc-ZG16dSP 
ER-Myc-ZG16dSP_D pDsRed2-ER D151Afw & D151Arv ER-Myc-ZG16dSP 
ER-Myc-ZG16dSP_K_R pDsRed2-ER 
R55A.R58Afw & 
R55A.R58Arv 
ER-Myc-ZG16dSP_K 
ER-Myc-ZG16dSP_K_D pDsRed2-ER D151Afw & D151Arv ER-Myc-ZG16dSP_K 
ER-Myc-ZG16dSP_R_D pDsRed2-ER D151Afw & D151Arv ER-Myc-ZG16dSP_R 
ER-Myc-ZG16dSP_KRD pDsRed2-ER D151Afw & D151Arv ER-Myc-ZG16dSP_K_R 
ER-Myc-ZG16dBM pDsRed2-ER 
ER-Myc-Up & 
ZG16part1down & 
ZG16part2up & 
ZG16down 
Myc-ZG16dSP 
ER-Myc-ZG16d21 pDsRed2-ER 
ER-Myc-Up & 
ZG16d24down 
Myc-ZG16dSP 
Myc-ZG16dSP 
pCMV-Tag 
3A 
ZG16up & ZG16down 
Rat cDNA 
Myc-ZG16dSP_K 
pCMV-Tag 
3A 
K33A.K36A.R37Afw & 
K33A.K36A.R37Arv 
Myc-ZG16dSP 
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Name Vector Primer Template 
Myc-ZG16dSP_R 
pCMV-Tag 
3A 
R55A.R58Afw & 
R55A.R58Arv 
Myc-ZG16dSP 
Myc-ZG16dSP_D 
pCMV-Tag 
3A 
D151Afw & D151Arv 
Myc-ZG16dSP 
GFP-ZG16dSPγ pEGFP-C1 
UpGFPZG16 & 
DownGFPZG16 
Myc-ZG16dSP 
GFP-ZG16dSP_K pEGFP-C1 
K33A.K36A.R37Afw & 
K33A.K36A.R37Arv 
GFP-ZG16dSP 
GFP-ZG16dSP_R pEGFP-C1 
R55A.R58Afw & 
R55A.R58Arv 
GFP-ZG16dSP 
GFP-ZG16dSP_D pEGFP-C1 D151Afw & D151Arv GFP-ZG16dSP 
ZG16dSPγ pcDNA3 
ZG16-dSP_f2 & 
ZG16down 
Myc-ZG16dSP 
# KDEL (ER retention signal) sequence was removed during cloning; γ Cloned by María Gómez Lázaro (Centre 
for Cell Biology, University of Aveiro) 
 
Table 5. Primer sequences used for cloning in this study 
Name Sequence Enzyme 
UpHis-Zg16 CTA GCT AGC AAT TCC ATT CAG TCC AGG TCC TCC NheI 
ZG16down CCG CTC GAG TCA ACA AGT GTT GCA GTG GCT AG XhoI 
UpHisMycZG16 CTA GCT AGC ATG GAG CAG AAA CTC ATC TCT GAA G NheI 
ER-Myc-Up T TAC CGG TCC ATG GAG CAG AAA CTC ATC TCT GAG G AgeI 
K33A.K36A.R37Afw¥ 
GGA GAG TAT GGC GGT GCA GGA GGA GCG GCA TTC 
TCT CAC TCT GG 
– 
K33A.K36A.R37Arv¥  
CCA GAG TGA GAG AAT GCC GCT CCT CCT GCA CCG 
CCA TAC TCT CC 
– 
R55A.R58Afw¥ 
CT GCC ATC CGG ATC GCT GTC AAC GCA TAC TAC ATA 
ATA GGT CTC C 
– 
R55A.R58Arv¥ 
G GAG ACC TAT TAT GTA GTA TGC GTT GAC AGC GAT 
CCG GAT GGC AG 
– 
D151Afw¥ CGA TCT GGC TCT GCC ATA GCT GCT ATC AGC CTG CAC – 
D151Arv¥ 
GTG CAG GCT GAT AGC AGC TAT GGC AGA GCC AGA 
TCG 
– 
ZG16part1downλ  GCA GGC TGA TAG CAG ATC GGC CAC TAA TGA AAC GG – 
ZG16part2upλ GTG GCC GAT CTG CTA TCA GCC TGC ACT GGG ATA C – 
ZG16d24down  CCG CTC GAG TCA GTA GGT ATC CCA GTG CAG XhoI 
ZG16up  
AA CTG CAG AGC TCG CAA TTC CAT TCA GTC CAG GTC 
CTC C 
PstI 
ZG16down CCG CTC GAG TCA ACA AGT GTT GCA GTG GCT AG XhoI 
UpGFPZG16 CCC AAG CTT TGA ATT CCA TTC AGT CCA GGT CCT Hind III 
DownGFPZG16 GG GGT ACC TCA ACA AGT GTT GCA GTG GCT A KpnI 
ZG16-dSP_f2  CCC AAG CTT ACC ATG AAT TCC ATT CAG TCC AGG TCC HindIII 
¥ Primers used for the QuikChange site-directed mutagenesis method. λ Primers used for deletion of ZG16p 
carbohydrate recognition domain (CRD) 
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3.3. Molecular biology techniques 
3.3.1. Cloning of DNA plasmids  
The PCRs performed for cloning in this study are listed with template, primer pair 
and target vector in Table 4, and primer sequences and restriction endonuclease cutting sites, 
in Table 5. PCRs were performed with KOD DNA polymerase (Novagen, Darmstadt, 
Germany). PCR products and other DNA samples were separated by agarose gel 
electrophoresis. Routinely 0.8 to 1% (w/v) gels were used. Agarose was dissolved in TAE 
buffer (3.1) by boiling in a microwave. The solution was cooled down until being hand-hot 
and ethidium bromide was added (0.5 µg/ml). DNA samples were mixed with 6x DNA 
loading dye (Thermo Scientific) and a co-migrating DNA ladder (ruler DNA ladder mix) 
(Fermentas) was used to mark DNA sizes. Gene Separation was performed at maximal 5 V 
per cm electrode distance (60 to 130 V) for 30 to 60 minutes. Digital images were taken 
using AlphaImager HP (ProteinSimple, California, USA) and quantification was done with 
the provided software. The PCR product and the target vector were isolated from agarose 
gels using a gel extraction kit (Nucleospin gel and PCR clean Up, Macherey-Nagel, Duren, 
Germany). The DNA bands visible with UV light were cut with a scalpel and transferred to 
a microtube. Agarose was melted at 50°C in the supplied buffer and the DNA was extracted 
with spin columns. Elution was performed using 30 µl of distilled water. PCR product 
extracted from the agarose gel and the target vector were digested with the same two 
enzymes. Routinely, preparative digestions were performed at 37°C overnight. Afterwards, 
successful digestion was checked on an agarose gel, the DNA was isolated and the vector 
was incubated with 1 µl Antarctic phosphatase in the provided buffer for 30 minutes at 37°C. 
Subsequently, phosphatase was inactivated at 65°C for 10 minutes. For ligation, DNA 
concentrations of vector and insert were determined by comparing each gel band intensity 
with the intensity of the bands of co-migrated DNA ladder with known quantity on an 
agarose gel. The molecule ratios chosen between vector and insert were mostly between 1:3 
and 1:5 following the estimated calculation:  
𝑚𝑎𝑠𝑠𝑖𝑛𝑠𝑒𝑟𝑡 (𝑛𝑔) =  
5 × 𝑚𝑎𝑠𝑠𝑣𝑒𝑐𝑡𝑜𝑟 (𝑛𝑔) × 𝑙𝑒𝑛𝑔𝑡ℎ𝑖𝑛𝑠𝑒𝑟𝑡 (𝑘𝑏)
𝑙𝑒𝑛𝑔ℎ𝑡𝑣𝑒𝑐𝑡𝑜𝑟 (𝑘𝑏)
 
Ligation was assembled by preparing a 20 µl reaction with T4 Ligase (400 U/µl), 50 
ng of vector and the corresponding amount of insert, and incubated at 16°C overnight. The 
plasmid formed was transformed and amplified in E. coli (3.6.4) and screened for correct 
Material and Methods 
35 
 
ligations by analytical RE digestion (3.6.5.1). A control reaction without insert was 
performed side-by-side. The PCR products were cloned in frame into cloning vectors (Table 
4) and all constructs were veriﬁed by sequencing (Eurofins Genomics, Ebersberg Germany).  
 
Table 6. PCR programme for cloning 
 
Construct 
PCR programme 
  30 Cycles  
Denaturation 
& activation 
Denaturation Annealing  Elongation 
Elongation 
(final) 
Myc-ZG16dSP 
ER-Myc-ZG16dSp 
H-ZG16dSp 
HMyc-ZG16dSP  
GFP-ZG16dSp 
ZG16dSP 
 ER-Myc-ZG16d21 
2 min 
95˚C 
20 s 
55˚C 
10 s 
70˚C 
10 s 
70˚C 
2 min 
 
3.3.2. Bacterial culture  
For cloning and amplification of DNA plasmids Escherichia coli (DH5α or XL1-
Blue) cultures were used. The bacteria were cultured in LB medium containing a selective 
antibiotic (100 mg/ml Ampicillin or 30 µg/ml Kanamycin) at 37˚C and 200 rpm in an 
incubator shaker. Long-time storage of E. coli cultures was performed as 15% glycerol 
mixtures at –80˚C. For single-cell colonies bacteria were spread on LB agar plates and 
incubated overnight in a 37˚C incubator. Plates were short-term stored at 4˚C and the 
bacterial colonies were used for inoculation of liquid cultures (3 to 5 ml). 
 
3.3.3. Preparation of competent bacterial cells  
5 ml of an E. coli DH5α culture grown overnight were diluted in 500 ml LB medium 
and shaken at 37˚C for 2 to 3 hours until an optical density of OD600 = 0.4 was reached. The 
culture was chilled on ice for 15 minutes and centrifuged at 3000 rpm, 4°C for 15 minutes. 
The pellet was resupended in 40 ml ice-cold 0.1 M calcium chloride (CaCl2) solution and 
incubated on ice for 30 minutes. The bacteria were re-centrifuged, the pellet was resuspended 
in 20 ml ice-cold 0.1 M calcium chloride solution and 20% (v/v) glycerol was added. After 
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incubation on ice for 2 hours aliquots of 100 µl were frozen in liquid nitrogen and stored at 
–80˚C. 
 
3.3.4. Chemical transformation  
100 µl competent E. coli cells were mixed with the plasmid DNA (e.g. from a ligation 
reaction) and incubated on ice for 30 minutes. After a 90 seconds heat shock at 42˚C the 
bacteria were chilled on ice and 700 µl LB medium without antibiotics was added, followed 
by 1 hour shaking incubation at 37˚C. A cell pellet was formed by centrifugation (3 minutes 
at 5000 rpm) and resuspended in 25 - 50 µl LB medium. The suspension was spread on a 
LB agar plate containing a selective antibiotic using sterile glass beads and grown overnight 
at 37˚C. 
 
3.3.5. Plasmid isolation  
3.3.5.1. Analytical restriction endonuclease (RE) digestion  
Plasmid isolation for screening for correct plasmid ligation by analytical RE 
digestion was done as follows: 3 ml E. coli cultures inoculated from single colonies were 
grown overnight and sedimented twice by centrifugation at 5000 rpm for 3 minutes. The 
supernatant was carefully removed and the pellet was completely resuspended in 100 µl cold 
solution I. 200 ml solution II were added and mixed by inverting the tube five times 
(maximal 5 minutes). After addition of 150 µl cold solution III and mixing by inverting the 
lysate was incubated on ice for 3 to 5 minutes. The precipitate formed was removed by 
centrifugation at 13000 rpm, 4°C for 10 minutes and the supernatant was transferred to a 
new tube. The DNA was precipitated by addition of 2 volumes 96% ethanol, incubation at 
room temperature for 2 minutes and centrifugation at 13000 rpm, 4°C for 5 minutes. The 
pellet was washed with 1 ml 70% ethanol and centrifuged for 5 minutes at 13,000 rpm, 4°C. 
After air-drying the pellet was resuspended in 50 ml water supplemented with 20 µg/ml 
RNase, if the RNase has not been added to solution I.  
 
Solution I: 50 mM glucose; 25 mM Tris; 10 mM EDTA; (100 µg/ml RNase), pH 8.0, 
autoclaved 
Solution II: 0.2 M sodium hydroxide; 1% (w/v) SDS   
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Solution III: 3 M potassium acetate; 11.5% v/v glacial acetic acid, pH 4.8 
 
3.3.5.2. Mini-prep 
Plasmid isolation for sequencing was done with the Nucleospin® plasmid kit 
(Macherey-Nagel). 3 ml E. coli cultures were grown overnight and sedimented twice by 
centrifugation at 5,000 rpm for 3 minutes. The supernatant was carefully removed and the 
pellet was completely resuspended in 250 µl of buffer A1. Then, 250 μL of buffer A2 were 
added, the tube was mixed gently by inverting 6-8 times and incubated at room temperature 
for up to 5 min. 300 μL of buffer A3 were added, the tube was mixed gently by inverting 6-
8 times and centrifuged for 5 min, 11000×g at room temperature. The column was placed in 
a collection tube (2 ml), the supernatant was decanted to the column and centrifuged for 1 
min at 11000×g. The flow-through was discarded. The silica membrane was washed with 
600 μL buffer A4 and dried by centrifugation for 2 min at 11000×g. The column was placed 
on a 1.5 mL microcentrifuge tube, 30 µl of sterile distilled water were added to the column 
and incubated for 1 min at room temperature. The DNA was eluted with centrifugation for 
1 min at 11000×g. To increase the elution yield the last step was repeated with 20 µl of 
sterile distilled water. 
 
3.3.5.3. Midi-prep 
For isolation of larger quantity of plasmids the Nucleobond® Xtra Midi (Macherey-
Nagel) was used. 200 ml E. coli cultures were grown overnight and sedimented by 
centrifugation at 6000×g for 15 minutes. The supernatant was carefully removed and the 
pellet was completely resuspended in 8 ml of buffer RES. Then, 8 ml of buffer LYS were 
added, the tube was mixed gently by inverting 6-8 times and incubated at room temperature 
for up to 5 min. 8 ml of buffer NEU were added and the tube was mixed gently by inverting 
6-8 times. The column together with the filter were equilibrated with 12 ml of buffer EQU 
and the lysate was loaded on the Nucleobond® Xtra column filter. The column was washed 
with 5 ml of buffer EQU and the Nucleobond® Xtra column filter discarded. The column 
was washed again with 8 ml of buffer WASH the DNA eluted with 5 ml of buffer ELU. The 
DNA was precipitated with 3.5 ml of isopropanol and centrifuged at 15000×g for 30 min at 
4˚C. The DNA pellet was washed with 2 ml of 70% ethanol and centrifuged at 15000×g for 
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5 min at 4˚C. After drying the DNA was reconstituted in 200-300 µl of sterile distilled water 
and frozen at –20°C until usage.  
 
3.3.6. Measurement of DNA concentrations  
1 µl of a DNA preparation was diluted 1:500 (midi-prep) or 1:200 (mini-prep) in 
water and measured in a quartz cuvette with water as blank at 260 and 280 nm. A clean DNA 
preparation should have an OD260/OD280 ratio of 1.8 
 
3.3.7. In vitro site-directed mutagenesis 
Mutant plasmids were generated using the QuickChange site-directed mutagenesis 
kit (Agilent Technologies, California, USA). The mutagenic oligonucleotide primers were 
designed individually according to the desired mutation (Table 5) and they anneal at the 
same sequence on opposite strands of the plasmid. Typically, 20 ng of double-stranded DNA 
(dsDNA) was used and sample reactions were prepared with KOD DNA polymerase and 
125 ng of each primer. Cycling parameters were set as indicated on Table 7. Then, the 
amplification products were digested with 1 µl of the Dpn I restriction enzyme (10 U/µl) at 
37˚C for 1 hour. Transformation of XL1-Blue was performed as described in 3.6.4 with 1 µl 
of the Dpn I treated DNA. All constructs were veriﬁed by sequencing (Eurofins Genomics). 
 
Table 7. PCR programme for the QuickChange site-directed mutagenesis method 
Cycles Temperature Time 
1 95˚C 30 sec. 
16 
95˚C 30 sec. 
55˚C 1 min. 
68˚C 5 min 
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3.4. Biochemical Methods 
3.4.1. Cellular subfractionation 
3.4.1.1. Isolation of Zymogen Granules 
ZG were isolated from the pancreas of male Wistar rats (200-230 g) (Charles River, 
Sulzfeld, Germany) which were fasted overnight. Tissue homogenization was performed in 
zymogen granule homogenization buffer. 4-6 Pancreata were individually minced with a 
scissor on 1 ml of homogenization buffer. Then the total volume was made up to 10 ml with 
homogenization buffer and it was further homogenized on ice using a brendle type 
homogenizer (Yellow line, OST20 Digital, Imlab, Belgium). The homogenate was 
transferred to conical glass tubes, centrifuged for 10 min, 4°C at 500×g, and the resulting 
post nuclear supernatant was further centrifuged for 10 min, 4°C at 2000×g to sediment ZG. 
The brownish layer of mitochondria on top of the pellet was removed by resuspending in 
homogenization buffer. The white zymogen granules in the bottom were collected in 
homogenization buffer. Tissue homogenization was repeated 2-3 times. The collected ZG 
fractions were combined and centrifuged for 20 min, 4 °C at 2000×g. The final ZG pellet 
was resuspended (2-3 ml) in HEPES buffer and frozen at -20˚C. All centrifugation steps 
were performed in an Eppendorf centrifuge 5810R (Eppendorf, Hamburg, Germany) with a 
swinging bucket rotor.  
 
3.4.1.2. Zymogen Granule Subfractionation 
Isolated granules (in HEPES buffer) were carefully lysed by freezing and thawing 
and separated into zymogen granule content (ZGC) and membrane (ZGM) fractions by 
centrifugation at 100000×g for 30 min in a swinging-bucket rotor (SW50.1) (Beckman 
Coulter, Fullerton, USA). The membranes were rinsed and resuspended in HEPES buffer 
and treated with 150 mM Na2CO3, pH 11.5 for 2 h on ice. Treated membranes (ZGMcarb) 
were recovered by centrifugation at 100000×g for 30 min and thereby separated from 
peripheral membrane proteins (Wash). Isolated ZGMcarb were resuspended in 50 mM 
HEPES, pH 8.0. 
Alternatively, puriﬁed ZG were resuspended in HEPES buffer with 80 mM KCl, 
carefully lysed by freezing and thawing and centrifuged through a 0.3/1 M sucrose step 
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gradient for 1 h, 4°C at 200000×g (Beckman 80 Ti rotor). ZGM were recovered at the 
interface and washed twice in HEPES buffer or in 100 mM NaHCO3, pH 8.1. After each 
washing step, ZGM were recovered by centrifugation for 1 h, 4°C at 150000×g (Beckman 
80 Ti rotor). Finally, membranes were rinsed and resuspended in HEPES buffer.  
A microsome-enriched fraction was obtained from a pancreas homogenate after 
subcellular fractionation and ultracentrifugation (100000×g for 1 h, 4°C; Beckman SW50.1). 
 
3.4.2. Determination of protein concentration 
Protein concentrations were determined using the Bradford assay (Bradford 1976). 
Standards containing 1 to 20 µg BSA, blank, and samples (1 to 10 µl) were filled up to 100 
µl with 0.1 M NaOH. Protein assay solution (Bradford) (Biorad, California, USA) was 
diluted 1:5 with distilled water and 1 ml of the solution was added to each sample. All 
standards and samples were prepared as triplicates. After 15 minutes of incubation at room 
temperature the absorption at 595 nm compared to the blank was measured. Using the 
standard curve prepared from the mean values, the protein concentration of the samples was 
calculated. Assays were run with a recording spectrophotometer (Ultraspec 100 pro, 
Amersham Biosciences, Uppsala, Sweden). 
 
3.4.3. Protein precipitation 
Routinely, precipitation was performed using trichloroacetic acid (TCA) by mixing 
(1:1) the sample (if below 100 µl the volume was completed with distilled water) and 20% 
(w/v) TCA. The mixture was then incubated on ice for 15-20 min and centrifuged for 5 min 
at 13000 rpm, 4˚C and the supernatant was discarded. The resulting pellet was washed with 
5% TCA, centrifuged for 2 min at 13000 rpm, 4˚C and the supernatant was discarded. The 
pellet was re-washed with distilled water and centrifuged as before. Finally, the pellet was 
washed with 500 µl of ice-cold acetone, centrifuged for 15 min at 13000 rpm, 4˚C and the 
supernatant was discarded. Samples were then air-dried and resuspended in the suitable 
buffer (e.g. SDS-PAGE loading buffer). 
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3.4.4. Enterokinase assay 
Isolated ZG or ZG fractions (ZGM, ZGC, Wash) with concentration of 5 µg/µl were 
incubated with and without Enterokinase (0.02 units) (Sigma-Aldrich, Karlsruhe, Germany) 
in HEPES buffer (pH 8.0), 37˚C for 24 h or 48 h. After digestion, 40 µg of total protein were 
analysed by SDS-PAGE on 15% acrylamide gels 
 
3.4.5. Digestion of HMyc-ZG16dSP and H-ZG16dSP with trypsin 
3 µg of recombinant protein were mixed with 30 ng of sequence grade modiﬁed 
porcine trypsin (Promega, Madison, USA) prepared in 25 mM ammonium bicarbonate and 
incubated overnight at 37˚C. Then the sample was mixed with SDS-PAGE loading buffer, 
analysed by SDS-PAGE gel and stained with Coomassie blue. The Wash subfraction from 
ZG (40 µg) was used as endogenous ZG16p control. For immunoblot analysis 1/10 of the 
sample was separated by SDS-PAGE.  
 
3.4.6. Sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Standard SDS-PAGE was performed with 15% polyacrylamide (PA) separating and 
5% PA stacking gels. Gel electrophoresis in mini gel chambers was conducted for 
approximately 1 h at 180 V until the running front (bromophenol blue) reached the bottom 
of the gel. The gel chambers were filled with 1x SDS running buffer (3.1). Several protein 
molecular weight markers were used according to final application of the gel: for Coomassie 
blue staining the BenchMark™ protein ladder (Invitrogen, Carlsbad, USA) was used; for 
immunoblotting the Precision Plus Protein™ Kaleidoscope™ standards (BioRad) were 
applied. 
 
3.4.7. Sample preparation for SDS-PAGE  
Typically samples were prepared with SDS-PAGE loading buffer (3.1), heated at 
95˚C for 5 min and loaded on the SDS-PAGE gel. Alternatively, samples were prepared on 
SDS-PAGE loading buffer, heated at 37˚C or 65˚C for 5 min or heated at 95˚C for 10 min, 
previous to gel loading. 
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3.4.8. Bidimensional gel electrophoresis (2D-GE) 
The ﬁrst dimension of 2D-GE was performed in a horizontal apparatus (Ettan 
IPGphor, GE Healthcare, San Francisco, USA). Granule subfractions were precipitated with 
TCA (3.2.2). Protein samples (300 µg) were solubilized for 30 min at 30 °C in rehydration 
buffer (3.1). The samples were then applied onto IPG strips (11 cm, pH 3-11) and isoelectric 
focusing was conducted at 20 °C with 50 µA, for a minimum of 10 h at 50 V, 1 h at 500 V, 
1 h at 1000 V and 110 min at 8000 V. The strips were afterwards incubated for 15 min in 
equilibration buffer (3.1) and then applied on top of a SDS-PAGE gel (14 cm by 14 cm, 15% 
PAA). Proteins were separated according to molecular weight in a Hoefer 600 SE RUBY 
chamber (GE Healthcare, Connecticut, USA), 200 V for 3-4 hours.  
 
3.4.9. Staining with Colloidal Coomassie Brilliant Blue G-250  
Gels were fixed agitating for 30 min in 10% (v/v) acetic acid and 40% (v/v) methanol, 
followed by a washing step in distilled water. Staining was performed for 2 h in 0.32% (w/v) 
Coomassie G250 in 20% (v/v) methanol. To wash out unbound Coomassie-G250 and 
visualize protein bands, gels were destained by washing in dH2O for 1-2 min followed by 
several times washing in destaining solution containing 25% (v/v) methanol. Gels were then 
kept in dH2O and scanned with a Bio-Rad GS-710 Calibrated Imaging Densitometer. 
 
3.4.10. Alcian Blue Staining 
Gels were fixed and stained overnight with 0.5% (w/v) alcian blue in 2% (v/v) acetic 
acid and destained with distilled water. Gels were then kept in dH2O and scanned with a Bio-
Rad GS-710 Calibrated Imaging Densitometer. 
 
3.4.11. Immunoblotting 
Protein transfer from SDS-PAGE gels to the membrane was performed by semidry 
Western blotting (Trans-Blot SD, Biorad) (Kyhse-Andersen 1984). The nitrocellulose 
membrane and two Whatman filter papers (3 mm) were soaked with semidry blotting buffer 
(3.1) and a stack of Whatman filter, membrane, gel, and Whatman filter was formed. Air 
bubbles in between the layers had to be removed to guarantee complete transfer. The stack 
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was put into a semidry transfer chamber and the proteins were blotted for 45 minutes at 12 
V. Next, the membrane was blocked by incubation with 5% low fat powdered milk in PBS 
for 1 h. For incubation with the primary antibody the membrane was sealed into a plastic 
bag with the respective antibody dilution in PBS and incubated with shaking over night at 
4°C or for 2 to 3 h at room temperature. Afterwards the membrane was washed three times 
for 10 minutes to remove excess (unbound) antibody. The incubation with the secondary 
antibody was performed for 1 to 2 h at room temperature. For the ECL (Amersham, New 
Jersey, USA) reaction, ECL 1 (containing luminol) and ECL 2 (phenol-containing enhancer) 
solutions were mixed (ratio 1:1) and the membrane was incubated for 1 min. Film exposure 
(1 to 30 minutes), development and fixation (Carestream® Kodak® autoradiography GBX 
developer/fixer, Sigma-Aldrich) were performed in a light protected environment. For 
presentation and quantification the films were scanned with a Bio-Rad GS-710 Calibrated 
Imaging Densitometer and densitometric analysis for quantification was done using Bio-Rad 
Laboratories Quantity One software.  
 
3.4.12. Reprobing of immunoblots 
Reprobing of immunoblots was done after inactivation of peroxidase activity of the 
secondary antibody as described by Sennepin et al. 2009. Typically, the irreversible HRP 
inhibition was performed by incubating the membrane (48 cm2) for 30 min with 2 ml of 30% 
H2O2 (Sigma-Aldrich) at 37˚C.  
 
3.4.13. Co-Immunoprecipitation 
Usually, two confluent 100 mm dishes of COS-7 cells transfected with GFP-
ZG16dSP_K, GFP-ZG16dSP or GFP by electroporation (3.4.6) were used. The cells were 
washed with PBS and carefully harvested in a total volume of 3 ml PBS by scraping. All 
further steps were performed on ice. A cell pellet was prepared by centrifugation (5 min, 
500×g) and resuspended in 500 µl lysis buffer containing protease inhibitors. The cells were 
lysed by passing ten times through a 26 G needle followed by overhead rotation for 30 
minutes at 4°C. In order to remove DNA and cell debris the lysate was cleared by 
centrifugation at 13000 rpm and 4°C for 15 minutes. Co-immunoprecipitation was 
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performed either by using Pureproteome™ magnetic beads (Merck Millipore, Darmstadt, 
Germany) or the GFP-Trap® (Chromotek, Munich, Germany).  
Incubation of GFP-ZG16dSP_K and GFP with HMyc-ZG16p before co-
immunoprecipitation was done by adding 2 µg of recombinant protein to cell lysate and 
incubating on ice for 2 h with gentle mixing every 10 min.  
 
Lysis buffer, pH 7.5: 25 mM Tris-HCl; 50 mM Sodium chloride; 0.5% (w/v) Sodium 
deoxycholate; 0.5% (w/v) Triton X-100 
Dilution/Wash buffer, pH 7.5: 10 mM Tris-HCl; 150 mM NaCl; 0.5 mM EDTA 
 
3.4.14. Pureproteome™ magnetic beads  
The cell lysate was diluted with 750 µl of dilution buffer in order to keep the final 
concentration of detergent below 0.2%. An aliquot of 50 µl of the lysate was saved to use as 
expression control in immunoblot analysis (SN1). Then, 2 µl of the anti-GFP antibody (2 
mg/ml) was added to the lysate and incubated at 4˚C with over-head rotation for 2-3 h. 
PureProteome protein G magnetic beads were gently mixed to be uniformly resuspended 
and 25 µl of suspended beads were washed twice with 500 µl of PBS, added to the lysate 
and incubated for 30 min with over-head rotation at 4˚C. The beads were magnetically 
separated until the supernatant was clear. 50 µl of the supernatant were saved to use in 
immunoblot analysis (SN2). The beads were washed twice with 500 μl of dilution buffer. 
The beads were resuspended in 50 μl of 2x SDS-PAGE loading buffer and boiled for 10 min 
at 95˚C. 25 µl were loaded in a SDS-PAGE gel and analysed by immunoblotting. 
 
3.4.15. GFP-Trap®  
The cell lysate was diluted with 750 µl of dilution buffer in order to keep the final 
concentration of detergent below 0.2%. An aliquot of 50 µl of the lysate was saved to use as 
expression control in immunoblot analysis (SN1). GFP-Trap®_M beads were gently mixed 
to be uniformly resuspended and 20 µl of suspended beads were washed twice with 500 µl 
of PBS, added to the lysate and incubated for 30 min with over-head rotation at 4˚C. The 
beads were magnetically separated until the supernatant was clear. 50 µl of the supernatant 
were saved to use in immunoblot analysis (SN2). The beads were washed twice with 500 μl 
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of dilution buffer. The beads were resuspended in 50 μl of 2x SDS-sample buffer and boiled 
for 10 min at 95˚C. 25 µl were loaded in a SDS-PAGE gel and analysed by immunoblotting. 
 
3.4.16. Cross-linking  
4 mg of DSP (dithiobis[succinimidyl propionate]) were freshly dissolved in DMSO 
(dimethyl sulfoxide) and added drop-wise to 10 ml of PBS resulting in a final concentration 
of 400 µg/ml. Before harvesting the cells (see Chapter 3.4.13) they were incubated with DSP 
solution for 30 minutes at room temperature. DSP reactivity was quenched by incubation 
with 1 ml of 500 mM of Tris-HCl, pH 7.4 for 15 min.  
 
3.4.17. Purification of His-tagged proteins 
DNA fragments encoding rat ZG16p (amino acid residues 17-167) and rat Myc-
ZG16p (amino acid residues 17-167) were subcloned in pET28b vector. The plasmid 
constructs were transformed into Escherichia coli Rosetta (DE3) and colonies were screened 
for protein expression. Plasmids from selected colonies were verified by sequencing.  
For protein expression and purification bacteria were grown overnight in 5 ml of LB 
medium at 37˚C. Then 250 ml of fresh LB medium was inoculated with 2.5 ml of the grown 
culture and incubated with agitation at 37˚C until the OD600 reached ~0.6. Protein expression 
was induced with 1 mM of IPTG and culture was further incubated at 37˚C with shaking for 
3 h. The bacteria were collected by centrifugation at 6000×g for 15 min, 4˚C. The pellet was 
resuspended in 5 ml of lysis buffer and the cells were lysed by sonication (15 s pulses, 50% 
amplitude per cycle) with an ultrasonic probe sonicator. The lysate was cleared by 
centrifugation at 12000×g for 30 min, 4˚C. The supernatant was collected and used for 
protein purification with the Talon® single step column (5 ml). The resin was first washed 
with 5 ml of distilled water and then equilibrated with 5 ml of equilibration buffer. The 
bottom closure was placed on the column and 5 ml of the supernatant were loaded in the 
column. The column was closed with the top cap and the suspension was mixed by overhead 
rotation for 30 min, 4˚C. The resin was allowed to settle, the top cap and the bottom closure 
were removed and the liquid allowed to drain by gravity flow. Then, the resin was washed 
twice with 5 ml of washing buffer 1, followed by washing with 5 ml of washing buffer 2. 
The purified protein was eluted with 5 ml of elution buffer. 500 µl fractions of the second 
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wash and the elution were collected for protein analysis. The most pure fractions of 
recombinant proteins were selected, combined and dialyzed against PBS, pH 7.4. 
 
Lysis buffer / equilibration buffer / washing buffer 1: 50 mM sodium phosphate; 300 mM 
NaCl; pH 8.0 
Washing buffer 2: 50 mM sodium phosphate; 300 mM NaCl; 10 mM imidazole; pH 8.0 
Elution buffer: 50 mM sodium phosphate; 300 mM NaCl; 150 mM imidazole; pH 8. 
 
3.4.18. Tryptic Digestion 
The protein spots were excised from the gels and washed three times with 25 mM 
ammonium bicarbonate/50% acetonitrile (ACN), one time with ACN and dried. 25 µL of 10 
µg/mL sequence grade modiﬁed porcine trypsin in 25 mM ammonium bicarbonate were 
added to the dried gel pieces and the samples were incubated overnight at 37 °C. Extraction 
of tryptic peptides was performed by adding 10% formic acid (FA)/50% ACN (3x) being 
lyophilized in a SpeedVac (Thermo Fisher Scientiﬁc, Asheville, NC). Tryptic peptides were 
resuspended in 13 µL of a 50% acetonitrile/0.1% formic acid solution.  
 
3.4.19. Mass Spectrometry 
Aliquots of samples (0.5 µL) were spotted onto the MALDI sample target plate and 
mixed (1:1) with a matrix consisting of a saturated solution of α-cyano-4-hydroxycinnamic 
acid (5 mg/mL) prepared in 50% acetonitrile/0.1% formic acid. Peptide mass spectra were 
obtained on a MALDI-TOF/TOF mass spectrometer (4800 Proteomics Analyzer, Applied 
Biosystems, Europe) in the positive ion reﬂector mode. Spectra were obtained in the mass 
range between 800 and 4500 Da with ca. 1500 laser shots. For each sample spot, a data 
dependent acquisition method was created to select the six most intense peaks, excluding 
those from the matrix, trypsin autolysis, or acrylamide peaks, for subsequent MS/MS data 
acquisition. Trypsin autolysis peaks were used for internal calibration of the mass spectra, 
allowing a routine mass accuracy of better than 20 ppm. Spectra were processed and 
analyzed by the Global Protein Server Workstation (Applied Biosystems, Foster City, CA), 
which uses internal Mascot (Matrix Science Inc., Boston, MA) software for searching the 
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peptide mass ﬁngerprints and MS/MS data. Searches were performed against the NCBI non 
redundant protein database. 
 
3.4.20. Liquid Chromatography  
Analyses were performed using an Ultimate 3000 ‘‘LcPackings’’ (Thermo Scientific, 
California, USA). 20 µl of each sample (3 µg of peptide extract) were injected onto a C18 
trapping column (Zorbax 300SB-C18, 5 µm particle size, 5 x 0,3 mm, Agilent Technologies) 
using an autosampler. The sample was washed over the trapping column for 3 min with 95% 
buffer A (water, 0.1% TFA), 5% Buffer B (acetonitrile, 0.1% TFA) at a flow rate of 30 
μl/min. Flow was then reversed over the trapping column, and sample was eluted onto a 150 
mm × 75 μm Zorbax 300SB capillary analytical C18 column with 3.5-μm particle size 
(Agilent Technologies) at a flow rate of 0.3 μl/min. A linear gradient of 5% Buffer B to 55% 
Buffer B was run over a period of 35 min. The column was then washed with a 3 min gradient 
from 55% to 90% Buffer B, followed by a 5-min hold at 90% Buffer B. The column was 
then re-equilibrated in 5% Buffer B prior to future analyses. The peptides eluting off the 
monolithic capillary column were directly deposited onto 384-well MALDI plates at 20 s 
intervals for each spot using Probot (LcPackings) adding 170 nl of α-CHCA (α-Cyano-4-
hydroxycinnamic acid) (Sigma-Aldrich) matrix solution (prepared by diluting saturated α-
CHCA with 70% acetonitrile/0.1% TFA with the addition of 10 fmol of Glu-Fib as internal 
standard).  
 
3.5. Cell Culture and Transfection Experiments  
3.5.1. Cell lines  
 
COS-7 
Source: ATCC (Rockville, USA) no. CRL-1651  
Cercopithecus aethiops (African green monkey), kidney 
SV40 transformed, produce large T antigen, 
Adherent, fibroblast morphology   
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HepG2  
Source: ATCC (Rockville, USA) no. HB-8065  
Homo sapiens (human), liver  
Hepatoblastoma cells  
Adherent, epithelial morphology 
 
AR42J 
Source: ATCC (Rockville, USA) no. CRL-149 
Rattus norvegicus (Wistar strain), pancreas 
Pancreatic exocrine tumor 
Adherent when plated on matrigel coated surfaces. Differentiation into acinar-like cells with 
formation of zymogen granules can be induced with dexamethasone  
 
3.5.2. Cell culture  
COS-7, AR42J, and HepG2 cells were cultured in Dulbecco’s modified Eagle 
medium (DMEM) high glucose (4.5 g/l) supplemented with fetal bovine serum and (FBS) 
penicillin (100 U/mL)/streptomycin (100 µg/mL) (PAA Laboratories GmbH, Linz, Austria) 
at 37 °C in a 5% CO2-humidiﬁed incubator. Cell culture work was performed in a sterile 
laminar flow safety cabinet and all materials and solutions were sterilized by filtration, 
autoclaving or heat sterilization. Routinely, cells were grown in 100 mm in diameter dishes 
and seeded on coverslips in 60 mm in diameter dishes for immunofluorescence experiments. 
To improve cell adherence of AR42J cells, the culture dishes were coated with an extract of 
Engelbreth-Holm-Swarm tumour (Kleinman, H. 1979). To induce differentiation and 
zymogen granule formation, cells were incubated with 10 nM dexamethasone for 2-3 days. 
 
3.5.3. Cell passage  
Routinely, passaging or splitting of cell was performed twice per week, after the cells 
reached confluency (~1.7x104 cells/cm²). Cells were washed with PBS and incubated with 
2 ml trypsin EDTA solution (0.5 mg/ml trypsin and 0.22 mg/ml EDTA) for 3-5 minutes at 
37°C. Cells were resuspended in 8 ml medium containing FBS and pelleted by centrifugation 
for 5 minutes at 500×g. The pellet was resuspended in medium and cells were seeded as 
single cell suspension in a dilution of 1:10 (104 cells/ml).  
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3.5.4. Cell freezing  
For long term storage, cells were frozen and stored in the vapour phase of liquid 
nitrogen. Cell pellets prepared as described above (3.4.3) were resuspended in freezing 
medium containing 20% FBS and 10% DMSO to avoid crystal formation. Cell suspension 
aliquots of 1 ml were filled into cryovials, slowly frozen overnight at -80˚C and subsequently 
transferred into the liquid nitrogen storage tank. For unfreezing, cells were thawed quickly 
in a water bath (37˚C) or by mixing with pre-warmed culture medium, and the cells were 
seeded with pre-warmed medium in a regular dish. After adhesion of the cells to the bottom 
of the dish, the medium was changed to remove DMSO and debris. 
 
3.5.5. PEI transfection  
For morphological experiments, like immunofluorescence studies, COS-7 cells were 
usually transfected using PEI (polyethylenimine) (Sigma). 24 hours before transfection cells 
were seeded on coverslips in 60 mm dishes. 10 µg DNA were diluted in 750 µl 150 mM 
sodium chloride, and 100 µl PEI (0.9-1 mg/ml in water) were diluted with 650 µl sodium 
chloride solution. After 15 minutes of incubation at room temperature the PEI solution was 
added drop-wise to the DNA solution and the mixture was incubated for additional 15 
minutes. 500 µl of the mixture were added drop-wise to 2.5 ml medium into the cell dish 
and the cells were incubated for 3 to 6 hours at 37°C. Afterwards cells were washed with 
PBS and incubated for 24 to 48 hours in fresh medium before fixation and processing for 
immunofluorescence (3.5.1).  
 
3.5.6. Electroporation  
A confluent dish of cells was trypsinized as described in 3.4.3. The cell pellet was 
washed by resuspension in 5 ml HBS buffer (3.1) and re-centrifuged. The cell pellet was 
resuspended in 1 ml HBS buffer and 0.5 ml of this cell suspension was mixed with DNA (10 
µg) in a 4 mm gap electroporation cuvette. Electroporation of COS-7 cells was performed at 
230 V, 1500 µF, and 125 Ω. Subsequently, the cells were mixed quickly with 1 ml of 
complete medium and seeded in dishes prepared with pre-warmed medium.  
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3.5.7. Turbofect™ transfection 
For morphological experiments like immunofluorescence studies in AR42J and 
HepG2 cells were usually transfected using Turbofect™ (Fermentas). 24 hours before 
transfection cells were seeded on coverslips in 60 mm dishes. 4 µg DNA were diluted in 400 
µl DMEM and 6 µl of Turbofect™ were added. After 20 minutes of incubation at room 
temperature the mixture was added drop-wise into the cell dish with 3.6 ml of DMEM and 
the cells were incubated for 3 to 6 hours at 37°C. Afterwards cells were washed with PBS 
and incubated for 24 to 48 hours in fresh complete medium before fixation and processing 
for immunofluorescence (3.5.1).  
 
3.6. Microscopic techniques 
3.6.1. Immunofluorescence  
Cells grown on coverslips were washed twice with PBS to remove residual medium 
and fixed with 4% paraformaldehyde (PFA) (3.1) for 20 minutes at room temperature. The 
cells were washed tree times with PBS and washing was performed in between all further 
incubation steps. Cellular membranes were permeabilized using 0.2% Triton X-100 for 10 
minutes. Afterwards unspecific binding sites were blocked by incubation with 1% BSA for 
10 minutes. Incubation with the primary antibodies (Table 1) was performed for 1 hour in a 
humid and dark environment to avoid drying of the cells, followed by incubation with the 
secondary antibodies (Table 2) in the same way. If a set of several (primary or secondary) 
antibodies was used, the incubation occurred simultaneously. The coverslips were washed 
with distilled water to avoid crystal formation of the salts present in PBS, mounted on glass 
slides using Mowiol and dried overnight before microscopic examination. 
 
3.6.2. Fluorescence microscopy  
For morphological studies an Olympus BX-61 microscope (Olympus Optical Co. 
GmbH, Hamburg, Germany) equipped with the appropriate ﬁlter combinations and a 100× 
objective (Olympus Plan-Neoﬂuar; numerical aperture, 1.35) was used. Digital images were 
acquired with an F-view II CCD camera (Soft Imaging System GmbH, Munster, Germany) 
driven by Soft imaging software.  
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3.6.3. Confocal microscopy  
Confocal images were acquired on a Zeiss LSM510 confocal microscope (CarlZeiss, 
Oberkochen, Germany) using a Plan-Apochromat 63X or 100X /1.4 oil objective. Images 
were processed and quantiﬁed using LSM- 510 software (Carl Zeiss MicroImaging, Inc.). 
Background noise was minimal when optimal gain/offset settings for the detectors were 
used. 
 
3.6.4. Live cell imaging  
The Zeiss LSM-510 confocal microscope was equipped with a closed chamber which 
was aerated with 5% warm (37°C) CO2 to create normal culture conditions. Cells growing 
in glass bottom dishes in medium without phenol red were placed in a heated chamber and 
live cell time-lapse imaging was performed. Images were taken in time intervals of 13 
seconds. 
 
3.6.5. TexasRed-transferrin 
COS-7 cells grown on coverslips were incubated in serum-free medium for 2 hours, 
37˚C. The medium was replaced by DMEM with 20 mM HEPES buffer and the cells were 
incubated for 30 min at 37˚C. Then the medium was replaced with DMEM with 1% BSA 
and 100 nM of TexasRed-transferrin (TexasRed-tf) and the cells were incubated for 30 min 
at 37˚C. The cells were cooled to 4˚C, washed twice with ice-cold PBS and fixed with 4% 
PFA. The coverslips were washed with distilled water to avoid crystal formation of the salts 
present in PBS, mounted on glass slides using Mowiol and dried overnight before 
microscopic examination.  
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4. Results 
 
Zymogen granules (ZG) are specialized storage organelles within the acinar cells of 
the exocrine pancreas. Their main cargo is constituted by pancreatic digestive enzymes as 
inactive precursors which are released by regulated apical secretion, triggered by an external 
stimulus. ZG formation is initiated at the trans-Golgi network (TGN) where the regulated 
secretory ZG proteins co-aggregate at the mildly acidic pH and high Ca2+ levels and 
condensing vacuoles/immature secretory granules are formed (Colomer et al., 1996; Dartsch 
et al., 1998; Freedman and Scheele, 1993; Leblond et al., 1993). Their maturation involves 
further concentration of the cargo proteins with selective removal of components not 
destined for regulated secretion, and a reduction in granule size (Arvan and Castle, 1998; 
Borgonovo et al., 2006; Tooze et al., 2001). The mature ZGs are transported to the apical 
domain of the acinar cell, where they are stored until a neuronal or hormonal stimulus (e.g., 
acetylcholine and cholecystokinin) releases intracellular calcium stores, thus triggering the 
fusion of ZGs with the plasma membrane and with neighbouring granules (compound 
exocytosis). Fusion results in exocytosis of digestive enzymes into the apical lumen and the 
pancreatic duct system (Wasle and Edwardson, 2002; Williams, 2006). Although the ZG has 
long been a model for the understanding of secretory granule biogenesis and functions, the 
molecular mechanisms required for ZG formation at the TGN, for packaging and sorting of 
cargo proteins, as well as for granule fusion and exocytosis are still poorly deﬁned 
(Borgonovo et al., 2006; Borta et al., 2010; Schrader, 2004; Williams, 2006). According to 
recent models, part of the molecular machinery required for digestive enzyme sorting, 
granule trafﬁcking and exocytosis is supposed to be associated with the zymogen granule 
membrane (ZGM). The submembranous matrix model predicts high molecular mass 
components (e.g. a proteoglycan scaffold and associated (glyco)proteins) attached to the 
luminal side of the granule membrane which fulfil important functions during the sorting 
and packaging of secretory proteins (Scheele et al., 1994; Schrader, 2004). The 
glycoconjugate scaffold underneath the ZGM is supposed to serve as the backbone of a 
complex submembrane matrix, and a bridge between the ZGM and the zymogens. In 
addition to basic research interests, ZG play important roles in pancreatic injury and disease 
(Gaisano and Gorelick, 2009; Parikh et al., 2012). Thus, there is currently great interest in 
the identiﬁcation and characterization of ZG and ZGM components by conducting antibody 
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screens, raft analyses and proteomic studies (Borta et al., 2010; Faust et al., 2008; Rindler et 
al., 2007; Schmidt et al., 2000, 2001; Sun and Jiang, 2013).  
In the first part of the work I have focused on the identiﬁcation of a “basic” group of 
peripheral granule membrane proteins from rat exocrine pancreas (4.1). In the second part I 
have discovered and characterized new biochemical properties of the lectin ZG16p (a 
component of the submembranous matrix) (4.2). The last section presents functional 
analyses of ZG16p by expression and mutational studies in mammalian cells (4.3).  
 
4.1. Identification of peripheral membrane proteins of zymogen 
granules 
To understand the biogenesis and further processing of pancreatic ZG as well as their 
role in disease a deep analysis of their proteome is required. We focused on the analysis of 
membrane-associated ZG proteins by applying a suborganellar proteomics approach to 
identify peripheral membrane-associated ZG proteins (Figure 7 A-D). Zymogen granules 
were isolated from rat pancreas according to a standardized protocol (Dartsch et al., 1998; 
Faust et al., 2008; Schmidt et al., 2000). The purity of the isolated ZG fractions (≥ 90%) was 
controlled by electron microscopy and immunoblotting (Faust et al., 2008; Gómez-Lázaro 
et al., 2010). Intact granules were gently lysed and further separated in a membrane (ZGM) 
and content fraction (ZGC). The isolated membranes (ZGM) were treated with carbonate to 
liberate membrane-associated proteins and separated in a pellet (ZGMwashed) and 
supernatant fraction (Wash) (see Chapter 3.4.1.2). To characterize the ZG peripheral 
membrane-associated proteins, 2D gel maps were generated for the supernatant fraction 
(Wash) of carbonate-washed ZGM. For comparison typical 2D gel patterns of the Wash and 
the content subfractions (ZGC) separated under equal conditions are shown in Figure 7.  
Note that the representative gels exhibit unique spot patterns for the two different 
subfractions. In a representative gel for the Wash fraction about 104 spots were reproducibly 
visualized, which represent an acidic and more basic group of ZG protein spots (Figure 7 B 
and D). We focussed on the analysis of the spots from the “basic” group (pH range 6.2-11). 
In this region, 46 spots were visualized among which 44 were identified by tandem mass 
spectrometry (Figure 7 D, Supplementary Table 1).  
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Figure 7. Separation of rat ZG content and ZGM Wash subfractions by two-dimensional IEF/SDS-PAGE. The 
whole complement of ZGC (A) and the supernatant fraction (Wash) (B, D) of carbonate-treated ZGM were 
subjected to 2D-PAGE followed by Coomassie blue staining. For IEF, 300 µg of protein were separated on 11 
cm IPG strips (pH 3-11NL) and on 15% polyacrylamide gels in the 2nd dimension. Note the differences in the 
spot pattern of ZGC (A) and the Wash fraction (B). The boxed areas in (B, C) highlight basic protein spots 
(chymase, PpiB, RNase A) which have been selected for further analysis and are verified by immunoblotting 
(C) using specific antibodies to rat mast cell chymase, PpiB, and RNase A. The boxed region (D) highlights 
the basic protein spots (B1-46) analysed by MS.  
The identified spots corresponded to 16 unique proteins (Figure 8 A), which were 
categorized in 6 groups based on their known subcellular localization: ZGC (n=6; 38%) and 
ZGM (n=6; 38%) proteins, mast cell proteins (n=1; 6%), ER resident proteins (n=1; 6%), 
and proteins with other localizations (n=2; 12%) (Figure 8 B). Considering their predicted 
biological functions we identified 12 enzymes including 9 digestive enzymes (usually 
attributed to the ZGC), 2 matrix proteins (ZG16p, syncollin) and 3 slightly acidic 
glycoproteins (CEL, pancreatic lipase related protein 1 and 2). Based on literature and the 
Protein Knowledgebase (UniProtKB), all of the identified proteins are soluble or peripheral 
D 
A B C 
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membrane proteins, and no transmembrane or membrane-anchored proteins have been 
identified in the Wash fraction. Furthermore, except for two cytosolic proteins (vinculin 
(fragment), an actin-binding protein, and ubiquitin carrier protein involved in 
ubiquitination/quality control) all identified proteins are supposed to be components of the 
secretory pathway. This further confirms the applicability of the carbonate and gel-based 
proteomic approach.  
 
Figure 8. (A) Proteins identified from the “basic group” of a ZGM carbonate Wash fraction. Functional 
annotation and organelle assignments were made using the UniprotKB database, additional annotation was 
incorporated from literature search. Extra information supporting the identification of the potential ZGM 
proteins is summarized in Supplementary Table 1. (B) Diagram illustrating the intracellular distribution of the 
identified proteins of the Wash fraction. On the basis of published data, annotations in databases or predictions 
based on similarity to related proteins, the identified proteins are grouped in a pie chart according to their 
subcellular distribution and function.  
In addition, some classical content proteins such as amylase, elastase, colipase and 
triacylglycerol lipase were identified in the Wash fraction (Figure 8, Supplementary Table 
1). This can be due to a cross-contamination of the subfractions or due to the fact that the 
A 
B 
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interactions established between the proteins from the different subfractions are not 
completely disrupted in the separation procedure. The identification of some abundant 
theoretical acidic proteins within the “basic” group (e.g., CEL, lipase related protein 1) is 
likely to be a result of protein degradation and/or glycosylation. 
To validate our suborganellar proteomic data, we selected three proteins for further 
characterization: chymase, PpiB and RNase A. Chymase (RMCP-1) and peptidyl-prolyl cis-
trans isomerase B (PpiB; cyclophilin B) are likely to be previously unknown genuine 
membrane-associated ZG proteins. Chymase was initially identified as a proteoglycan-
associated serine protease in granules of mast cells (Pejler and Berg, 1995; Pejler and 
Maccarana, 1994). In support of our findings, chymase was also identified in ZGM fractions 
in a proteomic study combining two-dimensional LC and tandem mass spectrometry (Chen 
et al., 2008). PpiB has been reported to be an ER-resident enzyme with proteoglycan-binding 
properties (Hanoulle et al., 2007; Iwai and Inagami, 1990). Furthermore, we selected RNase 
A originally known as a typical content protein of ZG, but prominently present in our Wash 
fraction. Based on the spot size, chymase and PpiB appear to be low abundant components 
of ZGM (Figure 7 D). To confirm their presence in our 2D gels and thus, their correct 
identification, immunoblotting was performed with the 2D-gels of the Wash fraction. As 
shown in Figure 7, the corresponding chymase, PpiB and RNase A spots identified by 
tandem mass spectrometry were recognized by specific antibodies after immunoblotting 
(Figure 7 C).  
 
4.1.1. Chymase and PpiB are novel peripheral ZGM proteins  
To compare the distribution of chymase and PpiB among granule subfractions, equal 
amounts of protein from the four granule subfractions (ZGC, ZGM, ZGMwashed and Wash) 
were separated on 12.5% acrylamide gels and immunoblotted using antibodies directed to 
chymase and PpiB (Figure 9). Furthermore, antibodies to the granule marker proteins 
amylase, CEL, RNase A, GP2, and ZG16p were used to monitor proper granule 
subfractionation. As shown in Figure 3, amylase was mainly present in the ZGC fraction, 
whereas GP2, a major GPI-anchored glycoprotein of ZG, was predominantly found in the 
ZGM fraction. The secretory lectin ZG16p, a peripheral ZGM protein (Cronshagen et al., 
1994), was concentrated on isolated ZGM, and a major portion was liberated by carbonate 
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treatment (Figure 3). Interestingly, chymase and PpiB showed a similar distribution pattern 
to ZG16p. Both enzymes were associated with isolated ZGM, but barely detectable in the 
ZGC fraction. Upon carbonate-treatment the majority of chymase and PpiB was removed 
from the ZGM and detected in the Wash fraction indicating that both proteins are peripheral 
components of the ZGM. Furthermore, we investigated the distribution of CEL and RNase 
A within the granule subfractions. Remarkably, the majority of CEL appears to be associated 
with the ZGM (Figure 9). However, only a small portion can be removed from the ZGM by 
carbonate treatment indicating that the enzyme is more tightly associated with the ZGM. 
This might be due to its affinity to lipid surfaces (Bruneau and Lombardo, 1995; Bruneau et 
al., 2000; Lombardo, 2001; Lombardo and Guy, 1980). In the case of RNase A, the majority 
of the enzyme is located in the ZGC fraction, but a surprisingly high amount (about 40%, 
Figure 9) is associated with the ZGM and can be liberated by carbonate treatment. Note that 
the ZGM associated portion of RNase A is much higher than that of membrane-associated 
amylase (13%, Figure 9).  
To exclude a contamination of the ZG subfractions with granules from mast cells 
(e.g., from pancreatic tissue), an antibody to tryptase β1, a prominent mast cell marker, was 
applied. A lysate of rat tongue, which is rich in mast cells containing chymase, was used as 
a positive control. In contrast to chymase, tryptase β1 was absent from the ZG subfractions. 
However, both tryptase β1 and chymase were detected in lysates of rat tongue. To check for 
contamination of the ZG subfractions with ER or ER-resident proteins, speciﬁc antibodies 
directed to the ER marker proteins BiP (GRP78, 78 kDa glucose regulated protein), PDI 
(protein disulﬁde isomerase) and calnexin (an abundant ER transmembrane protein) were 
applied. PpiB, BiP, PDI and calnexin were all detected in a microsome-enriched fraction 
which was used as a positive control. In contrast to PpiB, which was prominently labeled in 
the ZGM and Wash fractions, BiP and calnexin were below the detection level in all ZG 
subfractions. Interestingly, a small amount of PDI was detected in the ZGC fraction, but PDI 
was not detectable in all other ZG subfractions. This is consistent with morphological studies 
where small amounts of PDI have been detected in the ZG content. The presence of PDI is 
supposed to be due to occasional escape from the ER (Yoshimori et al., 1990). PpiB was as 
well identiﬁed in ZGM fractions in a recent proteomics report using 2D-GEP and LC-
MS/MS (Rindler et al., 2007). As PpiB is selectively enriched in the ZG or ZGM fraction, 
but calnexin, BiP and PDI are not (or are barely detectable), a contamination with ER appears 
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unlikely. In addition, other major microsomal proteins were not identiﬁed in our 2D gel 
analyses. These ﬁndings support the notion that PpiB is a bona ﬁde ZG protein and not the 
result of a contamination. 
 
Figure 9. Chymase and PpiB represent peripheral membrane proteins of rat ZG. (A) Lysed granules were 
separated into a content (ZGC) and membrane fraction (ZGM). In addition, isolated membranes were treated 
with Na2CO3 at pH 11.0 and separated into pellet (ZGMcarb) and supernatant (Wash) fractions. Equal amounts 
of protein (20 µg) were run on 12.5% acrylamide gels, blotted onto nitrocellulose membranes and incubated 
with antibodies to amylase (ZGC marker protein), GP2 (ZGM marker protein), ZG16p (peripheral ZGM 
marker protein), chymase, tryptase β1 (mast cell control), carboxyl ester lipase (CEL), RNase A, BiP and PDI 
(ER control) and PpiB. (B) Densitometric quantification of immunoblots shown in (A). The distribution to 
ZGC and ZGM (% of total ZGC + ZGM) as well as the distribution to ZGMcarb and Wash (% of total ZGM) 
is depicted (see also Supplementary Table 3). Note that the distribution of chymase and PpiB resembles that 
of ZG16p, a peripheral ZGM marker protein. A lysate from rat tongue and a microsome-enriched fraction 
(Micros.) served as controls for the detection of mast cell proteins and ER resident proteins, respectively.  
To exclude a contamination of the ZG subfractions with granules from mast cells 
(e.g., from pancreatic tissue), an antibody to tryptase β1, a prominent mast cell marker, was 
applied. A lysate of rat tongue, which is rich in mast cells containing chymase, was used as 
a positive control. In contrast to chymase, tryptase β1 was absent from the ZG subfractions. 
However, both tryptase β1 and chymase were detected in lysates of rat tongue. To check for 
A B 
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contamination of the ZG subfractions with ER or ER-resident proteins, speciﬁc antibodies 
directed to the ER marker proteins BiP (GRP78, 78 kDa glucose regulated protein), PDI 
(protein disulﬁde isomerase) and calnexin (an abundant ER transmembrane protein) were 
applied. PpiB, BiP, PDI and calnexin were all detected in a microsome-enriched fraction 
which was used as a positive control. In contrast to PpiB, which was prominently labeled in 
the ZGM and Wash fractions, BiP and calnexin were below the detection level in all ZG 
subfractions. Interestingly, a small amount of PDI was detected in the ZGC fraction, but PDI 
was not detectable in all other ZG subfractions. This is consistent with morphological studies 
where small amounts of PDI have been detected in the ZG content. The presence of PDI is 
supposed to be due to occasional escape from the ER (Yoshimori et al., 1990). PpiB was as 
well identiﬁed in ZGM fractions in a recent proteomics report using 2D-GEP and LC-
MS/MS (Rindler et al., 2007). As PpiB is selectively enriched in the ZG or ZGM fraction, 
but calnexin, BiP and PDI are not (or are barely detectable), a contamination with ER appears 
unlikely. In addition, other major microsomal proteins were not identiﬁed in our 2D gel 
analyses. These ﬁndings support the notion that PpiB is a bona ﬁde ZG protein and not the 
result of a contamination. 
To confirm that all of the content is solubilized and that aggregated zymogens do not 
sediment with the membranes, we have isolated ZG in a high salt buffer and recovered ZGM 
in a 0.3 M/1 M sucrose gradient without pelleting. The ZGM were as well more extensively 
washed either in 50 mM Hepes, pH 8.0 or in 100 mM NaHCO3, pH 8.1 (Figure 10).Whereas 
amylase was more efﬁciently removed from the ZGM fractions after extensive washing, the 
distribution of CEL, chymase and PpiB was not grossly altered by the different isolation 
procedures. The minor amount of amylase found in the ZGM fractions is as well an indicator 
for complete ZG lysis and solubilization of the granule content (at least of amylase-
containing complexes). Furthermore, membrane-association of some content proteins was 
also observed by others after more stringent washing/puriﬁcation conditions and gradient 
centrifugation (Chen et al., 2006; Rindler et al., 2007).  
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Figure 10. Distribution of granule proteins after isolation of ZGM by sucrose gradient centrifugation. (A) 
Purification scheme. Purified ZG were resuspended in 50 mM Hepes, pH 8.0, 80 mM KCl, gently lysed by 
freezing and thawing and centrifuged through a 0.3 M/1 M sucrose step gradient. ZGM were recovered at the 
interface and washed twice in 50 mM Hepes, pH 8.0 (ZGM H) or in 100 mM NaHCO3, pH 8.1 (ZGM HC). 
After each washing step, ZGM were recovered by centrifugation. Alternatively, ZGM were obtained by 
sedimentation as described in 3.4.1.2. (B) Equal amounts of protein (20 μg) were run on 12.5% acrylamide 
gels, blotted onto nitrocellulose membranes and incubated with antibodies to amylase, GP2, carboxyl ester 
lipase (CEL), chymase, and PpiB. Note that amylase is more efficiently removed from the ZGM fractions after 
extensive washing, whereas the distribution of CEL, chymase and PpiB is not grossly altered by the different 
isolation procedures.  
In summary, a 2D-gel approach combined with tandem mass spectrometry led to the 
identiﬁcation of membrane-associated proteins including classical ZG content proteins, lipid 
binding proteins as well as previously unknown low abundant proteins such as chymase, a 
serine protease earlier described in mast cell granules, and peptidyl-prolyl cis-trans 
isomerase B (PpiB), a known ER-resident enzyme. As we identiﬁed several peripheral ZGM 
proteins with proteoglycan-binding properties (e.g. ZG16p, chymase, PpiB, RNase A), our 
ﬁndings may help to unveil the possible role of proteoglycans in the sorting and packaging 
of zymogens. Furthermore, proteoglycans may also fulfil an important additional function 
after secretion. For example, the interaction of mast cell chymase with proteoglycans after 
B 
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degranulation has been shown to affect the kinetics of substrate cleavage and to protect 
chymase from several macromolecular protease inhibitors (Rönnberg et al., 2012).  
According to recent models, part of the molecular machinery required for digestive 
enzyme sorting, granule trafﬁcking and exocytosis is supposed to be associated with the 
granule membrane (ZGM). In addition to basic research interests, ZG play important roles 
in pancreatic injury and disease (Gaisano and Gorelick, 2009). Thus, there is currently great 
interest in the identiﬁcation and characterization of ZG and ZGM components.  
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4.2. Development and application of an Enterokinase assay 
Zymogen granules are specialized organelles in packaging, storage and regulated 
secretion of a complex mixture of digestive enzymes and isoenzymes. ZG contain a cocktail 
of proteases with five functional groups of hydrolytic enzymes: endoproteases (e.g., trypsin) 
and exoproteases (e.g., carboxypeptidase A), lipases (e.g., CEL), glycosidases (e.g., 
amylase) and RNases (e.g., RNase A). Those enzymes are released into the small intestine, 
where conversion of trypsinogen to trypsin is mediated by proteolytic cleavage via 
enterokinase (EK) (Gómez-Lázaro et al., 2010; Zheng et al., 2009). Enterokinase is a type II 
transmembrane serine protease, localized to the brush border of the duodenal and jejunal 
mucosa. Enterokinase converts trypsinogen to trypsin by cleavage of the specific 
trypsinogen activation peptide and then trypsin subsequently activates other digestive 
zymogens (Figure 11) in the lumen of the gut (Zheng et al., 2009).  
 
Figure 11. Scheme of protease activation by enterokinase (EK) of isolated zymogen granules (ZG). 
Enterokinase was added to isolated zymogen granules after being lysed by freezing and thawing. This enzyme 
converts trypsinogen into trypsin that subsequently activates the other proenzymes leading to a rapid chain 
activation of proteases and to digestion of the zymogen granule proteins.  
Bottom-up proteomics largely relies on tryptic peptides for protein identification but 
tryptic digestion often results in limited coverage of protein sequence due to problems such 
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as peptide length, ionization efficiency or posttranslational modification (PTM). One 
approach to increase sequence coverage is to use, in combination or alone, other proteases 
than trypsin for digestion (Guo et al., 2014). Thus, the number of identified peptides and 
proteins should improve significantly by the use of multiple enzymes in parallel, especially 
in whole proteome sequencing (Swaney et al., 2010; Switzar et al., 2013). To take advantage 
of the ZG protease cocktail and easy activation of the zymogens by enterokinase we 
developed a “bottom-up” proteomics approach with the objective of creating and identifying 
as many peptides as possible in order to uncover the ZG proteome. In brief, EK is added to 
lysed ZG leading to activation of the zymogens and consequent digestion of ZG proteins 
under native conditions by multiple enzymes.  
 
4.2.1. Activation of digestive enzymes from pancreatic zymogen granules 
by enterokinase uncovers several protease-resistant proteins  
Isolated zymogen granules were lysed by freezing and thawing and the zymogens 
were activated by addition of enterokinase (3.4.4). Samples with or without enterokinase 
(ZG_EK and ZG_control respectively) were incubated at 37˚C and aliquots were taken from 
5 min up to 48 h (Figures 12). Several time-points (0 h, 5 min, 1 h and 24 h) were analysed 
by LC-MS/MS but, contrary to what we expected, only the most abundant proteases were 
identified by this approach (Supplementary Table 2). ZG have a high concentration of active 
proteases that might lead to an over-digestion of the sample. So, to visualize the rate of 
digestion the samples from different time points were separated by SDS-PAGE. At 5 min 
after protease activation a prominent degree of digestion was observed when compared with 
the control (Figure 6 B and D). On the other hand, it was also observed that several bands 
did not change over time indicating that those proteins are protease resistant. The proteins 
present in those bands were identified by MS as: carboxypeptidase A (1), chymotrypsin C 
(2), elastase (3) and the lectin ZG16p (4) (Figure 12).  
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Figure 12. Digestion of lysed zymogen granules (ZG) reveals several protease resistant proteins. Isolated ZG 
were lysed by freezing and thawing and incubated at 37ºC without enterokinase (control) or with enterokinase 
(ZG_EK). Digestion was monitored by 15% SDS-PAGE and gels were stained with Coomassie blue. (A, C) 
In controls a slight digestion of ZG proteins is detected at 6 h indicated by the reduction of high molecular 
weight bands and the increase of low molecular weight bands. Digestion of proteins increases slowly over time. 
(B, D) In ZG_EK already after 5 minutes a prominent digestion of ZG proteins is observed when compared 
with the control. Several bands are protease resistant as they persist overtime and were identified by MS as: 
carboxypeptidase A (1), chymotrypsin C (2), elastase (3) and the lectin ZG16p (4).  
The exocrine pancreas secretes digestive enzymes and mucins immersed in a 
bicarbonate (HCO3-) rich fluid (pancreatic juice) to neutralize acid and provide optimal pH 
environment (slightly basic) for enzymatic digestion (Lee et al., 2012). On the other hand, 
digestive enzymes are stored in ZG under acidic pH (Lebel et al., 1988). To compare the 
extent of ZG protein digestion at different pH values (from acidic to basic), we induced the 
activation of zymogens by enterokinase at pH 6.0, 7.5, 8.0 and 9.0 (Figure 13). As expected, 
at basic pH (similar to the pancreatic juice, pH 8.0) protein digestion was fast and extensive, 
slowing down with the decrease of the pH. At basic pH, digestion is almost complete 
immediately after 1 h of incubation and only the identified protease resistant proteins remain. 
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In contrast, at an acidic pH of 6.0, ZG protein digestion is incomplete, as it can be observed 
by the band profile that is mostly similar from 1 h to 24 h of incubation (Figure 13 C). At 
neutral pH of 7.5, on the other hand, the digestion is still incomplete but more pronounced 
than at acidic pH (Figure 13 D). This is in accordance with physiological conditions since 
the acinar cells have several mechanisms to prevent premature intracellular activation of the 
zymogens under physiological conditions that include low concentrations of intracellular 
Ca2+, the presence of protease inhibitors and low pH within the zymogen granules (Weiss et 
al., 2008).  
 
Figure 13. Digestion of ZG is pH-dependent. Isolated ZG were lysed by freezing and thawing. The pH of the 
samples was adjusted to (A) pH 9.0, (B) pH 8.0, (C) pH 6.0 and (D) pH 7.5 before incubation at 37ºC with 
enterokinase (ZG_EK). Samples were analysed by 15% SDS-PAGE and stained with Coomassie blue.  
It is known that some of the pancreatic enzymes have a certain degree of protease 
resistance to each other (Szmola and Sahin-Tóth, 2007) what might explain their presence 
even at 48 h after protease activation. On the other hand, the presence of a small (16 kDa) 
non-enzymatic protein with no previous reference to protease resistance was quite intriguing. 
To confirm the MS identification of the lectin ZG16p and its resistance to protease digestion 
we performed an immunoblot with anti-ZG16p and anti-amylase antibodies. The digestion 
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of ZG (ZG_EK) was followed over a period of 24 h after enzymatic activation and it was 
possible to observe that amylase was completely digested after 2 h but the band 
corresponding to ZG16p remained constant over time (Figure 14).  
 
 
Figure 14. The lectin ZG16p is a protease resistant ZG 
protein. Isolated ZG were lysed by freezing and thawing 
and incubated at 37ºC with enterokinase (ZG_EK). 40 
µg of protein were separated by 15% SDS-PAGE and 
analysed by immunoblotting with anti-amylase and anti-
ZG16p antibodies.  
 
 
ZG16p is predominantly associated with the luminal surface of ZGM, and can be 
removed in conjunction with proteoglycans/GAGs by carbonate-, chondroitinase- or 
heparitinase-treatment (Kleene et al., 1999b; Kumazawa-Inoue et al., 2012; Schmidt et al., 
2000; Schrader, 2004). Interestingly, ZG16p was described to mediate the binding of 
aggregated secretory proteins to the submembranous matrix by associating with the dense 
granule core and the ZGM at acidic pH (Kleene et al., 1999b). ZG16p is likely a unique 
lectin with dual specificity to sulfated glycosaminoglycans (proteoglycan binding motif) and 
to polyvalent mannose and short chain α-manno-oligosaccharides (carbohydrate recognition 
domain) (Figure 15) (Kanagawa et al., 2014).  
 
Figure 15. Amino acid sequence of rat ZG16p and its protein domains. Same colour was used to highlight the 
amino acids and corresponding domain. SP - Signal Peptide; PGM – Proteoglycan Binding Motif; CRD – 
Carbohydrate Recognition Domain.  
Furthermore, ZG16p might have a protective function in the gut since it was 
identified as a prominent component of the mucus proteome, the first defence line of the 
gastrointestinal tract (Pelaseyed et al., 2014). In addition, ZG16p binds to pathogenic 
Candida and Malassezia species, heavily coated with mannan, through the carbohydrate 
recognition domain (see Chapter 1.5.3.5). Therefore, ZG16p is an interesting candidate to 
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play a major role in the sorting process in acinar cells and may also have a regulatory and/or 
a protective function after secretion.  
4.2.2. Preparation of recombinant rat ZG16p 
To investigate the protease resistant properties of the lectin ZG16p we prepared a 
recombinant protein. ZG16p has 167 amino acids (aa) where the first 16 aa represent a signal 
peptide that targets the protein to the ER (Cronshagen et al., 1994; Kanagawa et al., 2011). 
The signal peptide is removed upon entry into the ER, giving rise to the mature form of 
ZG16p (Kanagawa et al., 2011) (Figure 15). To purify the recombinant rat ZG16p by affinity 
chromatography, we generated two plasmids encoding ZG16p without the signal peptide to 
mimic the mature form of the protein (Figure 16).  
 
Figure 16. Purification of recombinant rat ZG16p. (A) Two ZG16p constructs with different tags were 
generated; a His-tagged version with 19 kDa (H-ZG16p) and a His-Myc-tagged construct with 21 kDa (HMyc-
ZG16p). (B) E. Coli Rosetta were transformed with each construct and protein expression was induced with 
IPTG. Bacterial lysates were separated by 15% SDS-PAGE and stained with Coomassie blue. The recombinant 
ZG16p corresponds to the higher intensity band on each lane (arrow heads). (C) Bacterial lysate was 
centrifuged at 16000 rpm, 5 min. and the pellet (P) and supernatant (SN) fractions were separated on a 15% 
SDS-PAGE and stained with Coomassie blue. Both recombinant proteins are enriched in the supernatant 
showing that it is soluble. (D) Recombinant proteins were purified in a TALON His-Tag column. After loading 
the supernatant in the column, the fractions of the washing and the elution step were collected. The wash and 
elution were separated by 15% SDS-PAGE and stained with Coomassie blue. The fractions indicated (blue 
bracket) were collected and combined, constituting the purified ZG16p.  
D 
A 
B C 
 Results 
71 
 
In addition, two tags were added to the N-terminus of ZG16p: a hexahistidine (His) 
tag to aid in the purification of the protein (H-ZG16p) in one case and a His plus a Myc tag 
to help in differentiating both recombinant proteins (HMyc-ZG16p) in the other case. 
Plasmids were transformed into E. coli Rosetta, and production of recombinant proteins was 
induced by addition of IPTG. After sonication of the bacteria, recombinant proteins were 
purified by affinity chromatography on a Cobalt (Co2+) sepharose column (Figure 16). After 
purification, the recombinant proteins were used to characterize ZG16p by accessing 
resistance to digestion, formation of dimers and migration in polyacrylamide (PA) gels.  
 
4.2.3. Protease resistance is an intrinsic property of ZG16p 
We have shown (4.2.1) that endogenous ZG16p is a protease resistant protein. We 
now aimed to elucidate if this is an intrinsic property of ZG16p or the result of the interaction 
between ZG16p and other components of zymogen granules (e.g., submembranous matrix). 
The enzyme trypsin is normally used in proteomics to digest proteins in solution and in gel 
(Guo et al., 2014; Zhang et al., 2013). To investigate the protease resistance of ZG16p we 
incubated the recombinant proteins (H-ZG16p and HMyc-ZG16p) and the endogenous 
ZG16p (from the ZG subfractions – Wash) was used as a control, with and without trypsin 
at 37˚C for 16 h. If the recombinant proteins were not digested in the presence of trypsin it 
would mean that ZG16p resistance to proteases is an intrinsic property of the protein and if 
they were digested it would mean that the protease resistance depends on an external factor 
(e.g., binding to proteoglycans). Samples were separated by SDS-PAGE and stained with 
Coomassie blue or blotted and probed with an anti-ZG16p antibody (Figure 17 A and B). 
Although H-ZG16p, HMyc-ZG16p and the endogenous ZG16p have different molecular 
weights, due to the different protein tags, it was observed that after trypsin digestion all 
proteins migrate the same distance in the PA gel, indicating that they have the same 
molecular weight as a result of partial digestion of the recombinant proteins (Figure 17 A 
and B). Thus, the digestion of recombinant ZG16p resulted in a 3 kDa and 5 kDa shift (H-
ZG16p and HMyc-ZG16p, respectively) in the protein size. Interestingly, this difference in 
the protein size corresponds to the size of the added tags to each recombinant protein (Figure 
16 A). To investigate if the N-terminal tags are removed by trypsin digestion we used 
specific antibodies to His and Myc tags (Figure 17 C). As expected, before trypsin digestion 
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the His tag is detected in both recombinant proteins and the Myc tag is only detected on 
HMyc-ZG16p by western blot. However, after digestion both tags are no longer detected by 
immunoblotting suggesting that they were removed by trypsin. Since the molecular weight 
of both recombinant proteins, before and after digestion, only differs in the size that 
corresponds to the protein tags and the size after digestion is similar to the endogenous 
ZG16p, it indicates that ZG16p is not digested. These results show that resistance to 
digestion is an intrinsic property of ZG16p.  
 
Figure 17. Recombinant ZG16p is protease resistant. (A) The purified recombinant proteins (HMyc-ZG16p 
and H-ZG16p) and the Wash fraction of the ZG with (first three lanes) and without (last three lanes) trypsin 
digestion were separated by 15% SDS-PAGE. The gel was stained with Coomassie blue. (B) Immunoblot of a 
gel similar to (A) probed with an anti-ZG16p antibody. After trypsin digestion the recombinant and endogenous 
proteins have the same protein size. (C) Immunoblot of recombinant ZG16p with and without trypsin digestion 
probed with an anti-histidine tag and anti-Myc tag antibodies. Note that both tags are removed after trypsin 
digestion.  
 
4.2.4. Migration of ZG16p in SDS-PA gels is temperature sensitive 
The lectin ZG16p, a resistant protein to pancreatic proteases, interacts with highly 
sulfated GAGs of proteoglycans present at the ZGM (Kumazawa-Inoue et al., 2012). 
Sulfated proteoglycans have previously been identified as constituents of pancreatic 
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zymogen granules (see Chapter 1.4). The glycosaminoglycans (GAGs) of the proteoglycans 
should resist the digestion after protease activation by enterokinase since no 
endoglycosidases (e.g., heparitinase, chondroitinase) were identified in ZG. To investigate 
if ZG16p is bound to proteoglycan GAGs after digestion of ZG subfractions the samples 
were analysed by immunoblotting with different temperature treatment before loading to the 
PA gel (see Chapter 3.4.7). In brief, the ZG subfractions digested after protease activation 
by enterokinase were heated at 95˚C or prepared at room temperature (RT) with SDS-PAGE 
loading buffer. The objective was to compare the migration of ZG16p of both samples, 
where the treatment at RT should not disrupt the interaction of ZG16p with the GAGs 
resulting in a shift of the molecular weight (correspondent to the size of ZG16p and the 
GAGs) observed in the immunoblotting. Remarkably, ZG16p was found by immunoblotting 
at the top of the gel (Figure 18) when the sample was prepared at RT. However, when the 
sample was prepared at 95˚C, ZG16p was identified at the expected size by immunoblotting. 
This indicates that ZG16p is present in a high molecular weight complex that is not able to 
enter the PA gel. The submembranous matrix model predicts high molecular weight 
components (e.g., a proteoglycan scaffold and associated (glyco)proteins) attached to the 
luminal side of the granule membrane and might be the responsible for retaining ZG16p on 
top of the gel.  
          
 
 
Figure 18. Migration of ZG16p in SDS-PAGE is temperature dependent. 
Digested ZGM (ZGM_EK) was prepared with or without boiling (95˚C or RT 
respectively) in SDS loading buffer before analysis by immunoblotting. An 
anti-ZG16p antibody was used. Note that ZG16p is detected at the top of the 
stacking gel (4% PA) when the sample is processed at RT and at the expected 
molecular weight after heating at 95˚C. RT, room temperature.  
 
 
 
In support of the hypothesis that ZG16p interacts with the submembranous matrix 
and is thus retained on top of the PA gel, we repeated the same assay with several ZG 
subfractions. The submembranous matrix is localized at the luminal surface of the ZGM and 
is released by carbonate treatment, thus it is present in the ZGM fraction and constitutes 
most of the Wash fraction (obtained after carbonate treatment of the ZGM) and is absent in 
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the ZGC fraction. By comparing the ZGM and the Wash fractions it should be possible to 
rule out the presence of lipids and membrane proteins as the responsible for the formation 
of a high molecular weight complex that interferes with the migration of ZG16p in SDS-
PAGE. We digested the ZG and the ZG subfractions (ZGM, Wash and ZGC) by addition of 
enterokinase and prepared the samples in SDS sample buffer at RT or 95˚C before 
immunoblotting analysis. The recombinant protein HMyc-ZG16p was used as a control to 
show that purified ZG16p migrates to the expected size in the PA gel when the sample is 
prepared at RT. As expected ZG16p was identified by immunoblotting at the top of the gel 
in different ZG subfractions when the samples were prepared at RT (Figure 19). However, 
HMyc-ZG16p was always found at the correct size showing that it is not the biochemical 
characteristics of ZG16p that disturb the migration of the protein in SDS-PAGE. This also 
indicates that the recombinant protein does not bind to the potential proteoglycans present 
in the high molecular weight complex probably because the binding sites are occupied by 
endogenous ZG16p. Several bands corresponding to the recombinant protein (HMyc-
ZG16p) were observed due to partial protein digestion (Figure 19) by the proteases present 
in the samples. Interestingly, when the ZG and ZG subfractions were not digested, a fraction 
of endogenous ZG16p was also observed at the correct size (first lane in Figure 19 A, B and 
D) when prepared at RT in SDS-PAGE loading buffer. In addition, there was no observable 
difference between the ZGM and Wash subfractions allowing us to exclude the presence of 
the ZG membranes as the responsible for ZG16p retention on top of the gel (Figure 19 B and 
D). Taken together, these data is in favour of the presence of a high molecular weight 
complex associated with the ZGM.  
In fact, the interaction of ZG16p with proteoglycans at the ZGM was already 
suggested. It was proposed that ZG16p mediates the binding of aggregated secretory proteins 
to the submembranous matrix at acidic pH and that impairment of in vitro condensation-
sorting results in removal of both ZG16p and the proteoglycans from ZGM (Kleene et al., 
1999b; Schmidt et al., 2000). Most recently Kumazawa-Inoue and colleagues identified two 
positive patches in the protein surface constituted by basic amino acids (lysine and arginine) 
that are responsible for the interaction of ZG16p with highly sulfated GAGs of proteoglycans 
present at the ZGM (Kumazawa-Inoue et al., 2012). Those GAGs were successfully digested 
with heparitinase II (HPRT). 
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Figure 19. Migration of ZG16p in SDS-PAGE is temperature dependent and is observed in different ZG 
subfractions. ZG fractions were prepared with or without enterokinase and recombinant ZG16p (HMyc-
ZG16p) was added to the sample with enterokinase right before loading. All samples were processed at room 
temperature (RT) or at 95˚C before analysis by immunoblotting with an anti-ZG16p antibody. Endogenous 
ZG16p is detected at the top of the stacking gel (4% PA) when is prepared at RT and at the expected molecular 
weight after heating at 95˚C (A, B and D) except for ZGC (C). On the other hand, the migration of recombinant 
ZG16p shows the same pattern at RT or 95˚C therefore it is independent of the sample treatment temperature. 
Arrows indicate endogenous ZG16p and brackets indicate recombinant ZG16p. Arrowheads indicate potential 
ZG16p dimers.  
To test whether the interaction of ZG16p with GAGs prevents ZG16p from entering 
the PA gel we incubated the digested ZG fractions (ZG_EK and ZGM_EK) with the enzyme 
HPRT overnight at 30˚C (Figure 20). HPRT should be able to digest the GAG chains of the 
proteoglycans, disrupting the high molecular weight complex and allowing ZG16p to enter 
the PA gel. As a control we used ZG_EK without HPRT incubated under the same 
conditions. Samples were separated in 15% PA gel with (+) or without (-) heating at 95˚C 
A B 
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(Figure 20). To test if the enzyme HPRT was active at the conditions used we included a 
solution of heparin. The band corresponding to heparin is degraded after HPRT incubation, 
confirming that the enzyme is active (Figure 20 A, C, D and E). Under these experimental 
conditions, we did not observe differences between the samples with and without HPRT. 
Contrary to what was expected ZG16p did not enter the PA gel in the samples containing 
HPRT and prepared SDS-PAGE loading buffer without heating at 95˚C (-). Moreover, 
several bands appeared in the samples with and without HPRT that were not observed before 
(e.g., Figure 20). 
 
Figure 20. Digestion of ZG_EK and ZGM_EK with heparitinase II (HPRT). ZG_EK was incubated with (+) 
or without (-) HPRT overnight at 30°C. After incubation the samples were prepared for SDS-PAGE with (+) 
or without (-) heating at 95°C. As a control for HPRT activity a solution of heparin with a concentration of 1 
mg/ml was used. (A and D) The gel was stained with Alcian Blue (specific for proteoglycans). The same 
pattern of bands is observed with or without HPRT incubation of ZG_EK or ZGM_EK. On the other hand, 
heparin is digested in the presence of HPRT confirming that this enzyme is active. (B and E) Immunoblotting 
of ZG_EK and ZGM_EK samples with or without HPRT incubation and probing with a ZG16p antibody. The 
same pattern of bands is observed in the presence or absence of HPRT. “x” indicates that no sample was loaded 
in the gel. (C and F) The same gel as in A and D respectively but stained with Coomassie blue. Again, there is 
no observable alteration in the band pattern. White Arrow indicates known ZG16p bands. Arrowhead indicates 
added HPRT. M, Marker.  
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These results indicate that either the binding of ZG16p to GAGs is not the responsible 
for retaining ZG16p at the top of the gel or that denaturation of the sample before addition 
of HPRT is required to provide access of the enzyme to the GAGs in order to accomplish 
the digestion. This may happen due to conformation of the GAGs that avoid binding of 
HPRT and/or due to binding of ZG16p to the GAGs protecting them from digestion by 
HPRT. Previously, ZG proteoglycans were successfully digested by HPRT after 
denaturation of the proteoglycans by boiling for 5 min (Kumazawa-Inoue et al., 2012).  
 
4.2.5. ZG16p forms highly stable homodimers 
Recently, it was suggested that ZG16p is a monomeric protein based on analysis by 
size exclusion chromatography, even though contact areas between ZG16p molecules were 
observed in crystals prepared for structure determination (Kanagawa et al., 2011). On the 
other hand, due to the observation of a band double the size (32 kDa) of ZG16p on 
immunoblots prepared with an anti-ZG16p antibody it was previously suggested that ZG16p 
might form dimers (Kalus et al., 2002; Kleene et al., 1999b). We have made a similar 
observation on immunoblots (e.g., Figure 19 B), despite the denaturing conditions used in 
the preparation of such immunoblots. To confirm the presence of ZG16p dimers we 
performed immunoblots prepared with endogenous and recombinant ZG16p with different 
molecular weights (ZG16p – 16 kDa, H-ZG16p – 19 kDa and HMyc-ZG16p – 21 kDa). This 
way, the resulting dimers should also differ between them (32, 38 and 42 kDa, respectively). 
Digested ZG (ZG_EK) were used as a source of endogenous ZG16p to reduce the 
complexity of the sample and to rule out unspecific binding of the antibody to other ZG 
proteins. The samples were prepared in SDS-PAGE loading buffer and heated at 65˚C for 5 
min, 95˚C for 5 min or 95˚C for 10 min, separated by SDS-PAGE, blotted and probed with 
an anti-ZG16p antibody (Figure 21). Two bands were detected in all lanes, one 
corresponding to the monomeric form of ZG16p and the other, double the size, 
corresponding to the dimeric form. Furthermore, the intensity of the dimeric band decreased 
with increasing temperature and time, indicating that disruption of the dimer occurs only 
after prolonged exposure to high denaturing temperature. These results confirm that ZG16p 
forms dimers that are highly stable and resistant to denaturation.  
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Figure 21. ZG16p is a dimeric protein. 
Endogenous (ZG_EK) and recombinant ZG16p 
(H-ZG16p, HMyc-ZG16p) were heated at 65˚C, at 
95˚C for 5 minutes and at 95˚C for 10 minutes and 
analysed by immunoblotting with an anti-ZG16p 
antibody. In all lanes a monomeric (arrow) and a 
dimeric form (arrowhead) of ZG16p is detected. 
The intensity of the band that corresponds to the 
dimeric form decreases with both temperature and 
heating time.  
We have generated several plasmids (see Table 4 and Chapter 4.3.1) to study the 
targeting of ZG16p to ZG in AR42J cells, a pancreatic model system. The cloning process 
involved two steps: first step was the addition of a Myc tag to the N-terminus of ZG16p and 
the second step was the addition of an ER targeting signal to the N-terminus of the Myc-tag. 
Surprisingly, when we tested the first plasmid (Myc-ZG16dSP) in COS-7 cells we 
discovered that when ZG16p is in the cytoplasm it binds to spherical and elongated tubular 
organelles (see Chapter 4.3.4). To further investigate this feature, we generated a GFP-
tagged version of ZG16p (GFP-ZG16dSp) along with plasmids with point mutations in the 
proteoglycan and glycan binding motifs. We discovered that only the fusion protein with a 
mutation in one of the proteoglycan binding motifs (GFP-ZG16_K) lost its binding to the 
endo-lysosomal compartment (see Chapter 4.3.7) and was evenly distributed through the 
cytoplasm.  
To demonstrate the formation of dimers by ZG16p we incubated the recombinant 
protein HMyc-ZG16p and the lysate of COS-7 cells expressing GFP-ZG16_K and 
performed a co-immunoprecipitation (co-IP) with an anti-GFP antibody (see Chapter 
3.4.13). We expected to be able to co-immunoprecipitate GFP-ZG16p with HMyc-ZG16p, 
proving that both proteins were interacting due to the capacity of ZG16p to form dimers. A 
plasmid encoding for GFP alone was used as a control. We succeeded at co-
immunoprecipitating GFP-ZG16p with HMyc-ZG16p (Figure 22 A and C) suggesting that 
both proteins were interacting, but a similar result was obtained when the GFP protein was 
used instead of GFP-ZG16_K. The co-immunoprecipitation was performed with two 
different systems: the GFP-Trap® and the PureProteome™ protein G magnetic beads 
coupled with an anti-GFP antibody. The use of two different antibodies allowed use to avoid 
a false positive result that could arise from the unspecific interaction between the antibody 
and HMyc-ZG16p resulting in the co-immunoprecipitation of the recombinant protein.  
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Figure 22. Co-immunoprecipitation (co-IP) of COS-7 cells transfected with GFP or GFPZG16_K via the GFP-
Trap® magnetic beads or PureProteome™ protein G magnetic beads (Millipore) with an anti-GFP antibody. 
HMyc-ZG16p was added to the cell lysate before the co-IP in order to perceive the formation of dimers with 
GFP-ZG16_K. SN1a corresponds to the cell lysate. SN1b is the cell lysate after supplementation with HMyc-
ZG16p and before addition of magnetic beads and SN2 is the supernatant after the co-IP. (A and C) Immunoblot 
with an anti-ZG16p antibody in which only GFP-ZG16_K (46 kDa) (1) and HMycZG16 (21 kDa) (2) are 
labelled. Note that HMyc-ZG16p was pulled-down in both samples (co-IP of GFP and GFP-ZG16_K). “x” 
indicates that HMyc-ZG16p was not added to the sample and the presence of the recombinant protein indicates 
interaction with GFP and GFP-ZG16_K. (B and D) Same membrane as in (A and C) but probed with an 
antibody to GFP. In this case only GFP (27 kDa) (3) and GFP-ZG16_K (4) bands are observed.  Arrowheads 
indicate the bands corresponding to the heavy chain of the GFP antibody used in the co-IP with the 
PureProteome™ beads.  
We were able to co-immunoprecipitate GFP-ZG16_K with HMyc-ZG16p by using 
both systems (Figure 22 A and C). However, co-immunoprecipitation of HMyc-ZG16p was 
also observed together with the GFP protein, indicating that the recombinant protein might 
interact with GFP (Figure 22 B and D). Thus, we could not confirm the dimerization of 
ZG16p based on this method because the co-immunoprecipitation of HMyc-ZG16p could 
be the result from interaction of the recombinant protein with “ZG16_K” (GFP-ZG16_K) or 
with GFP (GFP-ZG16_K or GFP protein).  
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These findings demonstrate that ZG16p is highly protease resistant and has the 
capacity to form dimers. Furthermore, we have shown that ZG16p is part of a high molecular 
weight complex associated with the ZGM (submembranous matrix). Since specific 
membrane receptors or sorting signals have not yet been identified in exocrine cells, the 
concept of the submembranous matrix offers an interesting alternative to understand the 
packaging and sorting of a complex mixture of proteins in an exocrine system. ZG16p is a 
unique lectin with dual specificity to sulfated glycosamynoglycans and to α-mannose-related 
glycans and might mediate the binding of the submembranous matrix and the aggregated 
zymogens. In the next chapter I have addressed if those binding domains are involved in the 
targeting of ZG16p to ZG in AR42J cells.   
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4.3. Functional analysis of ZG16p by expression and mutational studies 
in mammalian cells 
ZG within acinar cells of the exocrine pancreas have long served as model organelles 
to understand regulated secretion. While the selective aggregation of ZG proteins has been 
well documented (see Chapter 1.2), their interaction with the TGN/ZG membrane is poorly 
understood at the molecular level, and neither a common sorting signal nor a sorting receptor 
has been identified so far. Although the application of proteomics has largely contributed to 
the identification of novel ZG proteins (Borta et al., 2010; Chen et al., 2006; Gómez-Lázaro 
et al., 2010; Rindler et al., 2007; Sun and Jiang, 2013) it was not yet accompanied by a better 
characterization of their functions. Since specific membrane receptors or sorting signals have 
not yet been identified in exocrine cells, the concept of the submembranous matrix offers an 
interesting alternative to understand the packaging and sorting of a complex mixture of 
proteins in an exocrine system. In support of this concept, we have identified novel ZG 
proteins, associated with the ZGM, with proteoglycan-binding properties (Chapter 4.1). 
Furthermore, it was suggested that ZG16p mediates the binding of aggregated secretory 
proteins to the submembranous matrix by associating with the dense granule core and the 
ZGM at acidic pH, and by impairment of in vitro condensation-sorting after removal of both 
ZG16p and the proteoglycans from ZGM (Kleene et al., 1999b; Schmidt et al., 2000). 
Surprisingly, using an in vitro digestion assay we discovered that ZG16p is highly protease-
resistant and appears to be part of a high molecular weight complex within ZG, which might 
be as well protease-resistant. Furthermore, ZG16p is likely a unique lectin with dual 
specificity to sulfated glycosaminoglycans (proteoglycan binding motif) and to α-mannose-
related glycans (carbohydrate recognition domain) (Figure 15) (Kanagawa et al., 2011, 2014; 
Kumazawa-Inoue et al., 2012; Tateno et al., 2012). Moreover, the glycan binding site does 
not compete with the heparin binding site on ZG16p (Kanagawa et al., 2014) (see Chapter 
1.5.3.2). 
In this chapter, we generated ZG16p constructs to be expressed in AR42J cells, a 
pancreatic cell model system, and screened, by mutational studies of the binding motifs, for 
alterations in ZG16p targeting/sorting into ZG. Pancreatic AR42J cells have been used as a 
model system for granule formation and pancreatic exocrine secretion. They were originally 
derived from a rat pancreatic tumour following exposure to azaserine (Longnecker et al., 
1979). Treatment with the synthetic glucocorticoid dexamethasone induces the 
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differentiation of AR42J cells into exocrine, acinar-like cells and the de novo formation of 
electron-opaque secretory granules, which contain the major pancreatic zymogens. 
However, when compared to acinar cells from rat pancreas, AR42J cells are non-polarized, 
do not express all rat ZG proteins and exhibit smaller ZG (Logsdon et al., 1985; Rinn et al., 
2012). The generation of wild type and mutated versions of ZG16p aimed at examining if 
the proteoglycan and/or the carbohydrate recognition motifs of ZG16p are essential for its 
sorting into ZG. Additionally, several constructs targeting ZG16p to the cytoplasm were 
generated and expressed in COS7 cells. Although ZG16p is not targeted to the cytoplasm 
under normal conditions it might escape from the ZG into the cytoplasm under disease 
conditions (e.g., pancreatitis).  
 
4.3.1. Cloning of ZG16p with a Myc-tag at the N-terminus for expression in 
mammalian cells 
ZG16p has 167 amino acids (aa) where the first 16 aa represent a signal peptide that 
targets the protein to the ER (Cronshagen et al., 1994; Kanagawa et al., 2011) and it does 
not have any transmembrane domains (Borta et al., 2010; Cronshagen et al., 1994; Kanagawa 
et al., 2011, 2014). Additionally, the residues 36-159 correspond to the jacalin-related 
domain. In order to investigate the targeting of ZG16p to ZG in AR42J cells we generated a 
plasmid with a Myc tag at the N-terminus of the mature form of ZG16p (16-167 aa). This 
was achieved in two steps: the first step was to insert ZG16p without the signal peptide 
(ZG16dSP) in the vector pCMV-tag3A in order to add a Myc tag at the N-terminus of 
ZG16dSP (Myc-ZG16dSP). And the second step consisted in the amplification of Myc-
ZG16dSP and insertion in the vector pDsREd2-ER (Supplementary Figure 1) in order to add 
an ER signal (calreticulin) at the N-terminus of the Myc tag (ER-Myc-ZG16p) (Figure 23). 
The DsRed2 sequence and KDEL retention signal were removed from the pDsREd2-ER 
plasmid during the cloning procedure (Supplementary Figure 1).  
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Figure 23. Cloning strategy for expression of ZG16p in mammalian cells. 1 – ZG16p; 2 – removal of the signal 
peptide (SP) from ZG16p; 3 – Addition of a Myc tag to the N-terminus of ZG16p; 4 – Addition of a SP to the 
N-terminus of the Myc tag. 5 – Removal of the SP after entering the ER and processed ZG16p N-terminally 
tagged.  
Expression of ER-Myc-ZG16p in mammalian cells targets ZG16p to the ER, where 
the ER signal is removed giving rise to the mature form of the protein with a Myc tag at the 
N-terminus (Figure 24).  
 
 
Figure 24. Expression of ER-
Myc-ZG16p in COS-7 and HepG2 
cells. Cells were transfected with 
ER-Myc-ZG16p construct and 
fixed after 24 h with 4% 
paraformaldehyde. 
Immunostaining was performed 
with an anti-Myc antibody. In 
both cell lines an ER like staining 
is observed. Bars, 20µm.  
 
 
 
 
 
4.3.2. Deletion of the carbohydrate recognition domain inhibits ZG16p 
targeting to ZG in AR42J cells 
While the selective aggregation of ZG proteins has been well documented, their 
interaction with the TGN/ZG membrane is poorly understood at the molecular level, and 
neither a common sorting signal nor a sorting receptor has been identified so far. ZG16p has 
a carbohydrate recognition domain (CRD) that is conserved in the majority of β-prism fold 
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lectins (Kumazawa-Inoue et al., 2012; Raval et al., 2004; Sharma et al., 2007). It is composed 
by 5 amino acids with a glycine and an aspartic acid separated by a 3-amino-acid spacer 
(GXXXD). In order to investigate if this domain is responsible for the targeting of ZG16p 
to ZG we generated a mutant protein by removing the CRD (aa 147-151) (ER-Myc-
ZG16dCRD). AR42J cells were transfected with the wild type plasmid (ER-Myc-ZG16p) 
and the mutant (ER-Myc-ZG16dCRD) (Figure 25) and stimulated for granule formation with 
dexamethasone. After 2-3 days, cells were processed for indirect immunofluorescence with 
antibodies directed to carboyxpeptidase A (CBP, ZG marker), to the Myc tag and the Golgi 
markers TGN38 and p115. Colocalization between CBP and Myc was observed in 
dexamethasone stimulated AR42J cells transfected with ER-Myc-ZG16p (Figure 25 A-C) 
showing that the wild type ZG16p is targeted to ZG. On the other hand, cells transfected 
with ER-Myc-ZG16dCRD only showed limited colocalization between CBP and Myc 
indicating that the mutant protein is not targeted to ZG. Nevertheless, normal granule 
formation was not affected in transfected cells (Figure 25 D). Furthermore, immunostaining 
with anti-Myc antibody of transfected cells revealed absence of labelling in the Golgi region 
(Figure 25 E), supporting the idea that the mutant ZG16p fails to enter the secretory pathway. 
We then used two Golgi markers (TGN38 and p115) to further confirm if the mutant ZG16p 
was present in the Golgi complex. We did not observe colocalization between the Golgi 
markers TGN38 (Figure 25 J-L) and p115 (Figure 25 P-R) with the mutant ER-
MycZG16dCRD. On the other hand, the wild type protein colocalized with the TGN38 
(Figure 25 G-I) and with the p115 (Figure 25 M-O) proteins.  
The zymogens are synthesized by ribosomes, associated with ER membranes, and 
inserted into the lumen of the rough ER. In the supranuclear region, the Golgi complex 
receives the products of the rough ER and starts the sorting of proteins into forming ZG. 
These results suggest that the mutant ER-Myc-ZG16dCRD is not transported to the Golgi 
complex and is most probably retained in the ER. This may happen because the CRD is 
essential for the sorting of ZG16p into the Golgi complex or the removal of the 5 amino 
acids interferes with the correct folding of the protein and inhibits the transport to the Golgi 
complex. The involvement of the CRD domain on targeting of ZG16p to ZG in AR42J cells 
was further investigated by mutational analyses.  
 Results 
85 
 
 
Figure 25. The ER-Myc-ZG16dCRD mutant is not target to ZG in pancreatic acinar AR42J cells. AR42J cells 
were transfected with a ER-Myc-ZG16p construct (A-C, G-I and M-O) or with the ER-Myc-ZG16dCRD 
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mutant (D-F, J-L and P-R) stimulated for granule formation and processed for indirect immunofluorescence 
72 h after transfection using antibodies directed to carboxypeptidase A (CBP) (A and D), the Myc tag (B, E, 
G, J, M, P) and the Golgi markers TGN38 (H and K) and p115 (N and Q). Overlays (Merge) of (A-B; D-E; G-
H; J-K, M-N and P-Q) are shown in (C, F, I, L, O and R). The ER-Myc-ZG16p colocalizes with the ZG marker 
(CBP) (C) and the Golgi markers TGN38 and p115 (I and O respectively). The ER-Myc-ZG16dCRD mutant 
does not colocalize completely with CBP (F). Yellow arrow points to an area devoided of ER-Myc-
ZG16dCRD. Additionally, ER-Myc-ZG16dCRD does not colocalize neither with the TGN38 (L) or the p115 
(R). Bars, 20µm.  
 
4.3.3. Sorting of ZG16p into ZG is independent of the proteoglycan and 
glycan binding motifs 
The concept of the submembranous matrix (a putative proteoglycan/glycoprotein 
scaffold at the luminal side of the ZGM) offers an interesting alternative to understand the 
packaging and sorting of a complex mixture of proteins in an exocrine system. ZG16p is a 
component of the submembranous matrix where it interacts with sulfated proteoglycans 
(Kleene et al., 1999b; Kumazawa-Inoue et al., 2012; Schmidt et al., 2000; Schrader, 2004) 
through two positively charged basic patches, constituted by lysine and arginine residues on 
the surface of the protein that interact with the negatively charged side chains of sulfated 
proteoglycans (Kanagawa et al., 2011; Kleene et al., 1999b; Kumazawa-Inoue et al., 2012). 
Point mutation of those sites (K33A, K36A, R37A and R55A, R58A) abolished the binding 
to heparin (Kumazawa-Inoue et al., 2012). In addition, ZG16p binds to polyvalent mannose 
and short chain α-manno-oligosaccharides via the carbohydrate recognition domain 
(GXXXD) and mutation of the amino acid D151A abolished the binding (Kanagawa et al., 
2014; Tateno et al., 2012).  
Although the removal of the CRD inhibited the targeting of ZG16p to ZG in AR42J 
cells we were not able to confirm if that inhibition was due to the absence of the CRD or to 
interference with the correct folding of the protein. Thus, we decided to address this by point 
mutation of the amino acids involved in the binding of ZG16p to proteoglycans and to 
glycans. We generated several constructs with point mutations (see Chapter 3.3.7) to 
investigate if inhibition of the proteoglycan and glycan binding motifs inhibits sorting of 
ZG16p to ZG in AR42J cells, namely: ER-Myc-ZG16_K (K33A, K36A, and R37A), ER-
Myc-ZG16_R (R55A and R58A) and ER-Myc-ZG16_D (D151A) (Figure 26). AR42J cells 
were transfected with the wild type plasmid (ER-Myc-ZG16p) and the mutants (ER-Myc-
ZG16_K, ER-Myc-ZG16_R and ER-Myc-ZG16_D) (Figure 27) and stimulated for granule 
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formation with dexamethasone. After 2-3 days, cells were processed for indirect 
immunofluorescence with anti-Carboyxpeptidase A (CBP, ZG marker) and anti-Myc 
antibodies. Colocalization between CBP and Myc was observed in transfected and 
dexamethasone stimulated AR42J cells (Figure 27), showing that the three mutants were 
targeted to ZG in AR42J cells.  
 
 
Figure 26. ZG16p amino acid sequence. Amino acids subjected to point mutation are highlighted. K33A, 
K36A, and R37A corresponds to mutant “K”; R55A, R58A corresponds to mutant “R” and D151A corresponds 
to mutant “D”.  
 
Figure 27. ER-Myc-ZG16p and ER-Myc-ZG16p mutants are targeted to ZG in pancreatic acinar AR42J cells. 
AR42J cells were transfected with a ER-Myc-ZG16p construct (A-C) or with the mutants: ER-Myc-ZG16_K 
(D-F), ER-Myc-ZG16_R (G-I) or ER-Myc-ZG16_D (J-L); stimulated for granule formation and processed for 
indirect immunofluorescence 72 h after transfection using antibodies directed to carboxypeptidase A (CBP) 
(A, D, G and J) and the Myc tag (B, E, H and K). Overlays (Merge) of (A-B; D-E; G-H; J-K) are shown in (C, 
F, I, L). Yellow dots represent colocalization of the transfected protein (green) with the ZG marker, 
carboxypeptidase A (red). Nuclei are stained with Hoechst (blue). Bars, 20µm.  
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Double and triple mutants (ER-Myc-ZG16_K_R, ER-Myc-ZG16_K_D, ER-Myc-
ZG16_R_D and ER-Myc-ZG16_KRD, respectively) were also generated and all of them 
were targeted to ZG in AR42J cells after dexamethasone stimulation (Figure 28). Thus, 
mutation of the proteoglycan or glycan binding motifs, either alone or in parallel, did not 
inhibit the targeting of ZG16p to ZG in AR42J cells.  
 
Figure 28. ER-Myc-ZG16p double and triple mutants are targeted to ZG in pancreatic acinar AR42J cells. 
AR42J cells were transfected with the mutants: ER-Myc-ZG16_K_R (A-C), ER-Myc-ZG16_K_D (D-F), ER-
Myc-ZG16_R_D (G-I) or ER-Myc-ZG16_K_R_D (J-L); stimulated for granule formation and processed for 
indirect immunofluorescence 72 h after transfection using antibodies directed to carboxypeptidase A (CBP) 
(A, D, G and J) and the Myc tag (B, E, H and K). Overlays (Merge) of (A-B; D-E; G-H; J-K) are shown in (C, 
F, I, L). In the right column is shown the zoom of dashed areas on the merge panel (C,F, I, L). Yellow dots 
represent colocalization of the transfected protein (green) with the ZG marker, carboxypeptidase A (red). Bars, 
20µm.  
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4.3.4. ZG16p binds to spherical and elongated tubular structures when 
expressed in the cytoplasm of mammalian cells 
As described before (see Chapter 4.3.1) the cloning of ER-Myc-ZG16p followed two 
steps: first the removal of the signal peptide and insertion of a Myc tag at the N-terminus of 
ZG16p, and then the insertion of an ER-targeting signal in the N-terminus of the Myc tag. 
Once the first part was accomplished, the generated construct (Myc-ZG16dSP) was tested 
in COS-7 cells. Surprisingly, instead of an expected cytosolic localisation, ZG16p was found 
to label a membrane compartment composed of spherical and elongated tubular structures 
(Figure 29). In addition, we expressed Myc-ZG16dSP in cell lines originating from different 
tissues and species: COS-7 cells (Kidney, monkey), HepG2 cells (liver, human) and AR42J 
(pancreas, rat) and observed the same phenotype in all cell lines (Figure 29) indicating that 
the membrane binding partner of ZG16p is conserved across species and is not tissue 
specific.  
 
 
 
Figure 29. Expression of Myc-ZG16dSP in 
different cell lines shows a similar 
phenotype. COS-7 (monkey, kidney), 
HepG2 (human, liver) and AR42J (rat, 
pancreas) were transfected with Myc-
ZG16dSP and processed for indirect 
immunofluorescence 24 h after transfection 
using antibodies directed to the Myc tag. In 
all cell lines the construct labels a 
membrane compartment composed of 
spherical and elongated tubular structures 
Bars, 20µm.  
 
 
 
Next, a GFP-tagged construct was generated (GFP-ZG16dSP) in order to perform 
live cell microscopy and investigate if the observed structures are motile. Interestingly, 
transfection of COS-7 cells with GFP-ZG16dSP revealed a different phenotype from Myc-
ZG16dSP (Figure 30). Instead of the spherical and elongated tubular structures observed 
after expression of Myc-ZG16dSP only spherical structures were observed along with 
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concentration of relatively large structures in the perinuclear region after expression of GFP-
ZG16dSP (Figure 30). Thus, two distinct phenotypes were observed depending on the tag 
fused to ZG16p. We then generated an untagged version of ZG16p without the signal peptide 
(ZG16dSP) to investigate which one of the phenotypes is closest to a condition were ZG16p 
would escape from the ZG to the cytoplasm. Expression of ZG16dSP in COS-7 cell resulted 
in a phenotype similar to the one observed after expression of the Myc-ZG16dSP construct: 
the labelling of spherical and elongated structures (Figure 30).  
 
 
Figure 30. Expression of Myc-ZG16dSP, 
GFP-ZG16dSP and ZG16dSp in COS-7 
cells reveals different phenotypes. COS-7 
cells were transfected with Myc-ZG16dSP, 
GFP-ZG16dSP or ZG16dSp and processed 
for indirect immunofluorescence 24 h after 
transfection using antibodies directed to the 
Myc tag or to ZG16p. Myc-ZG16dSP and 
ZG16dSP show a similar phenotype with 
spherical and elongated tubular structures 
(A-B and E-F), while GFP-ZG16dSP shows 
a phenotype composed of spherical 
structures with concentration of relatively 
large structures in the perinuclear region 
(arrow) (C and D). Bars, 20µm.  
 
 
These results show that it is clearly possible to distinguish two membrane phenotypes 
of ZG16p labelled structures after expression of the three plasmids: a similar phenotype after 
expression of Myc-ZG16dSP and ZG16dSP that is different from the phenotype obtained 
after expression of GFP-ZG16dSP. The GFP-tag is quite large (~28 kDa) when compared 
with the Myc-tag (~1 kDa) and it is almost double the size of ZG16p, what might limit the 
full extent of the interaction of ZG16p with the binding partner or with other components, 
resulting in a different membrane phenotype.  
 
4.3.5. GFP-ZG16dSP and Myc-ZG16dSp bind to the same motile structures  
As observed before (4.3.4), expression of GFP-ZG16dSP and Myc-ZG16dSP in 
mammalian cells results in the labelling of morphologically different membrane structures. 
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To verify if the labelling of both proteins corresponds to the same organelle/structure both 
constructs were co-transfected in COS-7 cells (Figure 31). Co-transfected cells showed a 
phenotype with labelled spherical and elongated structures, similar to expression of Myc-
ZG16dSp or ZG16dSP alone. Furthermore, GFP-ZG16dSP and Myc-ZG16dSP colocalized 
showing that they were bound to the same organelle/structure (Figure 31 A-C). This finding 
shows that although expression of GFP-ZG16dSP or Myc-Zg16dSP alone results in different 
phenotypes, the labelling corresponds to the same structure/organelle. And, since co-
expression of both plasmids results in a membrane compartment composed of spherical and 
elongated tubular structures that correspond to a phenotype similar to expression of Myc-
ZG16dSP or ZG16dSP, we suggest that this is the “dominant” phenotype or the phenotype 
that would result from escape of ZG16p to the cytoplasm.  
 
Figure 31. GFP-ZG16dSP and Myc-Zg16dSP bind to the same organelle. COS-7 cells were co-transfected 
with GFP-ZG16dSP and Myc-ZG16dSP and processed for indirect immunofluorescence 24 h after transfection 
using antibodies directed to the Myc tag. Overlays (Merge) of the confocal images are shown on the right (C 
and F). Yellow dots show colocalization of both proteins (C). Co-transfected cells show a phenotype similar 
to expression of Myc-ZG16dSP alone (A-C). This phenotype is clearly different from the one observed in cells 
transfected only with GFP-ZG6dSP (D-F). Bars, 20 µm  
Additionally, we performed live cell experiments after co-expression of Myc-
ZG16dSP and GFP-ZG16dSp in order to investigate the mobility of the labelled 
structures/organelles. Co-expression of both constructs allowed the visualization of the 
“dominant” phenotype as shown before. Figure 32 shows single planes taken every 13 
second using a laser scanning confocal microscope. The yellow arrow highlights a mobile 
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membrane structure in co-transfected COS-7 cells. The fact that the observed structures are 
mobile and dynamic indicates that ZG16p is bound to a membranous organelle.  
 
Figure 32. Cytoplasmic ZG16p binds to mobile organelles. COS-7 cells were co-transfected with GFP-
ZG16dSP and Myc-ZG16dSP and prepared for live cell microscopy in the following day. Single planes were 
taken using a laser scanning confocal microscope. ZG16p positive organelles were tracked over an 11 minutes 
period taking pictures every 13 second. Co-transfection is indicated by the phenotype of the organelles (similar 
to Myc-ZG16dSP) and the green fluorescence (from GFP-ZG16dSP). Yellow arrow indicates an organelle 
with clear movement.  
 
4.3.6. Cytoplasmic ZG16p binds to the endo-lysosomal compartment 
Aiming at the identification of the organelles that are labelled by cytoplasmic ZG16p 
we performed colocalization experiments with endosomal and lysosomal markers. The 
protein EEA1 (early endosome antigen 1) is a known endosomal marker. COS-7 cells 
transfected with Myc-ZG16dSP or GFP-ZG16dSP were prepared for immunofluorescence 
with anti-Myc and anti-EEA1 antibodies (Figure 33). Myc-ZG16dSP colocalized partially 
with EEA1 (Figure 33 A-C), while GFP-ZG16dSP has a higher degree of colocalization 
(Figure 33 D-F). Both fusion proteins colocalized partially with the endosomal marker EEA1 
but their localization is not restricted to endosomes containing EEA1 protein. Since 
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expression of Myc-ZG16p or GFP-ZG16p showed a different phenotype and a different 
degree of colocalization with the EEA1 marker it indicates that the fusion proteins might 
interfere with the normal dynamics of the endosome compartment. We have shown that 
when co-expressed both constructs bind to the same structures. Thus, if both ZG16p 
constructs bind to the same structure but show a different degree of colocalization with the 
same marker it indicates that those structures are being affected differently by the expressed 
proteins. In support of this we can observe that the phenotype of normal endosomes (cells 
not transfected) shown by staining of the EEA1 marker (Figure 33 G-H) is different from 
the phenotype observed after expression of GFP-ZG16p (Figure 33 D-F) or Myc-ZG16p 
(Figure 33 A-C).  
 
Figure 33. Expression of ZG16p in the cytoplasm partially colocalizes with the early endosomal marker 
(EEA1). COS-7 cells were transfected with GFP-ZG16dSP or Myc-ZG16dSP and processed for indirect 
immunofluorescence 24 h after transfection using antibodies directed to the Myc tag and EEA1. Overlays 
(Merge) of the confocal images are shown on the right (C, F and I). Yellow dots show colocalization of the 
transfected protein (green) with EEA1 marker (red). Myc-ZG16dSP show a partial colocalization with 
EEA1(C) and a higher degree of colocalization is observed between GFP-ZG16dSP and EEA1 (F). (H and I) 
show the typical phenotype for EEA1 in non transfected cells. Bars, 20µm.  
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In addition we have used the endosomal probe transferrin conjugated with the 
fluorophore Texas Red (TexasRed-Tf) to investigate the colocalization of endosomes with 
GFP-ZG16dSP. The serum protein transferrin is of major importance for the cellular iron 
uptake mechanism (Baravalle et al., 2005; Chung and Wessling-Resnick, 2003). Iron-loaded 
transferrin binds to the transferrin receptor (TfnR) and both are efficiently internalized into 
acidic early endosomes, in which both Fe3+ ions are released, with apotransferrin remaining 
bound to the receptor. The apotransferrin-TfnR complex is then recycled to the plasma 
membrane where the neutral pH of the extracellular environment causes its dissociation 
(Baravalle et al., 2005). Figure 34 shows partial colocalization between GFP-ZG16dSP and 
TexasRed-Tf (arrows) supporting the finding that cytoplasmic ZG16p interacts with the 
endosomal compartment.  
 
Figure 34. Expression of ZG16p in the cytoplasm partially colocalizes with the endosomal marker transferrin 
(TexasRed-Tf). COS-7 cells were transfected with GFP-ZG16dSP and incubated with TexasRed-transferrin 
(TexasRed-Tf) for 1 h and fixed with 4% paraformaldehyde. Overlays (Merge) of the confocal images are 
shown on the right column (C and F). Arrows indicate colocalization of the transfected protein (green) with 
TexasRed-Tf (red). (D-F) Images of non transfected cells. Bars, 20µm.  
Next, we tested colocalization of Myc-ZG16dSP and ZG16dSP with the lysosomal 
compartment. The most abundant transmembrane proteins of the lysosomal membrane are 
the lysosomal associated membrane proteins LAMP-1 and LAMP-2 (Schwake et al., 2013). 
To investigate the interaction of ZG16dSP with lysosomes we used the construct GFP-
Lamp1 either co-expressed with the ZG16dSP or Myc-ZG16dSP constructs in COS-7 cells. 
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Partial colocalization was observed by confocal microscopy between ZG16dSP and GFP-
Lamp1 (Figure 35 A-C) and between Myc-ZG16dSP and GFP-Lamp1 (Figure 35 D-F). This 
indicates that cytoplasmic ZG16p also binds to lysosomes. Images of cells expressing GFP-
Lamp1, ZG16dSp and Myc-ZG16dSP alone were taken during the same experiment (Figure 
35 G-O), showing the characteristic phenotype that results from expression of each 
construct.  
Taken together, these results indicate that expression of the lectin ZG16p in the 
cytoplasm leads to its interaction with the endo-lysosomal compartment.  
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Figure 35. Expression of cytoplasmic ZG16p partially colocalizes with the lysosomal marker Lamp1. COS-7 
cells were co-transfected either with GFP-Lamp1 and ZG16dSP or GFP-Lamp1 and Myc-Zg16dSP and 
processed for indirect immunofluorescence 24 h after transfection using antibodies directed to the Myc tag and 
ZG16p. Overlays (Merge) of the confocal images are shown on the right (C, F, I, L and O). Yellow dots 
represent colocalization of the lysosomal marker Lamp1 (green) with the cytoplasmatic ZG16p (red) (C and 
F). Both ZG16p constructs partially colocalize with GFP-Lamp1, as indicated by arrows on the right column 
(zoom of dashed areas on the corresponding merge panel – C and F). (G-O) Images of single transfected cells 
showing the phenotype corresponding to each construct taken in the same experiment. Bars, 20µm. 
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4.3.7. Cytoplasmic ZG16p binds to endo-lysosomal compartment through 
the proteoglycan binding site K33A.K36A.R37A. 
We discovered that cytoplasmic ZG16p is able to bind to the endo-lysosomal 
compartment but the details of the interaction and the binding partner(s) were still unknown. 
To perceive if the proteoglycan and/or the glycan binding motifs, present in the ZG16p, were 
responsible for the cytoplasmic ZG16p interaction with the endo-lysosomal compartment, 
we generated several point mutations in a similar way to the ER-Myc-ZG16p construct (see 
Chapter 4.3.3). New constructs were generated based on Myc-ZG16dSP and GFP-
ZG16dSP: Myc-ZG16dSP_K, Myc-ZG16dSP_R, Myc-ZG16dSP_D and GFP-
ZG16dSP_K, GFP-ZG16dSP_R, GFP-ZG16dSP_D (K and R represent the mutation of 
proteoglycan binding sites, while D represents the mutation of the glycan binding site). 
Expression of the Myc-tagged mutants in COS-7 cells revealed that only the Myc-
ZG16dSP_K mutant inhibited the binding of cytoplasmic ZG16p to the endo-lysosomal 
compartment and was now observed spread through the cytoplasm (Figure 36). The same 
result was obtained in the case of the GFP-tagged mutants, where only GFP-ZG16dSP_K 
did not bind to the endo-lysosomal compartment (Figure 36). This indicates that the 
interaction of cytoplasmic ZG16p with the endo-lysosomal compartment is mostly 
electrostatic, being mediated by positive amino acids (K33A.K36A.R37A) present on the 
surface of ZG16p (see Figure 5).  
Surprisingly, during the generation of a construct for expression of ZG16p in 
mammalian cells we discovered that ZG16p binds to the endo-lysosomal compartment when 
expressed in the cytoplasm. Although ZG16p is not present in the cytoplasm under normal 
conditions its release from the ZG might happen under disease conditions. Furthermore we 
showed that the binding of ZG16p to the endo-lysosomal compartment is mediated by a 
positive patch constituted by positive amino acids (K33 K36, R37) present on the surface of 
ZG16p. This further supports a potential (patho)physiological role of ZG16p in mammalian 
cells. We should not forget that the expression of ZG16p is not limited to the pancreas but 
is observed throughout the gastro-intestinal tract and other tissues as well (see Chapter 
1.5.3.4).  
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Figure 36. Mutation of the proteoglycan binding site K33A.K36A.R37A inhibits the binding of cytoplasmic 
ZG16p. COS-7 cells were transfected with Myc-ZG16dSP or GFP-ZG16dSP or with the mutants Myc-
ZG16pdSP_K, Myc-ZG16dSP_R, Myc-ZG16dSP_D and GFP-ZG16dSP_K, GFP-ZG16dSP_R, GFP-
ZG16dSP_D and processed for indirect immunofluorescence 24 h after transfection using antibodies directed 
to the Myc tag. Only the “K” mutant (Myc-ZG16dSP_K and GFP-ZG16dSP_K) shows a uniform 
cytoplasmatic and nuclear staining with no binding of the endo-lysosomal compartment (C-D and K-L). Bars, 
20µm.  
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5. Discussion 
The acinar cells of the exocrine pancreas are “specialists” in the synthesis, mass 
packaging/sorting, storage and regulated secretion of a complex mixture of digestive 
(iso)enzymes and associated proteins. This protein mixture is packaged in a condensed, 
predominantly inactive form into large (1 µm) zymogen granules (Arvan and Castle, 1992; 
Schrader, 2004). The digestive enzymes are released via the pancreatic duct system into the 
small intestine, where conversion of trypsinogen to trypsin is mediated by proteolytic 
cleavage via enterokinase, an enzyme of the duodenal mucosa. Activated trypsin then 
proteolytically cleaves and activates the other zymogens. Once in the intestinal tract, granule 
proteins are also supposed to fulfil important regulatory and protective functions, e.g. in host 
defence (e.g., ZG16p, Syncollin, GP2) (Bach et al., 2006; Hase et al., 2009; Parikh et al., 
2012; Szmola and Sahin-Tóth, 2007; Tateno et al., 2012).  
A first and crucial step in ZG biogenesis is the sorting of proteins to be packaged in 
the ZG. The zymogens progressively aggregate at the mildly acidic pH and high Ca2+ levels 
within the TGN and form dense core aggregates which are supposed to interact with the 
TGN membrane (Leblond et al., 1993). Whereas the selective aggregation of ZG proteins 
has been well documented, their interaction with the TGN/ZG membrane is poorly 
understood at the molecular level, and neither a common sorting signal nor a sorting receptor 
have been identified so far (Dikeakos and Reudelhuber, 2007; Fujita-Yoshigaki et al., 2013). 
Sorting during ZG biogenesis is supposed to take place also after the TGN, at the level of 
the ZG itself (Arvan and Castle, 1992).  
The application of proteomics has largely contributed to the identification of novel 
ZG proteins (Borta et al., 2010; Chen et al., 2006; Gómez-Lázaro et al., 2010; Rindler et al., 
2007), but was not yet accompanied by a better characterization of their functions. The 
analysis of ZG components has also led to the identification of unique mammalian proteins 
with unusual structural and biochemical properties (Cronshagen et al., 1994; Hase et al., 
2009; Hodel et al., 2001; Kanagawa et al., 2011). Whereas most of the cargo zymogens are 
well characterized on the molecular and biochemical level, there is still very little 
information available on the non-enzymatic ZG proteins (e.g. at the ZGM), their biochemical 
properties, interplay and functions. The current lack of knowledge has greatly hampered the 
development of therapeutic and pharmacological approaches to diagnose, prevent and treat 
acinar cell injury and pancreatic disease. The identification of ZG content and membrane 
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components, their molecular characterization and the unravelling of their biochemical 
properties and functions are therefore highly relevant for the understanding of granule 
biogenesis and regulated secretion and will help point the way to treatments for diseases of 
the pancreas and the gastrointestinal tract.  
 
5.1. Chymase and PpiB are two novel ZG proteins with proteoglycan-
binding properties 
As there is great need in the identification and molecular characterization of ZG and 
ZGM components, we have performed a suborganellar proteomics approach, based on 
carbonate-treatment of ZGM and analysis by 2D-PAGE of the corresponding supernatant 
(Wash) fraction, which has so far led to the identification of novel peripheral ZGM proteins 
with proteoglycan-binding properties (chymase, PpiB). In this part of the dissertation, we 
focused on the identiﬁcation and characterization of a “basic” group of membrane-associated 
proteins (pI range 6.2-11). As a veriﬁcation of our approach, two previously reported 
peripheral (basic) ZG proteins, the secretory lectin ZG16p (pI 9.2) and syncollin (pI 8.6), 
were identiﬁed in this study. ZG16p is supposed to interact with the ZGM via its lectin 
domain, whereas syncollin has been shown to interact with cholesterol and the GPI-anchored 
membrane glycoprotein GP2 (Kalus et al., 2002; Kleene et al., 1999b). Furthermore, no 
transmembrane proteins or classical membrane-anchored proteins were detected. On the 
basis of bioinformatic information and published results, almost all of the identiﬁed proteins 
are able to enter the secretory pathway, thus conﬁrming their interaction with the luminal 
side of the ZGM. The two identiﬁed cytosolic proteins vinculin (fragment), an actin-binding 
protein, and ubiquitin carrier protein involved in ubiquitination/quality control may be 
associated with the cytosolic side of the ZG. Two novel proteins, rat mast cell chymase and 
PpiB, an ER-resident protein, were selected for further validation of our approach. By 
applying immunoblotting for the detection of ER and mast cell marker proteins, we were 
able to rule out that the presence of chymase and PpiB in our granule subfractions was the 
result of a contamination with ER or mast cell granules/proteins. The distribution of chymase 
and PpiB in the granule subfractions resembled that of ZG16p, a typical peripheral ZGM 
marker, further conﬁrming that chymase and PpiB are genuine peripheral ZGM proteins. 
Chymase has been identiﬁed as a major, highly basic chymotrypsin-like serine protease of 
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mast cells, where it is stored in regulated secretory granules. Thus, its presence in ZGs of 
the exocrine pancreas is not that unusual at all. With respect to function, chymase is likely 
to act as a serine protease after ZG secretion. Chymase of mast cells is involved in 
inﬂammatory processes and tissue-remodelling (Leskinen et al., 2003). PpiB (Cyclophilin 
B) is a highly basic cyclosporin A-binding protein with peptidyl-prolyl cis-trans isomerase 
activity. It belongs to a group of enzymes (cyclophilins) that bind to the immunosuppressor 
cyclosporine A (Galat, 1993) and catalyse protein folding of prolin-containing polypeptide 
chains (Fischer et al., 1989; Takahashi et al., 1989; Wang and Heitman, 2005). PpiB is sorted 
to the secretory pathway via an ER targeting signal (Bose et al., 1994; Price et al., 1994) and 
has been reported to be retained in specialized regions of the ER (Arber et al., 1992), but 
also as a secretory protein without ER-retention signal (Mariller et al., 1996; Price et al., 
1994). PpiB was also identiﬁed in other exocrine secretions such as human saliva in a recent 
proteomic approach (Walz et al., 2006). Thus, besides its intracellular localization, PpiB can 
also be found in the extracellular space, where it might contribute to intercellular 
communication (Bukrinsky, 2002; Daum et al., 2009). PpiB in ZG might act as a chaperone 
in protein folding, and can assist in protein sorting and/or regulation of an active/inactive 
conformation of digestive enzymes. However, a function in the regulation of membrane 
channels, Ca2+-dependent processes or in immune defence after secretion are alternative or 
additional modes of action (Arber et al., 1992; Bram and Crabtree, 1994; Galat, 2003; 
Montague et al., 1997). 
 
5.1.1. Several ZG enzymes are also membrane-associated  
Interestingly, several known digestive enzymes, among them many lipid-interacting 
enzymes, were also identiﬁed in the Wash subfraction. The presence of these classical 
content (ZGC) proteins in a ZGM fraction is usually interpreted as a contamination. 
However, it should be noted that these enzymes remain partially attached to the ZGM even 
under more stringent puriﬁcation conditions (e.g., KBr wash before carbonate treatment) or 
after further puriﬁcation of crude ZGM by gradient centrifugation (Chen et al., 2006; Rindler 
et al., 2007). Interestingly, many of the membrane-associated enzymes identiﬁed in this 
study in a membrane Wash subfraction have been predicted to be potential luminal ZGM 
proteins in a recent topology analysis of puriﬁed ZGM (Chen et al., 2008). Thus, it is very 
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likely that the identiﬁed subset of peripheral digestive enzymes exhibits a more speciﬁc 
interaction with the ZGM than previously expected. Enzymes with lipid-binding properties 
might interact with membrane lipids to speciﬁcally associate with the ZGM. The presence 
of CEL at the ZGM might be mediated by its capability to bind to lipid surfaces. In support 
of this notion, sphingolipid-binding domains of CEL are supposed to mediate its interaction 
with lipid rafts (Aubert-Jousset et al., 2004). Furthermore, CEL has been found to be 
associated with lipid microdomains, which have been identiﬁed in ZGM (Berkane et al., 
2007; Schmidt et al., 2001). Their importance for granule biogenesis has been demonstrated 
in recent studies (Gondré-Lewis et al., 2006; Schmidt et al., 2001). We also detected a 
prominent amount of RNase A at the ZGM. Interestingly, this interaction might be mediated 
by the interaction of RNase A with proteoglycans, for example, of a predicted 
submembranous granule matrix (Scheele et al., 1994; Schmidt et al., 2000). RNase A has 
been shown to interact with heparin and chondroitin sulfate (Dvorak and Morgan, 1998a, 
1998b), and on the basis of these properties, a protein A-gold-RNase A technique has been 
developed to detect proteoglycans in cellular compartments and tissues (Dvorak and 
Morgan, 1999a). Protein A-gold-RNase A also labelled putative proteoglycans in ZG at the 
membrane and in the content (Dvorak and Morgan, 1999b). Furthermore, an interaction with 
proteoglycans has been described for chymase, PpiB, and CEL (Allain et al., 2002; Pejler 
and Maccarana, 1994; Rebaï et al., 2005; Vanpouille et al., 2004). This interaction is 
supposed to inﬂuence enzyme function (Dvorak and Morgan, 1998b; Pejler and Berg, 1995). 
The negatively charged proteoglycans in secretory granules of hematopoietic cells and mast 
cells are engaged in the binding of small positively charged molecules, such as histamine 
and proteases, and have therefore been considered to promote the efﬁcient packaging and 
concentration of secretory products (Rönnberg et al., 2012). Similarly, proteoglycans within 
ZGs are supposed to interact electrostatically and through speciﬁc protein-protein and 
carbohydrate-protein binding domains with the secretory proteins of the granule content 
(Borta et al., 2010; Gómez-Lázaro et al., 2010; Scheele et al., 1994; Schmidt et al., 2000; 
Schrader, 2004). 
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5.2. Discovery of new properties of the unusual lectin ZG16p 
5.2.1. Digestion of ZG under native conditions reveals several protease 
resistant proteins 
We started the identiﬁcation of peripheral, membrane-associated proteins of the 
ZGM by a suborganellar proteomics approach based on carbonate-treatment of ZGM and 
2D-PAGE of the corresponding Wash subfraction and revealed a “basic” group of membrane 
associated proteins (see above). However, the identification of the complementary “acidic” 
group of proteins from the Wash subfraction was not as successful, mostly due to a difficulty 
in identification of the acidic proteins by MS. One approach to increase sequence coverage 
is to use proteases other than trypsin for digestion (Guo et al., 2014). Pancreatic enzymes are 
secreted in an inactive form (pro-enzymes) and are activated in the duodenum by EK. Thus, 
in an attempt to improve the coverage of the ZG proteome we designed an experiment to 
take advantage of the easy activation of zymogens by EK followed by separation of the 
resulting peptides by LC and identification by MS. 
However, our goals were not accomplished since only the major zymogens were 
identified by this method. Two major drawbacks hampered the identification of the ZG 
proteome by the described method: a) the high amount of zymogens resulted in a high 
number of peptides that were hiding the lowest abundant peptides, and b) the high digestion 
rate observed, leading to the generation of very small peptides, not suited for analysis by 
MS. Nevertheless, this approach resulted in the discovery of a set of proteins that are highly 
resistant to proteolysis (e.g., CBP, CTRC, ELA and ZG16p). From these proteins only one 
is not an enzyme, the lectin ZG16p. It is generally accepted that the pancreatic enzymes have 
a certain degree of proteolytic resistance to each other. For example, it is known that 
chymotrypsin C is a regulator of trypsin activity. In the high Ca2+ environment of the 
duodenum it facilitates trypsinogen activation, while in the lower gastrointestinal tract (GIT), 
CTRC promotes trypsin degradation as a result of a reduction in Ca2+ concentration (Szmola 
and Sahin-Tóth, 2007). It was also shown that elastase is not significantly degraded during 
intestinal transit (Dominici and Franzini, 2002). Actually, bacterial enzymes are responsible 
for most of the degradation of endogenous pancreatic proteases in the intestine (Tooth et al., 
2014). However, the discovery that a small secretory lectin is highly protease resistant, 
caught our attention. ZG16p (16 kDa) is the first mammalian lectin that was shown to possess 
a Jacalin-related β-prism fold. It localizes at the luminal side of the ZGM where it associates 
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with cholesterol-glycosphingolipid-enriched microdomains together with GP2, syncollin 
and sulfated proteoglycans (Kalus et al., 2002; Schmidt et al., 2001; Schrader, 2004). 
Furthermore, it was shown recently to bind to mannose via its carbohydrate recognition 
domain and to sulphated proteoglycans through a proteoglycan binding motif (see Chapter 
1.5.3.1and 1.5.3.2). Furthermore, a function as a linker/helper protein in the binding of 
aggregated zymogens to the granule membrane has been proposed and it might as well have 
a role in host protection in the GIT (see Chapter 1.5.3.5). Other pancreatic lectins (e.g., the 
Reg family) were already shown to have some degree of protease resistance (Parikh et al., 
2012). This family belongs to the C-type lectins and is structurally different from ZG16p 
(e.g., different 3D structure and glycan binding motifs). Nevertheless the Reg family lectins 
belong to a new set of multifunctional pancreatic lectins that besides the recognition of 
glycans might possess other functions either in the pancreas before secretion or in the 
extracellular environment after secretion. Moreover, expression of ZG16p and the Reg 
family lectins is not limited to the pancreas but extends to the GIT and other organs (see 
Chapter 1.5.3.4), pointing to a general (patho)physiological role of those pancreatic lectins. 
Although the Reg family lectins have been consistently studied in the last 20 years (Parikh 
et al., 2012), the lectin ZG16p has received much less attention. After the initial discovery 
in 1994 and its implication in the sorting of zymogens to ZG a few years later (Kleene 
1999a), a thorough characterization of ZG16p structure and function only began recently 
(Kanagawa et al., 2011, 2014; Kumazawa-Inoue et al., 2012; Tateno et al., 2012).  
We have discovered new biochemical properties of ZG16p that might be of major 
importance to its multiple (patho)physiological roles and focused our studies on the further 
characterization of ZG16p. 
 
5.2.2. ZG16p protease resistance is an intrinsic property  
The finding that ZG16p is protease resistant raised the question if the resistance was 
a result of the binding of ZG16p to proteoglycans in ZG or if it was an intrinsic characteristic 
of ZG16p. To answer this questions we generated and purified recombinant ZG16p with the 
purpose of testing the resistance of the purified protein against commercial trypsin. ZG16p 
was cloned in a bacterial expression vector without the signal peptide since in the mature 
form of the lectin the SP is not present. Two constructs with two different tags at the N-
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terminus of ZG16p were generated: one with a histidine tag (His-ZG16p) and another with 
a histidine and a Myc tag (HMyc-ZG16p). This allowed us to purify both constructs with aid 
of the His tag and distinguish them by the molecular weight and by immunostaining with 
specific antibodies due to the presence of the Myc tag. Finally, digestion of both recombinant 
proteins with trypsin proved that core protein of ZG16p is protease resistant. Although 
partial digestion was observed, it was shown by immunoblotting that only the N-terminal 
tags were cleaved. After digestion the size of the recombinant proteins was equal to the 
endogenous protein and the N-terminal tags were no longer detected by the antibodies. 
Furthermore, cleavage of the C-terminus is unlikely because the last ≈20 aa are buried in the 
ZG16p molecule (Figure 37) and thus not accessible for enzymatic cleavage.  
 
 
 
Figure 37. Tertiary structure of ZG16p (PDB entry 
3APA) with indication of C- and N- terminus. 
 
 
 
 
Remarkably, ZG16p has 16 potential cleavage sites for trypsin (see Supplementary 
Figure 2) but it was shown to be highly protease resistance. The molecular determinants for 
the protease resistance remain to be discovered but we suggest that the tertiary structure of 
ZG16p must have a crucial role. ZG16p has a β-prism I fold consisting of 3 β-sheets that 
confer high stability to the protein (see Chapter 5.2.4). β-Sheet proteins have a higher 
percentage of residues that form contacts with residues distant in the primary sequence than 
α-helical proteins (Junker and Clark, 2010) what accounts for the increased stability. 
Proteolytic stability generally correlates with thermal stability of proteins (Akasako et al., 
1995; Daniel et al., 1982; McLendon and Radany, 1978; Parsell and Sauer, 1989) and most 
proteins in their native conformation offer some resistance to proteases, whereas they are 
rapidly degraded after unfolding (Markert et al., 2001). Futhermore, it is known that β-sheets 
are involved in the protease resistance of other proteins. For example, the protease resistant 
prion protein (PrPSc), an infectious agent responsible for a group of different rare animal and 
N-terminus C-terminus 
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human diseases known as transmissible spongiform encephalopathies (TSEs). The 
conversion of PrPC (normal cellular prion protein) into PrPSc involves a conformational 
change of the protein in which the total amount of β-sheets increases and that of α-helical 
secondary structures decreases. These conformational differences are the only demonstrated 
structural differences between PrPSc and PrPC (Sajnani et al., 2012). Furthermore, it has been 
described that the breakdown of β-sheets in PrPSc by denaturation results in loss of infectivity 
and proteinase K-sensitivity, suggesting a relationship between the structure and proteinase 
K-resistance (Sajnani and Requena, 2012).  
 
5.2.3. ZG16p interacts with a high molecular weight complex  
ZG16p is thought to mediate sorting of ZG proteins by interacting with aggregated 
zymogens and the predicted submembranous granule matrix composed by high molecular 
weight components (see Chapter 1.5.3.5). Here we show that ZG16p interacts with a protease 
resistant high molecular weight complex that prevents the migration of ZG16p in SDS-
PAGE. Preparation of digested ZG (ZG_EK) at 95˚C in SDS loading buffer and separation 
by SDS-PAGE resulted in the migration of ZG16p to its expected (monomeric) size (16 
kDa). In contrast, when the sample was prepared at room temperature, ZG16p was found at 
the top (stacking) gel indicating that it did not enter the gel. Furthermore, we have tested the 
ZGC, ZGM and Wash fractions in order to rule out the presence of aggregates (ZGC) or 
binding of ZG16p to membranes (ZGM) as the cause for retention of ZG16p on the top of 
the gel. The Wash subfraction is obtained after treatment of the ZGM with sodium carbonate 
at pH 11.5 followed by centrifugation to separate the “washed” membranes containing 
integral membrane proteins from a solution rich in membrane-associated proteins and 
proteoglycans (Figure 3). By comparing both fractions we were able to rule out the presence 
of lipids as part of the high molecular weight complex since it was observed that ZG16p is 
retained on top of the gel when digested ZGM or Wash samples are prepared at RT. Both 
fractions only share the membrane associated proteins (e.g., ZG16p) and sulfated 
proteoglycans (see Chapter 1.3.1), suggesting that the interaction of ZG16p with sulphated 
proteoglycans is responsible for the impairment of ZG16p migration in SDS-PAGE when 
the sample is prepared in SDS loading buffer at RT. Furthermore, the recombinant ZG16p 
was used as a control to confirm that ZG16p migrates to the correct molecular mass even 
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when prepared at RT in SDS loading buffer. Recently, it was shown by immunoblotting with 
an anti-heparan sulfate antibody (HepSS-1) that the proteoglycans of rat pancreatic ZG have 
an apparent molecular weight of 120,000-500,000 Da (Kumazawa-Inoue et al., 2012). This 
further indicates that the ZG proteoglycans are large molecules and may form a high 
molecular weight complex within ZG. 
The comparison of treatment with heparin lyases demonstrated that the heparan 
sulfate proteoglycans of ZG are preferentially digested with heparin lyase II (heparitinase II) 
(Kumazawa-Inoue et al., 2012). For that reason, we have used the enzyme heparitinase II to 
digest the GAGs of the proteoglycans of ZG_EK and ZGM_EK in order to break down the 
high molecular weight complexes and to allow ZG16p to enter the SDS-PAGE. This would 
further support our hypothesis that ZG proteoglycans are part of a HMW complex and 
responsible for retaining ZG16p at the top of the PA gel. However, this issue could not be 
addressed successfully. Most probably denaturation of the digested samples is required to 
provide access of the enzyme HPRT to the GAGs, but this would also interfere with our 
assay by promoting the release of ZG16p. In addition, we cannot rule out that the binding of 
ZG16p to the proteoglycans protects the GAGs from being digested. Further experiments 
may benefit from different digestion conditions and by using other enzymes (e.g., 
chondroitinase ABC). So far, the identification of the proteoglycan core proteins within ZG 
by MS analysis was not successful (Kumazawa-Inoue et al., 2012). It will be a great 
challenge for future studies to identify and characterize the high molecular weight 
components such as proteoglycans in ZG fractions to unveil the complex architecture and 
putative interactions at the granule membrane (Borta et al., 2010).  
 
5.2.4. ZG16p is a dimeric protein 
Although a potential ZG16p dimer was reported in earlier studies by immunoblotting 
(Kalus et al., 2002; Kleene et al., 1999b) it was recently suggested that ZG16p is a 
monomeric protein based on analysis by size exclusion chromatography of recombinant 
ZG16p (Kanagawa et al., 2011). However, this observation was based on analysis of a 
recombinant protein that lacks 8 aa at the C-terminus (160-167). This region might be 
important for formation or stabilization of ZG16p dimers.  
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We have investigated the formation of ZG16p dimers by denaturation of endogenous 
and recombinant proteins at different temperature and incubation times. Since endogenous 
and recombinant proteins have different molecular weights, the dimerization of each protein 
should result in the formation of dimers with different molecular weights. This was 
confirmed by immunoblotting with the appearance of a band double in size of the monomeric 
form for all proteins. In addition, the band that corresponds to the dimeric form decreased 
with rise of temperature and time of incubation but resisted at least for 10 min. at 95˚C, 
indicating that denaturation of ZG16p is only achieved after a long exposure to high 
temperatures. These results indicate that ZG16p forms highly stable dimers. Oligomeric 
proteins are abundant in nature. It was suggested that 35% or more of the cellular proteins 
are oligomeric (Goodsell and Olson, 2000), although the proportion of oligomeric protein 
structures deposited in the Protein Data Bank is significantly lower (Ali and Imperiali, 2005). 
ZG16p was the first Jacalin related lectin found in mammals and the structural 
alignment reveals that ZG16p is strikingly similar to the banana lectin Banlec (Figure 38). 
The percentage of sequence identity between both proteins is only 25.3% while the structure 
similarity is of 95%. Banlec is a dimer and displays substantial conformational stability in 
the presence of chaotropic agents (Gupta et al., 2008) and during high-temperature (400–
500 K) simulations (Gupta et al., 2009). The stability of the dimer results from strong 
hydrogen bonds and water bridges at the interface (Gupta et al., 2008).  
 
Figure 38. Structural alignment of ZG16p (PDB entry 3APA) and Banlec (PDB entry 2BMY.A). Different 
views are shown to demonstrate the high similarity between both structures: (A) top view, (B, C) lateral view. 
The blue structure corresponds to Banlec and the yellow to ZG16p.  
Based on our results and the similarity of the tertiary structure of ZG16p and Banlec 
we suggest that ZG16p is also a highly stable homodimeric protein. The slow denaturation 
A
  A 
B
  A 
C
  A 
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of the endogenous and recombinant ZG16p observed (Figure 15) may reflect the stability 
mediated by the presence of inter- and intramolecular hydrogen bonds (Figure 39).  
 
Figure 39. Tertiary structure of ZG16p (PDB entry 3APA) showing the hydrogen bounds formed between the 
3 β-sheets. (A, B) lateral view; (C) top view.  
Although both proteins are structurally very similar, they show some functional 
differences: BanLec possesses two carbohydrate-binding sites including the signature 
motifs GG and GXXXD (Meagher et al., 2005; Singh et al., 2005), which are partly conserved 
in ZG16p; ZG16p has only one carbohydrate recognition domain and a proteoglycan binding 
motif in the place of the second CRD of Banlec. Another major difference is that the surface 
of Banlec is mainly negative in contrast with the presence of positive patches on the surface 
of ZG16p (Kumazawa-Inoue et al., 2012). These differences account for the different 
binding activity.  
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5.3. Targeting of ZG16p to ZG in AR42J cells is not dependent on its 
CRD and PGM domains  
Whereas most of the cargo zymogens are well characterized on the molecular level, 
there is still very little information available on the molecular components of the granule 
membrane (ZGM), their biochemical properties, interplay and functions (Borta et al., 2010; 
Chen et al., 2006; Rindler et al., 2007; Wagner and Williams, 1994). Furthermore, the 
specific interaction of regulated secretory proteins with the TGN/ZGM and their ultimate 
sorting into immature granules is poorly understood, especially in exocrine systems, where 
specific sorting signals and receptor proteins have so far not been identified (Dikeakos and 
Reudelhuber, 2007). It was suggested that ZG16p mediates the binding of aggregated 
secretory proteins to the predicted submembranous matrix (see Chapter 1.5.3.5). This 
protein scaffold underneath the ZGM is supposed to serve as the backbone of a complex 
membrane matrix, and a bridge between the ZGM and the zymogens. ZG16p may act as a 
linker molecule between the ZGM/submembranous matrix and aggregated secretory 
proteins and thus, in protein sorting. We examined if the glycan binding motifs are required 
for proper targeting of ZG16p to ZG, first by deletion of the CRD and later by point mutation 
of CRD and PGM and expression in AR42J cells, a pancreatic cell model.  
 
5.3.1. Deletion of CRD inhibits targeting of ZG16p to ZG 
AR42J cells have been used as a model system for granule formation and pancreatic 
exocrine secretion. Treatment with the glucocorticoid dexamethasone induces both the 
differentiation of AR42J cells into acinar-like cells and the de novo formation of electron-
opaque secretory granules, which contain the major pancreatic zymogens (Logsdon et al., 
1985). To investigate the targeting of ZG16p in AR42J cells we have first generated a 
construct with ZG16p tagged at the N-terminus (ER-Myc-ZG16p) (Figure 18). We 
confirmed that this construct is targeted to ZG by colocalization with CBP (ZG marker) in 
AR42J cells. Then, we deleted the CRD (GXXXD) (ER-Myc-ZG16dCRD) to verify if the 
absence of this domain would influence the targeting of ZG16p in AR42J cells. 
Colocalization of ER-Myc-ZG16dCRD and CBP was not observed, indicating that the 
mutant is not targeted to ZG in AR42J cells. Furthermore, by absence of colocalization with 
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two Golgi markers (TGN38 and p115) we showed that the ER-Myc-ZG16dCRD construct 
is not transported to the Golgi either. However, the control (ER-Myc-ZG16p) colocalized 
with both Golgi markers. 
The ZG proteins are synthesized by ribosomes and inserted into the lumen of the 
ER. The Golgi complex receives the proteins from the ER and processes them further. Then, 
the sorting of proteins to be packaged in ZG takes place at the TGN. Our results indicate 
that the deletion of the CRD inhibits the transport of ZG16p from the ER to the Golgi 
complex, thus disrupting the targeting to ZG. However the deletion of the CRD (total of 5 
aa) might interfere with the correct folding of the protein. Polypeptides that fail to fold 
properly or never become part of a multisubunit complex are retained within the ER and 
later transported back across the ER membrane into the cytosol and degraded by the 
proteasome (Meusser et al., 2005).  
 
5.3.2. Point mutations of CRD and PGM do not inhibit the targeting of 
ZG16p 
To confirm that inhibition of ZG16p targeting was due to the impairment of the CRD 
and not to instability of the protein caused by the deletion of the domain, we inhibited the 
CRD by point mutation. Only one amino acid was changed, keeping the protein as similar 
to the wild type as possible. The aspartic acid residue of the CRD (GXXXD) was previously 
demonstrated by point mutation (D151A) to be essential for binding of ZG16p to mannose 
(Tateno et al., 2012). To confirm that the CRD is responsible for the targeting of ZG16p, we 
performed a point mutation of D151A (ER-Myc-ZG16_D) followed by expression in AR42J 
cells. Colocalization between ER-Myc-ZG16_D and CBP indicated that this mutant was 
properly targeted to ZG in AR42J cells. ZG16p also possesses a PGM that mediates the 
binding to sulphated proteoglycans, and it was shown that point mutation of the PGM 
residues (K33A, K36A, and R37A) and (R55A and R58A) abolishes the binding 
(Kumazawa-Inoue et al., 2012). Thus, we also generated point mutations in those PGM 
residues (resulting in ER-Myc-ZG16_K (K33A, K36A, and R37A) and ER-Myc-ZG16_R 
(R55A and R58A)) to verify if they interfere with the targeting of ZG16p. Finally, double 
and triple mutants were generated (ER-Myc-ZG16_K_R, ER-Myc-ZG16_R_D and ER-
Myc-ZG16_K_R_D). All mutants colocalized with the ZG marker CBP showing that they 
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are properly targeted to ZG in AR42J cells. This indicates that both domains (CRD and 
PGM) might not be directly involved in the targeting of ZG16p. However, once ZG16p is 
able to form stable homodimers, it is possible that the endogenous ZG16p present in AR42J 
cells dimerizes with the expressed mutants and targets them to ZG. Furthermore, it was 
suggested that the addition of the signal peptide, which is necessary for the translocation into 
the ER, is sufficient for the transportation and storage of cargo proteins in secretory granules 
of exocrine cells (Fujita-Yoshigaki et al., 2013). This is in line with a model known as 
“sorting by retention” (see Chapter 1.2) that proposes that proteins that are not destined for 
regulated secretion are loaded to immature granules at the TGN, and then are progressively 
removed from immature secretory granules via clathrin-coated vesicles (Klumperman et al., 
1998). Through the selective removal of nongranular proteins, immature granules are 
converted into mature granules (Fujita-Yoshigaki et al., 2013). 
We favour a model (Figure 40), in which a predicted submembranous matrix attached 
to the luminal side of the granule membrane fulfils important functions during the sorting 
and packaging of secretory proteins (Scheele et al., 1994; Schrader, 2004). We have 
identified novel ZG membrane/matrix proteins with proteoglycan-binding properties and 
presented evidence that a subset of peripheral digestive enzymes exhibits a more speciﬁc 
interaction with the ZGM than previously expected (Chapter 4.1.1). In light of the recent 
findings, the submembranous matrix might help in the retention of the proteins destined for 
regulated secretion by acting as a bridge between the ZGM and the aggregated zymogens. 
We showed here that ZG16p would be able to act as crosslinker as it can form stable dimers, 
thus potentially supporting the binding of aggregated zymogens to the submembranous 
granule matrix.  
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Figure 40. Proteoglycan matrix model. (A) Acinar unit. Zymogens are secreted into the pancreatic duct and 
further transported to the duodenum. (B) Acinar cell. Immature secretory granules (ISG) undergo maturation 
to form ZG. Their maturation involves further concentration of the cargo proteins with selective removal of 
components not destined for regulated secretion, and a reduction in granule size. A glycoconjugate scaffold 
underneath the ZGM is suggested to serve as the backbone of a complex membrane matrix, and a bridge 
between the ZGM and the zymogens. A membrane anchor is constituted by lipid microdomains and associated 
proteins (e.g., GP2) that are involved in the attachment of the matrix proteoglycans to the granule membrane. 
(C) Close view of ZG. The proteoglycan matrix is represented by a glycoconjugate scaffold underneath the 
ZGM, composed of proteoglycans, glycoproteins, ZG16p and other proteins (see Chapter 1.4). Separation of 
ZG into a ZGM fraction and a content fraction (ZGC) is obtained by gentle lysis of ZG followed by 
centrifugation. Carbonate treatment of the ZGM results into two subfractions: the treated membranes with 
integral membrane proteins (ZGMwashed) and a subfraction with membrane-associated proteins and a high 
molecular weight complex of proteoglycans and ZG16p (Wash). (D) Components of the proteoglycan matrix. 
Sulfated proteoglycans within ZG are supposed to interact electrostatically and through speciﬁc protein-protein 
and carbohydrate-protein binding domains with the secretory products of the granule content and promote the 
efficient packaging and concentration of secretory products. ZG16p interacts with sulfated proteoglycans and 
may act as a linker between the matrix and aggregated zymogens due to dimer formation. Chymase and PpiB 
were identified in ZG for the first time in this study and both were described previously to interact with sulfated 
proteoglycans; CEL was shown to be enriched in the wash subfraction and has been previously found to be 
associated with lipid microdomains and to interact with proteoglycans. 
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5.4. ZG16p as a new tool for the study of the endo-lysosomal 
compartment 
5.4.1. Cytosolic ZG16p labels the endo-lysosomal compartment  
ZG16p has an ER-targeting signal (SP) that directs the nascent protein to the ER. 
From there it is transported to the Golgi complex where it enters the secretory pathway and 
thereafter remains confined in membrane-bound organelles. However, we discovered that 
when ZG16p is expressed in the cytoplasm it binds to the endo-lysosomal compartment, as 
indicated by partial colocalization with endosomal and lysosomal markers. Remarkably, this 
interaction was observed after expression of ZG16p in various mammalian cell lines, 
pointing to a conserved ZG16p interaction partner across species. Additionally, we observed 
that expression of ZG16p tagged with Myc or GFP at the N-terminus results in two different 
endo-lysosomal phenotypes. The Myc-ZG16p is bound to a compartment composed of 
spherical and elongated tubular membrane structures, while GFP-ZG16p is bound to a 
membrane compartment composed by spherical structures only, with concentration of 
relatively large structures in the perinuclear region (Figure 41). These structures are likely 
lysosomes. It is important to note that the organelle morphology observed with the Myc-
tagged ZG16p is similar to the phenotype obtained after expression of an untagged version 
of ZG16p. For that reason, we suggest that this corresponds to the “physiological” phenotype 
or the phenotype that would result from an “escape” of native ZG16p to the cytoplasm. 
Furthermore, by co-expressing both tagged proteins it was demonstrated by confocal 
microscopy that both proteins colocalize with the same structures. This indicates that the 
tags do not interfere with the binding of ZG16p but might restrict the interaction with other 
components or even with itself (e.g., dimerization) resulting in different organelle 
morphologies. The Myc tag in contrary to the GFP tag is a small peptide and is less likely to 
disrupt the properties or localization of the tagged protein (Palmer and Freeman, 2004). The 
morphological differences observed after expression of Myc-ZC16p and GFP-ZG16p also 
indicate that the binding of ZG16p to endo-lysosomes might alter this compartment. This is 
supported by the different organelle morphologies observed after expression of the tagged 
proteins and also by comparison of organelle morphology in non-transfected cells.  
In order to characterize the binding of ZG16p to the endo-lysosomal compartment 
we manipulated the binding domains of ZG16p by point mutation. Several Myc-ZG16p and 
GFP-ZG16p constructs were generated with mutation of the CRD (Myc-ZG16p_D and GFP-
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ZG16p_D) and the PGM (Myc-ZG16_K, Myc-ZG16_R, GFP-ZG16_K and GFP-ZG16_R). 
Interestingly, only the mutants Myc-ZG16_K and GFP-ZG16_K abolished the binding to 
the endo-lysosomal compartment (Figure 41). This demonstrates that the binding of ZG16p 
to endo-lysosomes is mediated by a positive patch on the surface of ZG16p (aa K33, K36 
and R37) and is most probably due to electrostatic interaction with membrane components 
of the endo-lysosomal compartment. We have already started an approach to identify the 
lysosomal binding partner of ZG16p by expression of GFP-ZG16p in COS-7 cells and co-
immunoprecipitation with anti-GFP antibodies and crosslinking (data not shown).  
 
 
Figure 41. ZG16p is able to interact with different cell compartments. ZG16p has a signal peptide (SP) that 
targets the lectin to the ER (A), from where is able to enter the regulated secretory pathway (B). Expression of 
ZG16p without the SP leads to its interaction with the endo-lysosomal compartment (C and D). ZG16p tagged 
with Myc or GFP at the N-terminus results in two different endo-lysosomal phenotypes: Myc-ZG16p is bound 
to a compartment composed of spherical and elongated tubular membrane structures (C), while GFP-ZG16p is 
bound to a membrane compartment composed by spherical structures (D). However, mutation of the 
proteoglycan binding motif (K33A, K36A, and R37A) abolishes the binding of ZG16p to the endo-lysosomal 
compartment (E) for both tagged proteins (Myc-ZG16_K and GFP-ZG16_K).  
Altogether, these results reveal an interesting feature of ZG16p as a new endo-
lysosomal interacting protein. Furthermore, ZG16p has the capacity to modulate the endo-
lysosomal compartment. These observations indicate that ZG16p may be used as a novel 
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and specific tool to label (and manipulate) parts of the endosomal/lysosomal trafficking 
pathway. Lectins have the ability to act as recognition molecules inside cells, on cell surfaces 
and in physiological fluids (Reuter and Gabius, 1999) and have already been successfully 
used in the detection and assay of glycoconjugates in tissues, on cells or subcellular 
organelles and on gels, blots and many other techniques (Sharon and Lis, 2004) showing that 
lectins are very versatile biomolecules with great applicability in bioanalytical techniques 
and in biomedical diagnosis (Gemeiner et al., 2009).  
 
5.4.2. Does ZG16p have a role in the course of pancreatitis? 
As discussed above, ZG16p can interact with the endo-lysosomal compartment when 
expressed in the cytoplasm. Although this might be of debatable physiological importance 
as under normal conditions ZG16p is not present in the cytoplasm, it might be relevant under 
pathophysiological conditions. Interestingly, a treatment of mice with supraphysiological 
doses of cerulein inducing acute pancreatitis led to a rapid down regulation (12 h) of ZG16p 
mRNA in mouse pancreas with recovery of mRNA levels within 3 days (Neuschwander-
Tetri et al., 2004). During the course of pancreatitis the activated zymogens are capable of 
damaging vital cellular components (Logsdon and Ji, 2013) as a result of early activation 
and escape from the ZG. We can speculate that ZG16p might be able to escape from ZG 
under conditions of a pancreatitis and would be able to interact and interfere with the endo-
lysosomal compartment. It has been recently suggested that disordering of the endo-
lysosomal traffic is associated with pancreatitis via impairment of autophagy (see Chapter 
1.6.1). Recent studies have begun to elucidate the role of autophagy both in the normal 
function of the exocrine pancreas (Vaccaro, 2012) and in pancreatitis, the most common 
disease of this organ (Gukovskaya and Gukovsky, 2012). The predominant view is that 
efficient, physiologic autophagy is prosurvival, whereas defective autophagy can lead not 
only to the accumulation of vacuoles and active trypsin in acinar cells but also to 
inflammation and cell death, all key responses of pancreatitis (Gukovskaya and Gukovsky, 
2012). Autophagic dysfunction might occur at various steps, including decreased or 
defective formation of autophagosomes, their impaired fusion with lysosomes, or inefficient 
lysosomal proteolytic activity. Importantly, genetic alterations which specifically target the 
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lysosomal or autophagic function induce pancreatitis-like injury (Gukovskaya and 
Gukovsky, 2012).  
The high number and size of endo-lysosomes observed in transfected cells when 
compared with non-transfected cells suggests that the binding of ZG16p to the endo-
lysosomal compartment might interfere with the normal function of this compartment. Thus, 
understanding the effect of the binding of ZG16p to endo-lysosomes is of major biological 
importance. Additionally, the expression of ZG16p is not restricted to the pancreas (see 
Chapter 1.5.3.4) pointing to a potential (patho)physiological role in other locations.  
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6. Conclusions 
We favour a model, in which a predicted submembranous matrix attached to the 
luminal side of the granule membrane fulfils important functions during the sorting and 
packaging of secretory proteins (Scheele et al., 1994; Schrader, 2004). We have identified 
novel ZG membrane/matrix proteins with proteoglycan-binding properties and presented 
evidence that a subset of peripheral digestive enzymes exhibits a more speciﬁc interaction 
with the ZGM than previously expected (Chapter 4.1.1). Proteoglycans within ZGs are 
supposed to interact electrostatically and through speciﬁc protein-protein and carbohydrate-
protein binding domains with the secretory proteins of the granule content (Borta et al., 2010; 
Gómez-Lázaro et al., 2010; Scheele et al., 1994; Schmidt et al., 2000; Schrader, 2004). 
Furthermore, we have discovered new characteristics of ZG16p that might be of major 
importance to understand its (patho)physiological role. ZG16p is highly resistant to 
proteases, binds to a high molecular weight complex (also protease resistant) and forms 
homodimers. By point mutation we have shown that ZG16p domains (CRD and PGM) are 
not directly involved in the targeting of ZG16p to ZG in AR41J cells. In the light of the 
recent findings we suggest that the submembranous matrix might help in the retention of the 
proteins destined for regulated secretion by acting as a bridge between the ZGM and the 
aggregated zymogens. We have shown that ZG16p would be able to act as a crosslinker as 
it can form stable dimers, thus supporting the binding of aggregated zymogens to the 
submembranous granule matrix. In addition, we discovered that cytosolic ZG16p can 
interact with and modulate the endo-lysosomal compartment. These observations indicate 
that ZG16p may be used as a novel and specific tool to label (and manipulate) parts of the 
endosomal/lysosomal trafficking pathway. As disturbed autophagic processes have been 
linked to pancreatitis, an understanding of the binding and impact of ZG16p on endo-
lysosomes is of biological and clinical importance.  
 
 
 
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BIBLIOGRAPHY 
 
 
  
  
 
 
127 
 
Bibliography 
Adler, G., Gerhards, G., Schick, J., Rohr, G., and Kern, H.F. (1983). Effects of in vivo 
cholinergic stimulation of rat exocrine pancreas. Am. J. Physiol. 244, G623–G629. 
Aebersold, R., and Mann, M. (2003). Mass spectrometry-based proteomics. Nature 422, 
198–207. 
Akasako, A., Haruki, M., Oobatake, M., and Kanaya, S. (1995). High resistance of 
Escherichia coli ribonuclease HI variant with quintuple thermostabilizing mutations to thermal 
denaturation, acid denaturation, and proteolytic degradation. Biochemistry 34, 8115–8122. 
Ali, M.H., and Imperiali, B. (2005). Protein oligomerization: how and why. Bioorg. Med. 
Chem. 13, 5013–5020. 
Allain, F., Vanpouille, C., Carpentier, M., Slomianny, M.-C., Durieux, S., and Spik, G. 
(2002). Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-
mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. PNAS 99, 2714–2719. 
Arber, S., Krause, K.H., and Caroni, P. (1992). s-Cyclophilin is retained intracellularly via a 
unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J. 
Cell Biol. 116, 113–125. 
Arendorf, T.M., and Walker, D.M. (1980). The prevalence and intra-oral distribution of 
Candida albicans in man. Arch. Oral Biol. 25, 1–10. 
Arvan, P., and Castle, D. (1992). Protein sorting and secretion granule formation in regulated 
secretory cells. Trends Cell Biol. 2, 327–331. 
Arvan, P., and Castle, D. (1998). Sorting and storage during secretory granule biogenesis: 
looking backward and looking forward. Biochem. J 332, 593–610. 
Aubert-Jousset, E., Garmy, N., Sbarra, V., Fantini, J., Sadoulet, M.-O., and Lombardo, D. 
(2004). The combinatorial extension method reveals a sphingolipid binding domain on pancreatic 
bile salt-dependent lipase: role in secretion. Structure 12, 1437–1447. 
Bach, J.-P., Borta, H., Ackermann, W., Faust, F., Borchers, O., and Schrader, M. (2006). The 
secretory granule protein syncollin localizes to HL-60 cells and neutrophils. J. Histochem. 
Cytochem. 54, 877–888. 
Baravalle, G., Schober, D., Huber, M., Bayer, N., Murphy, R.F., and Fuchs, R. (2005). 
Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, 
nocodazole, and low temperature. Cell Tissue Res. 320, 99–113. 
Bartoli, C., Baeza, N., Figarella, C., Pellegrini, I., and Figarella-Branger, D. (1998). 
Expression of peptide-23/pancreatitis-associated protein and Reg genes in human pituitary and 
 128 
 
adenomas: comparison with other fetal and adult human tissues. J. Clin. Endocrinol. Metab. 83, 
4041–4046. 
Beaudoin, A.R., St-Jean, P., and Grondin, G. (1991). Ultrastructural localization of GP2 in 
acinar cells of pancreas: presence of GP2 in endocytic and exocytic compartments. J. Histochem. 
Cytochem. 39, 575–588. 
Berg, N.B., and Young, R.W. (1971). Sulfate metabolism in pancreatic acinar cells. J. Cell 
Biol. 50, 469–483. 
Berkane, A.A., Nguyen, H.T.T., Tranchida, F., Waheed, A. a, Deyris, V., Tchiakpe, L., 
Fasano, C., Nicoletti, C., Desseaux, V., Ajandouz, E.H., et al. (2007). Proteomic of lipid rafts in the 
exocrine pancreas from diet-induced obese rats. Biochem. Biophys. Res. Commun. 355, 813–819. 
Bieger, W., and Scheele, G. (1980). Two-dimensional isoelectric focusing/sodium dodecyl 
sulfate gel electrophoresis of protein mixtures containing active or potentially active proteases: 
analysis of human exocrine pancreatic proteins. Anal. Biochem. 109, 222–230. 
Bockman, D.E. (2008). Anatomy and Fine Structure. In The Pancreas: An Integrated 
Textbook of Basic Science, Medicine, and Surgery, H.G. Beger, A.L. Warshaw, M.W. Büchler, R.A. 
Kozarek, M.M. Lerch, J.P. Neoptolemos, K. Shiratori, D.C. Whitcomb, and B.M. Rau, eds. (Oxford, 
UK.: Blackwell Publishing Ltd), pp. 50–57. 
Borgonovo, B., Ouwendijk, J., and Solimena, M. (2006). Biogenesis of secretory granules. 
Curr. Opin. Cell Biol. 18, 365–370. 
Borta, H., Aroso, M., Rinn, C., Gomez-Lazaro, M., Vitorino, R., Zeuschner, D., 
Grabenbauer, M., Amado, F., and Schrader, M. (2010). Analysis of low abundance membrane-
associated proteins from rat pancreatic zymogen granules. J. Proteome Res. 9, 4927–4939. 
Bose, S., Mücke, M., and Freedman, R.B. (1994). The characterization of a cyclophilin-type 
peptidyl prolyl cis-trans-isomerase from the endoplasmic-reticulum lumen. Biochem. J. 300 ( Pt 3, 
871–875. 
Braganza, J.M., Lee, S.H., McCloy, R.F., and McMahon, M.J. (2011). Chronic pancreatitis. 
Lancet 377, 1184–1197. 
Bram, R.J., and Crabtree, G.R. (1994). Calcium signalling in T cells stimulated by a 
cyclophilin B-binding protein. Nature 371, 355–358. 
Braun, M., and Thévenod, F. (2000). Photoaffinity labeling and purification of ZG-16p, a 
high-affinity dihydropyridine binding protein of rat pancreatic zymogen granule membranes that 
regulates a K+-selective conductance. Mol. Pharmacol. 57, 308–316. 
Bruneau, N., and Lombardo, D. (1995). Chaperone function of a Grp 94-related protein for 
folding and transport of the pancreatic bile salt-dependent lipase. J. Biol. Chem. 270, 13524–13533. 
 Bibliography 
129 
 
Bruneau, N., Lombardo, D., and Bendayan, M. (2000). The affinity binding sites of 
pancreatic bile salt-dependent lipase in pancreatic and intestinal tissues. J. Histochem. Cytochem. 
48, 267–276. 
Bukrinsky, M.I. (2002). Cyclophilins: Unexpected messengers in intercellular 
communications. Trends Immunol. 23, 323–325. 
Bunn-Moreno, M.M., and Campos-Neto, A. (1981). Lectin(s) extracted from seeds of 
Artocarpus integrifolia (jackfruit): potent and selective stimulator(s) of distinct human T and B cell 
functions. J. Immunol. 127, 427–429. 
Cabana, C., Hugon, J.S., and Lamy, F. (1981). Freeze-fracture and deep-etching studies on 
zymogen-granule membranes of the rat pancreas. Cell Tissue Res. 214, 355–367. 
De Caro, A., Lohse, J., and Sarles, H. (1979). Characterization of a protein isolated from 
pancreatic calculi of men suffering from chronic calcifying pancreatitis. Biochem. Biophys. Res. 
Commun. 87, 1176–1182. 
Cash, H.L., Whitham, C. V, Behrendt, C.L., and Hooper, L. V (2006). Symbiotic bacteria 
direct expression of an intestinal bactericidal lectin. Science (80-. ). 313, 1126–1130. 
Chen, X., and Andrews, P.C. (2008). Purification and proteomics analysis of pancreatic 
zymogen granule membranes. Methods Mol. Biol. 432, 275–287. 
Chen, X., Walker, A.K., Strahler, J.R., Simon, E.S., Tomanicek-Volk, S.L., Nelson, B.B., 
Hurley, M.C., Ernst, S.A., Williams, J.A., and Andrews, P.C. (2006). Organellar proteomics: analysis 
of pancreatic zymogen granule membranes. Mol. Cell. Proteomics 5, 306–312. 
Chen, X., Ulintz, P.J., Simon, E.S., Williams, J. a, and Andrews, P.C. (2008). Global 
topology analysis of pancreatic zymogen granule membrane proteins. Mol. Cell. Proteomics 7, 2323–
2336. 
Chung, J., and Wessling-Resnick, M. (2003). Molecular mechanisms and regulation of iron 
transport. Crit. Rev. Clin. Lab. Sci. 40, 151–182. 
Colomer, V., Kicska, G.A., and Rindler, M.J. (1996). Secretory granule content proteins and 
the luminal domains of granule membrane proteins aggregate in vitro at mildly acidic pH. J. Biol. 
Chem. 271, 48–55. 
Cronshagen, U., Voland, P., and Kern, H.F. (1994). cDNA cloning and characterization of a 
novel 16 kDa protein located in zymogen granules of rat pancreas and goblet cells of the gut. Eur. J. 
Cell Biol. 65, 366–377. 
Dahan, S., Anderson, K.L., Weller, S., Krueger, E., and Mcniven, M.A. (2005). Agonist-
induced vesiculation of the Golgi apparatus in pancreatic acinar cells. Gastroenterology 129, 2032–
2046. 
 130 
 
Van Damme, E.J., Barre, a, Verhaert, P., Rougé, P., and Peumans, W.J. (1996). Molecular 
cloning of the mitogenic mannose/maltose-specific rhizome lectin from Calystegia sepium. FEBS 
Lett. 397, 352–356. 
Daniel, R.M., Cowan, D.A., Morgan, H.W., and Curran, M.P. (1982). A correlation between 
protein thermostability and resistance to proteolysis. Biochem. J. 207, 641–644. 
Dartsch, H., Kleene, R., and Kern, H.E. (1998). In vitro condensation-sorting of enzyme 
proteins isolated from rat pancreatic acinar cells. Eur. J. Cell Biol. 75, 211–222. 
Daum, S., Schumann, M., Mathea, S., Aumüller, T., Balsley, M.A., Constant, S.L., De 
Lacroix, B.F., Kruska, F., Braun, M., and Schiene-Fischer, C. (2009). Isoform-specific inhibition of 
cyclophilins. Biochemistry 48, 6268–6277. 
Delacour, D., Koch, A., and Jacob, R. (2009). The role of galectins in protein trafficking. 
Traffic 10, 1405–1413. 
Dikeakos, J.D., and Reudelhuber, T.L. (2007). Sending proteins to dense core secretory 
granules: still a lot to sort out. J. Cell Biol. 177, 191–196. 
Dominici, R., and Franzini, C. (2002). Fecal elastase-1 as a test for pancreatic function: a 
review. Clin. Chem. Lab. Med. 40, 325–332. 
Drissi, R., Dubois, M.-L., and Boisvert, F.-M. (2013). Proteomics methods for subcellular 
proteome analysis. FEBS J. 280, 5626–5634. 
Duplan, L., Michel, B., Boucraut, J., Barthellémy, S., Desplat-Jegoc, S., Marin, V., 
Gambarelli, D., Bernard, D., Berthézène, P., Alescio-Lautier, B., et al. (2001). Lithostathine and 
pancreatitis-associated protein are involved in the very early stages of Alzheimer’s disease. 
Neurobiol. Aging 22, 79–88. 
Dvorak, A.M., and Morgan, E.S. (1998a). Ribonuclease-gold labels chondroitin sulphate in 
guinea pig basophil granules. Histochem. J. 30, 603–608. 
Dvorak, A.M., and Morgan, E.S. (1998b). Ribonuclease-gold labels heparin in human mast 
cell granules. New use for an ultrastructural enzyme affinity technique. J. Histochem. Cytochem. 46, 
695–706. 
Dvorak, A.M., and Morgan, E.S. (1999a). Ribonuclease-gold ultrastructural localization of 
heparin in isolated human lung mast cells stimulated to undergo anaphylactic degranulation and 
recovery in vitro. Clin. Exp. Allergy 29, 1118–1128. 
Dvorak, A.M., and Morgan, E.S. (1999b). Ribonuclease-gold labels proteoglycan-containing 
cytoplasmic granules and ribonucleic acid-containing organelles - A survey. Histol. Histopathol. 14, 
597–626. 
Ermund, A., Schütte, A., Johansson, M.E. V, Gustafsson, J.K., and Hansson, G.C. (2013). 
Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have 
 Bibliography 
131 
 
different properties depending on location as well as over the Peyer’s patches. Am. J. Physiol. 
Gastrointest. Liver Physiol. 305, G341–7. 
Faust, F., Gomez-Lazaro, M., Borta, H., Agricola, B., and Schrader, M. (2008). Rab8 is 
involved in zymogen granule formation in pancreatic acinar AR42J cells. Traffic 9, 964–979. 
Feng, D., Park, O., Radaeva, S., Wang, H., Yin, S., Kong, X., Zheng, M., Zakhari, S., Kolls, 
J.K., and Gao, B. (2012). Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by 
inhibiting the autophagic pathway. Int. J. Biol. Sci. 8, 249–257. 
Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F., and Whitehouse, C.M. (1989). Electrospray 
ionization for mass spectrometry of large biomolecules. Science (80-. ). 246, 64–71. 
Fischer, G., Berger, E., and Bang, H. (1989). Kinetic β-deuterium isotope effects suggest a 
covalent mechanism for the protein folding enzyme peptidylprolyl cis/trans-isomerase. FEBS Lett. 
250, 267–270. 
Fortunato, F., and Kroemer, G. (2009). Impaired autophagosome-lysosome fusion in the 
pathogenesis of pancreatitis. Autophagy 5, 850–853. 
Freedman, S.D., and Scheele, G.A. (1993). Reversible pH-induced homophilic binding of 
GP2, a glycosyl-phosphatidylinositol-anchored protein in pancreatic zymogen granule membranes. 
Eur. J. Cell Biol. 61, 229–238. 
Freedman, S.D., Kern, H.F., and Scheele, G.A. (1994). Apical membrane trafficking during 
regulated pancreatic exocrine secretion-role of alkaline pH in the acinar lumen and enzymatic 
cleavage of GP2, a GPI-linked protein. Eur. J. Cell Biol. 65, 354–365. 
Freedman, S.D., Kern, H.F., and Scheele, G.A. (1998a). Cleavage of GPI-anchored proteins 
from the plasma membrane activates apical endocytosis in pancreatic acinar cells. Eur. J. Cell Biol. 
75, 163–173. 
Freedman, S.D., Kern, H.F., and Scheele, G.A. (1998b). Acinar lumen pH regulates 
endocytosis, but not exocytosis, at the apical plasma membrane of pancreatic acinar cells. Eur. J. Cell 
Biol. 75, 153–162. 
Fröhlich, T., and Arnold, G.J. (2006). Proteome research based on modern liquid 
chromatography--tandem mass spectrometry: separation, identification and quantification. J. Neural 
Transm. 113, 973–994. 
Fujita-Yoshigaki, J., Matsuki-Fukushima, M., Yokoyama, M., and Katsumata-Kato, O. 
(2013). Sorting of a HaloTag protein that has only a signal peptide sequence into exocrine secretory 
granules without protein aggregation. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G685–96. 
Fukumoto, Y., Okita, K., Kodama, T., Noda, K., Harada, T., Mizuta, M., and Takemoto, T. 
(1980). Studies of alpha-napthylisothiocyanate-induced hepatic disturbance. 
Hepatogastroenterology. 27, 457–464. 
 132 
 
Gabius, H.-J., André, S., Kaltner, H., and Siebert, H.-C. (2002). The sugar code: functional 
lectinomics. Biochim. Biophys. Acta 1572, 165–177. 
Gaisano, H.Y., and Gorelick, F.S. (2009). New insights into the mechanisms of pancreatitis. 
Gastroenterology 136, 2040–2044. 
Galat, A. (1993). Peptidylproline cis-trans-isomerases: immunophilins. Eur. J. Biochem. 
216, 689–707. 
Galat, A. (2003). Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-
targets-functions. Curr. Top. Med. Chem. 3, 1315–1347. 
Gallagher, J.T. (1989). The extended family of proteoglycans: social residents of the 
pericellular zone. Curr. Opin. Cell Biol. 1, 1201–1218. 
Gallagher, J.T., Lyon, M., and Steward, W.P. (1986). Structure and function of heparan 
sulphate proteoglycans. Biochem. J. 236, 313–325. 
Gemeiner, P., Mislovicová, D., Tkác, J., Svitel, J., Pätoprstý, V., Hrabárová, E., Kogan, G., 
and Kozár, T. (2009). Lectinomics II. A highway to biomedical/clinical diagnostics. Biotechnol. 
Adv. 27, 1–15. 
Geron, E., Schejter, E.D., and Shilo, B.-Z. (2013). Targeting secretion to the apical surface 
by mDia1-built actin tracks. Commun. Integr. Biol. 6, e25660. 
Ghazarian, H., Idoni, B., and Oppenheimer, S.B. (2011). A glycobiology review: 
carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem. 113, 236–247. 
Gómez-Lázaro, M., Rinn, C., Aroso, M., Amado, F., and Schrader, M. (2010). Proteomic 
analysis of zymogen granules. Expert Rev. Proteomics 7, 735–747. 
Gondré-Lewis, M.C., Petrache, H.I., Wassif, C. a, Harries, D., Parsegian, A., Porter, F.D., 
and Loh, Y.P. (2006). Abnormal sterols in cholesterol-deficiency diseases cause secretory granule 
malformation and decreased membrane curvature. J. Cell Sci. 119, 1876–1885. 
Goodsell, D.S., and Olson, A.J. (2000). Structural symmetry and protein function. Annu. 
Rev. Biophys. Biomol. Struct. 29, 105–153. 
Gorelick, F., and Thrower, E. (2009). The acinar cell and early pancreatitis responses. Clin. 
Gastroenterol. Hepatol. 7, S10–14. 
Gorelik, E., Galili, U., and Raz, A. (2001). On the role of cell surface carbohydrates and their 
binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 20, 245–277. 
Greene, L.J., Hirs, C.H., and Palade, G.E. (1963). On the protein composition of bovine 
pancreatic zymogen granules. J. Biol. Chem. 238, 2054–2070. 
Grondin, G., St-Jean, P., and Beaudoin, A.R. (1992). Cytochemical and 
immunocytochemical characterization of a fibrillar network (GP2) in pancreatic juice: possible role 
as a sieve in the pancreatic ductal system. Eur. J. Cell Biol. 57, 155–164. 
 Bibliography 
133 
 
Gukovskaya, A.S., and Gukovsky, I. (2012). Autophagy and pancreatitis. Am. J. Physiol. 
Gastrointest. Liver Physiol. 303, G993–G1003. 
Gukovsky, I., and Gukovskaya, A. (2010). Impaired autophagy underlies key pathological 
responses of acute pancreatitis. Autophagy 6, 428–429. 
Gukovsky, I., Pandol, S.J., and Gukovskaya, A.S. (2011). Organellar dysfunction in the 
pathogenesis of pancreatitis. Antioxid. Redox Signal. 15, 2699–2710. 
Guo, X., Trudgian, D., Lemoff, A., Yadavalli, S., and Mirzaei, H. (2014). Confetti: a 
multiprotease map of the HeLa proteome for comprehensive proteomics. Mol. Cell. Proteomics 13, 
1573–1584. 
Guo, X.W., Merlin, D., Laboisse, C., and Hopfer, U. (1997). Purinergic agonists, but not 
cAMP, stimulate coupled granule fusion and Cl- conductance in HT29-Cl.16E. Am. J. Physiol. 273, 
C804–9. 
Gupta, G., Sinha, S., and Surolia, A. (2008). Unfolding energetics and stability of banana 
lectin. Proteins 72, 754–760. 
Gupta, G., Vishveshwara, S., and Surolia, A. (2009). Stability of dimeric interface in banana 
lectin: Insight from molecular dynamics simulations. IUBMB Life 61, 252–260. 
Han, X., Aslanian, A., and Yates, J.R. (2008). Mass spectrometry for proteomics. Curr. Opin. 
Chem. Biol. 12, 483–490. 
Hanoulle, X., Melchior, A., Sibille, N., Parent, B., Denys, A., Wieruszeski, J.M., Horvath, 
D., Allain, F., Lippens, G., and Landrieu, I. (2007). Structural and functional characterization of the 
interaction between cyclophilin B and a heparin-derived oligosaccharide. J. Biol. Chem. 282, 34148–
34158. 
Hartupee, J.C., Zhang, H., Bonaldo, M.F., Soares, M.B., and Dieckgraefe, B.K. (2001). 
Isolation and characterization of a cDNA encoding a novel member of the human regenerating 
protein family: Reg IV. Biochim. Biophys. Acta 1518, 287–293. 
Hase, K., Kawano, K., Nochi, T., Pontes, G.S., Fukuda, S., Ebisawa, M., Kadokura, K., Tobe, 
T., Fujimura, Y., Kawano, S., et al. (2009). Uptake through glycoprotein 2 of FimH(+) bacteria by 
M cells initiates mucosal immune response. Nature 462, 226–230. 
Hashimoto, D., Ohmuraya, M., Hirota, M., Yamamoto, A., Suyama, K., Ida, S., Okumura, 
Y., Takahashi, E., Kido, H., Araki, K., et al. (2008). Involvement of autophagy in trypsinogen 
activation within the pancreatic acinar cells. J. Cell Biol. 181, 1065–1072. 
Hayashi, T., Matsubara, A., Ohara, S., Mita, K., Hasegawa, Y., Usui, T., Arihiro, K., 
Norimura, S., Sentani, K., Oue, N., et al. (2009). Immunohistochemical analysis of Reg IV in 
urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum 
tumor marker. Oncol. Rep. 21, 95–100. 
 134 
 
Hegyi, P., Maléth, J., Venglovecz, V., and Rakonczay, Z. (2011). Pancreatic ductal 
bicarbonate secretion: challenge of the acinar acid load. Front. Physiol. 2, 1–3. 
Ho, M.-R., Lou, Y.-C., Wei, S.-Y., Luo, S.-C., Lin, W.-C., Lyu, P.-C., and Chen, C. (2010). 
Human RegIV protein adopts a typical C-type lectin fold but binds mannan with two calcium-
independent sites. J. Mol. Biol. 402, 682–695. 
Hodel, A., An, S.J., Hansen, N.J., Lawrence, J., Wasle, B., Schrader, M., and Edwardson, 
J.M. (2001). Cholesterol-dependent interaction of syncollin with the membrane of the pancreatic 
zymogen granule. Biochem. J. 356, 843–850. 
Hokin, L.E. (1955). Isolation of the zymogen granules of dog pancreas and a study of their 
properties. Biochim. Biophys. Acta 18, 379–388. 
Hoops, T.C., and Rindler, M.J. (1991). Isolation of the cDNA encoding glycoprotein-2 (GP-
2), the major zymogen granule membrane protein. Homology to uromodulin/Tamm-Horsfall protein. 
J. Biol. Chem. 266, 4257–4263. 
Iovanna, J.L., and Dagorn, J.-C. (2005). The multifunctional family of secreted proteins 
containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim. Biophys. Acta 
1723, 8–18. 
Iovanna, J., Frigerio, J., Dusetti, N., Ramare, F., Raibaud, P., and Dragorn, J. (1993). 
Lithostathine, an inhibitor of CaCO3, crystal growth in pancreatic juice, induces bacterial 
aggregation. Pancreas 8, 597–601. 
Iwai, N., and Inagami, T. (1990). Molecular cloning of a complementary DNA to rat 
cyclophilin-like protein mRNA. Kidney Int. 37, 1460–1465. 
Jessen, B.A., Mullins, J.S., De Peyster, A., and Stevens, G.J. (2003). Assessment of 
hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression. Toxicol. Sci. 
75, 208–222. 
Johansson, M., Sjövall, H., and Hansson, G. (2013). The gastrointestinal mucus system in 
health and disease. Nat. Rev. Gastroenterol. Hepatol. 10, 352–361. 
Johansson, M.E. V, Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G.C. 
(2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. 
PNAS 105, 15064–15069. 
Junker, M., and Clark, P.L. (2010). Slow formation of aggregation-resistant beta-sheet 
folding intermediates. Proteins 78, 812–824. 
Kalus, I., Hodel, A., Koch, A., Kleene, R., Edwardson, J.M., and Schrader, M. (2002). 
Interaction of syncollin with GP-2, the major membrane protein of pancreatic zymogen granules, and 
association with lipid microdomains. Biochem. J. 362, 433–442. 
 Bibliography 
135 
 
Kanagawa, M., Satoh, T., Ikeda, A., Nakano, Y., Yagi, H., Kato, K., Kojima-Aikawa, K., 
and Yamaguchi, Y. (2011). Crystal structures of human secretory proteins ZG16p and ZG16b reveal 
a Jacalin-related β-prism fold. Biochem. Biophys. Res. Commun. 404, 201–205. 
Kanagawa, M., Liu, Y., Hanashima, S., Ikeda, A., Chai, W., Nakano, Y., Kojima-Aikawa, 
K., Feizi, T., and Yamaguchi, Y. (2014). Structural basis for multiple sugar recognition of Jacalin-
related human ZG16p lectin. J. Biol. Chem. 289, 16954–16965. 
Karas, M., and Hillenkamp, F. (1988). Laser desorption ionization of proteins with molecular 
masses exceeding 10,000 daltons. Anal. Chem. 60, 2299–2301. 
Kasai, H., Li, Y.X., and Miyashita, Y. (1993). Subcellular distribution of Ca2+ release 
channels underlying Ca2+ waves and oscillations in exocrine pancreas. Cell 74, 669–677. 
Keim, V., Rohr, G., Stöckert, H.G., and Haberich, F.J. (1984). An additional secretory 
protein in the rat pancreas. Digestion 29, 242–249. 
Kern, H.F., Rausch, U., and Scheele, G.A. (1987). Regulation of gene expression in 
pancreatic adaptation to nutritional substrates or hormones. Gut 28 Suppl, 89–94. 
Kerrigan, A.M., and Brown, G.D. (2009). C-type lectins and phagocytosis. Immunobiology 
214, 562–575. 
Kim, M.-S., Pinto, S.M., Getnet, D., Nirujogi, R.S., Manda, S.S., Chaerkady, R., 
Madugundu, A.K., Kelkar, D.S., Isserlin, R., Jain, S., et al. (2014). A draft map of the human 
proteome. Nature 509, 575–581. 
Kleene, R., Kastner, B., Rosser, R., and Kern, H.F. (1999a). Complex formation among rat 
pancreatic secretory proteins under mild alkaline pH conditions. Digestion 60, 305–313. 
Kleene, R., Dartsch, H., and Kern, H. (1999b). The secretory lectin ZG16p mediates sorting 
of enzyme proteins to the zymogen granule membrane in pancreatic acinar cells. Eur. J. Cell Biol. 
78, 79–90. 
Klumperman, J., Kuliawat, R., Griffith, J.M., Geuze, H.J., and Arvan, P. (1998). Mannose 
6-phosphate receptors are sorted from immature secretory granules via adaptor protein AP-1, 
clathrin, and syntaxin 6-positive vesicles. J. Cell Biol. 141, 359–371. 
Kolset, S.O., and Gallagher, J.T. (1990). Proteoglycans in haemopoietic cells. Biochim. 
Biophys. Acta 1032, 191–211. 
Kumazawa-Inoue, K., Mimura, T., Hosokawa-Tamiya, S., Nakano, Y., Dohmae, N., 
Kinoshita-Toyoda, A., Toyoda, H., and Kojima-Aikawa, K. (2012). ZG16p, an animal homolog of 
β-prism fold plant lectins, interacts with heparan sulfate proteoglycans in pancreatic zymogen 
granules. Glycobiology 22, 258–266. 
 136 
 
Küry, P., Abankwa, D., Kruse, F., Greiner-Petter, R., and Muller, H.W. (2004). Gene 
expression profiling reveals multiple novel intrinsic and extrinsic factors associated with axonal 
regeneration failure. Eur. J. Neurosci. 19, 32–42. 
Lane, C.S. (2005). Mass spectrometry-based proteomics in the life sciences. Cell. Mol. Life 
Sci. 62, 848–869. 
Larsson, J.M.H., Thomsson, K.A., Rodríguez-Piñeiro, A.M., Karlsson, H., and Hansson 
(2013). Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac 
and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am. J. Physiol. Gastrointest. 
Liver Physiol. 305, G357–63. 
Laurine, E., Grégoire, C., Fändrich, M., Engemann, S., Marchal, S., Thion, L., Mohr, M., 
Monsarrat, B., Michel, B., Dobson, C.M., et al. (2003). Lithostathine quadruple-helical filaments 
form proteinase K-resistant deposits in Creutzfeldt-Jakob disease. J. Biol. Chem. 278, 51770–51778. 
Lebel, D., Grondin, G., and Paquette, J. (1988). In vitro stability of pancreatic zymogen 
granules: roles of pH and calcium. Biol. Cell 63, 343–353. 
Leblond, F.A., Viau, G., Lainé, J., and Lebel, D. (1993). Reconstitution in vitro of the pH-
dependent aggregation of pancreatic zymogens en route to the secretory granule: implication of GP-
2. Biochem. J. 291, 289–296. 
Lee, M.G., and Muallem, S. (2008). Physiology of Duct Cell Secretion. In The Pancreas: An 
Integrated Textbook of Basic Science, Medicine, and Surgery, H.G. Beger, A.L. Warshaw, M.W. 
Büchler, R.A. Kozarek, M.M. Lerch, J.P. Neoptolemos, K. Shiratori, D.C. Whitcomb, and B.M. Rau, 
eds. (Oxford, UK: Blackwell Publishing Ltd), pp. 78–90. 
Lee, M.G., Ohana, E., Park, H.W., Yang, D., and Muallem, S. (2012). Molecular mechanism 
of pancreatic and salivary gland fluid and HCO3 secretion. Physiol. Rev. 92, 39–74. 
Lehotzky, R.E., Partch, C.L., Mukherjee, S., Cash, H.L., Goldman, W.E., Gardner, K.H., and 
Hooper, L. V (2010). Molecular basis for peptidoglycan recognition by a bactericidal lectin. PNAS 
107, 7722–7727. 
Leskinen, M.J., Kovanen, P.T., and Lindstedt, K.A. (2003). Regulation of smooth muscle 
cell growth, function and death in vitro by activated mast cells - A potential mechanism for the 
weakening and rupture of atherosclerotic plaques. In Biochemical Pharmacology, pp. 1493–1498. 
Lewis, B. (2008). Development of the Pancreas and Related Structures. In The Pancreas: An 
Integrated Textbook of Basic Science, Medicine, and Surgery, H.G. Beger, A.L. Warshaw, M.W. 
Büchler, R.A. Kozarek, M.M. Lerch, J.P. Neoptolemos, K. Shiratori, D.C. Whitcomb, and B.M. Rau, 
eds. (Oxford, UK: Blackwell Publishing Ltd.), pp. 42–49. 
De Lisle, R.C., and Hopfer, U. (1986). Electrolyte permeabilities of pancreatic zymogen 
granules: implications for pancreatic secretion. Am. J. Physiol. 250, G489–96. 
 Bibliography 
137 
 
De Lisle, R.C., Schulz, I., Tyrakowski, T., Haase, W., and Hopfer, U. (1984). Isolation of 
stable pancreatic zymogen granules. Am. J. Physiol. 246, G411–G418. 
Löbler, M., Saß, M., Kunze, C., Schmitz, K.P.K., and Hopt, U.T.U. (2002). Biomaterial 
patches sutured onto the rat stomach induce a set of genes encoding pancreatic enzymes. Biomaterials 
23, 577–583. 
Logsdon, C.D., and Ji, B. (2013). The role of protein synthesis and digestive enzymes in 
acinar cell injury. Nat. Rev. Gastroenterol. Hepatol. 10, 362–370. 
Logsdon, C.D., Moessner, J., Williams, J. a, and Goldfine, I.D. (1985). Glucocorticoids 
increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. 
J. Cell Biol. 100, 1200–1208. 
Lombardo, D. (2001). Bile salt-dependent lipase: its pathophysiological implications. 
Biochim. Biophys. Acta 1533, 1–28. 
Lombardo, D., and Guy, O. (1980). Studies on the substrate specificity of a carboxyl ester 
hydrolase from human pancreatic juice. II. Action on cholesterol esters and lipid-soluble vitamin 
esters. Biochim. Biophys. Acta 611, 147–155. 
Longnecker, D.S., Lilja, H.S., French, J., Kuhlmann, E., and Noll, W. (1979). 
Transplantation of azaserine-induced carcinomas of pancreas in rats. Cancer Lett. 7, 197–202. 
Lowenfels, A.B., Maisonneuve, P., Cavallini, G., Ammann, R.W., Lankisch, P.G., Andersen, 
J.R., Dimagno, E.P., Andrén-Sandberg, A., and Domellöf, L. (1993). Pancreatitis and the risk of 
pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 328, 1433–1437. 
Lowenfels, A.B., Maisonneuve, P., DiMagno, E.P., Elitsur, Y., Gates, L.K., Perrault, J., and 
Whitcomb, D.C. (1997). Hereditary pancreatitis and the risk of pancreatic cancer. International 
Hereditary Pancreatitis Study Group. J. Natl. Cancer Inst. 89, 442–446. 
Mareninova, O.A., Hermann, K., French, S.W., O’Konski, M.S., Pandol, S.J., Webster, P., 
Erickson, A.H., Katunuma, N., Gorelick, F.S., Gukovsky, I., et al. (2009). Impaired autophagic flux 
mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute 
pancreatitis. J. Clin. Invest. 119, 3340–3355. 
Mariller, C., Haendler, B., Allain, F., Denys, A., and Spik, G. (1996). Involvement of the N-
terminal part of cyclophilin B in the interaction with specific Jurkat T-cell binding sites. Biochem. J. 
317, 571–576. 
Markert, Y., Köditz, J., Mansfeld, J., Arnold, U., and Ulbrich-Hofmann, R. (2001). Increased 
proteolytic resistance of ribonuclease A by protein engineering. Protein Eng. 14, 791–796. 
Masedunskas, A., Porat-Shliom, N., and Weigert, R. (2012). Regulated exocytosis: novel 
insights from intravital microscopy. Traffic 13, 627–634. 
 138 
 
Massarwa, R., Schejter, E.D., and Shilo, B.Z. (2009). Apical Secretion in Epithelial Tubes 
of the Drosophila Embryo Is Directed by the Formin-Family Protein Diaphanous. Dev. Cell 16, 877–
888. 
McLendon, G., and Radany, E. (1978). Is protein turnover thermodynamically controlled? J. 
Biol. Chem. 253, 6335–6337. 
Meagher, J.L., Winter, H.C., Ezell, P., Goldstein, I.J., and Stuckey, J.A. (2005). Crystal 
structure of banana lectin reveals a novel second sugar binding site. Glycobiology 15, 1033–1042. 
Messenger, S.W., Falkowski, M. a, and Groblewski, G.E. (2014). Ca(2+)-regulated secretory 
granule exocytosis in pancreatic and parotid acinar cells. Cell Calcium 55, 369–375. 
Meusser, B., Hirsch, C., Jarosch, E., and Sommer, T. (2005). ERAD: the long road to 
destruction. Nat. Cell Biol. 7, 766–772. 
Mitchell, R.M.S., Byrne, M.F., and Baillie, J. (2003). Pancreatitis. Lancet 361, 1447–1455. 
Miyake, H., Hara, S., Eto, H., Kaminodo, S., and Hara, I. (2004). Global analysis of gene 
expression profiles in ileum in a rat bladder augmentation model using cDNA microarrays. Int. J. 
Urol. 11, 1009–1012. 
Moniaux, N., Song, H., Darnaud, M., Garbin, K., Gigou, M., Mitchell, C., Samuel, D., Jamot, 
L., Amouyal, P., Amouyal, G., et al. (2011). Human hepatocarcinoma-intestine-
pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating 
free-radical damage in injured livers. Hepatology 53, 618–627. 
Montague, J.W., Hughes, F.M., and Cidlowski, J.A. (1997). Native recombinant cyclophilins 
A, B, and C degrade DNA independently of peptidylprolyl cis-trans-isomerase activity. Potential 
roles of cyclophilins in apoptosis. J. Biol. Chem. 272, 6677–6684. 
Nakamura-Tsuruta, S., Uchiyama, N., Peumans, W.J., Van Damme, E.J.M., Totani, K., Ito, 
Y., and Hirabayashi, J. (2008). Analysis of the sugar-binding specificity of mannose-binding-type 
Jacalin-related lectins by frontal affinity chromatography-an approach to functional classification. 
FEBS J. 275, 1227–1239. 
Nanakin, A., Fukui, H., Fujii, S., Sekikawa, A., Kanda, N., Hisatsune, H., Seno, H., Konda, 
Y., Fujimori, T., and Chiba, T. (2007). Expression of the REG IV gene in ulcerative colitis. Lab. 
Invest. 87, 304–314. 
Neuschwander-Tetri, B. a, Fimmel, C.J., Kladney, R.D., Wells, L.D., and Talkad, V. (2004). 
Differential expression of the trypsin inhibitor SPINK3 mRNA and the mouse ortholog of secretory 
granule protein ZG-16p mRNA in the mouse pancreas after repetitive injury. Pancreas 28, e104–
e111. 
Oue, N., Mitani, Y., Aung, P.P., Sakakura, C., Takeshima, Y., Kaneko, M., Noguchi, T., 
Nakayama, H., and Yasui, W. (2005). Expression and localization of Reg IV in human neoplastic 
 Bibliography 
139 
 
and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine 
differentiation in gastric adenocarcinoma. J. Pathol. 207, 185–198. 
Palade, G. (1975). Intracellular aspects of the process of protein synthesis. Science 189, 867. 
Palmer, E., and Freeman, T. (2004). Investigation into the use of C- and N-terminal GFP 
fusion proteins for subcellular localization studies using reverse transfection microarrays. Comp. 
Funct. Genomics 5, 342–353. 
Pâquet, M.R., St-Jean, P., Roberge, M., and Beaudoin, A.R. (1982). Isolation of zymogen 
granules from rat pancreas and characterization of their membrane proteins. Eur. J. Cell Biol. 28, 20–
26. 
Parikh, A., Stephan, A., and Tzanakakis, E. (2012). Regenerating proteins and their 
expression, regulation, and signaling. Biomol. Concepts 3, 57–70. 
Parsell, D.A., and Sauer, R.T. (1989). The structural stability of a protein is an important 
determinant of its proteolytic susceptibility in Escherichia coli. J. Biol. Chem. 264, 7590–7595. 
Pejler, G., and Berg, L. (1995). Regulation of rat mast cell protease 1 activity. Protease 
inhibition is prevented by heparin proteoglycan. Eur. J. Biochem. 233, 192–199. 
Pejler, G., and Maccarana, M. (1994). Interaction of heparin with rat mast cell protease 1. J. 
Biol. Chem. 269, 14451–14456. 
Pelaseyed, T., Bergström, J.H., Gustafsson, J.K., Ermund, A., Birchenough, G.M.H., 
Schütte, A., van der Post, S., Svensson, F., Rodríguez-Piñeiro, A.M., Nyström, E.E.L., et al. (2014). 
The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the 
gastrointestinal tract and interact with the immune system. Immunol. Rev. 260, 8–20. 
Price, E.R., Jin, M., Lim, D., Pati, S., Walsh, C.T., and McKeon, F.D. (1994). Cyclophilin B 
trafficking through the secretory pathway is altered by binding of cyclosporin A. PNAS 91, 3931–
3935. 
Prydz, K., and Dalen, K.T. (2000). Synthesis and sorting of proteoglycans. J. Cell Sci. 113, 
193–205. 
Raval, S., Gowda, S.B., Singh, D.D., and Chandra, N.R. (2004). A database analysis of 
jacalin-like lectins: sequence-structure-function relationships. Glycobiology 14, 1247–1263. 
Rebaï, O., Le Petit-Thevenin, J., Bruneau, N., Lombardo, D., and Vérine, A. (2005). In vitro 
angiogenic effects of pancreatic bile salt-dependent lipase. Arterioscler. Thromb. Vasc. Biol. 25, 
359–364. 
Reggio, H.A., and Palade, G.E. (1978). Sulfated compounds in the zymogen granules of the 
guinea pig pancreas. J. Cell Biol. 77, 288–314. 
Reuter, G., and Gabius, H.J. (1999). Eukaryotic glycosylation: Whim of nature or 
multipurpose tool? Cell. Mol. Life Sci. 55, 368–422. 
 140 
 
Rindler, M.J. (1992). Biogenesis of storage granules and vesicles. Curr. Opin. Cell Biol. 4, 
616–622. 
Rindler, M.J. (2006). Isolation of zymogen granules from rat pancreas. In Current Protocols 
in Cell Biology, pp. 3.18.1–3.18.16. 
Rindler, M.J., and Hoops, T.C. (1990). The pancreatic membrane protein GP-2 localizes 
specifically to secretory granules and is shed into the pancreatic juice as a protein aggregate. Eur. J. 
Cell Biol. 53, 154–163. 
Rindler, M.J., Xu, C.F., Gumper, I., Smith, N.N., and Neubert, T.A. (2007). Proteomic 
analysis of pancreatic zymogen granules: Identification of new granule proteins. J. Proteome Res. 6, 
2978–2992. 
Rinn, C., Aroso, M., Prüssing, J., Islinger, M., and Schrader, M. (2012). Modulating 
zymogen granule formation in pancreatic AR42J cells. Exp. Cell Res. 318, 1855–1866. 
Rodríguez-Piñeiro, A.M., Bergström, J.H., Ermund, A., Gustafsson, J.K., Schütte, A., 
Johansson, M.E. V, and Hansson, G.C. (2013). Studies of mucus in mouse stomach, small intestine, 
and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of 
core proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G348–56. 
Rönnberg, E., Melo, F.R., and Pejler, G. (2012). Mast cell proteoglycans. J. Histochem. 
Cytochem. 60, 950–962. 
Rutten, W.J., De Pont, J.J., Bonting, S.L., and Daemen, F.J. (1975). Lysophospholipids in 
pig pancreatic zymogen granules in relation to exocytosis. Eur. J. Biochem. 54, 259–265. 
Sajnani, G., and Requena, J.R. (2012). Prions, proteinase K and infectivity. Prion 6, 430–
432. 
Sajnani, G., Silva, C.J., Ramos, A., Pastrana, M.A., Onisko, B.C., Erickson, M.L., Antaki, 
E.M., Dynin, I., Vázquez-Fernández, E., Sigurdson, C.J., et al. (2012). PK-sensitive PrP is infectious 
and shares basic structural features with PK-resistant PrP. PLoS Pathog. 8, e1002547. 
Sarles, H. (1986). Etiopathogenesis and definition of chronic pancreatitis. Dig. Dis. Sci. 31, 
91S–107S. 
Sastry, M. V, Banarjee, P., Patanjali, S.R., Swamy, M.J., Swarnalatha, G. V, and Surolia, A. 
(1986). Analysis of saccharide binding to Artocarpus integrifolia lectin reveals specific recognition 
of T-antigen (beta-D-Gal(1--3)D-GalNAc). J. Biol. Chem. 261, 11726–11733. 
Scheele, G.A. (1975). Two-dimensional gel analysis of soluble proteins. Charaterization of 
guinea pig exocrine pancreatic proteins. J. Biol. Chem. 250, 5375–5385. 
Scheele, G.A., and Palade, G.E. (1975). Studies on the guinea pig pancreas. Parallel 
discharge of exocrine enzyme activities. J. Biol. Chem. 250, 2660–2670. 
 Bibliography 
141 
 
Scheele, G., Pash, J., and Bieger, W. (1981). Identification of proteins according to biological 
activity following separation by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel 
electrophoresis: analysis of human exocrine pancreatic proteins. Anal. Biochem. 112, 304–313. 
Scheele, G.A., Palade, G.E., and Tartakoff, A.M. (1978). Cell fractionation studies on the 
guinea pig pancreas. Redistribution of exocrine proteins during tissue homogenization. J. Cell Biol. 
78, 110–130. 
Scheele, G.A., Fukuoka, S., and Freedman, S.D. (1994). Role of the GP2/THP family of 
GPI-anchored proteins in membrane trafficking during regulated exocrine secretion. Pancreas 9, 
139–149. 
Schick, J., Kern, H., and Scheele, G. (1984a). Hormonal stimulation in the exocrine pancreas 
results in coordinate and anticoordinate regulation of protein synthesis. J. Cell Biol. 99, 1569–1574. 
Schick, J., Verspohl, R., Kern, H., and Scheele, G. (1984b). Two distinct adaptive responses 
in the synthesis of exocrine pancreatic enzymes to inverse changes in protein and carbohydrate in 
the diet. Am. J. Physiol. 247, G611–G616. 
Schmidt, K., Dartsch, H., Linder, D., Kern, H.F., and Kleene, R. (2000). A submembranous 
matrix of proteoglycans on zymogen granule membranes is involved in granule formation in rat 
pancreatic acinar cells. J. Cell Sci. 113, 2233–2242. 
Schmidt, K., Schrader, M., Kern, H.F., and Kleene, R. (2001). Regulated apical secretion of 
zymogens in rat pancreas. Involvement of the glycosylphosphatidylinositol-anchored glycoprotein 
GP-2, the lectin ZG16p, and cholesterol-glycosphingolipid-enriched microdomains. J. Biol. Chem. 
276, 14315–14323. 
Schrader, M. (2004). Membrane targeting in secretion. In Subcellular Biochemistry, Volume 
37: Membrane Dynamics and Domains, P.J. Quinn, ed. (New York: Kluwer Academic / Plenum 
Publishers), pp. 391–421. 
Schwake, M., Schröder, B., and Saftig, P. (2013). Lysosomal membrane proteins and their 
central role in physiology. Traffic 14, 739–748. 
Sharma, A., Chandran, D., Singh, D.D., and Vijayan, M. (2007). Multiplicity of 
carbohydrate-binding sites in beta-prism fold lectins: occurrence and possible evolutionary 
implications. J. Biosci. 32, 1089–1110. 
Sharon, N., and Lis, H. (2004). History of lectins: from hemagglutinins to biological 
recognition molecules. Glycobiology 14, 53R–62R. 
Silva, A.M.N., Vitorino, R., Domingues, M.R.M., Spickett, C.M., and Domingues, P. (2013). 
Post-translational modifications and mass spectrometry detection. Free Radic. Biol. Med. 65, 925–
941. 
 142 
 
Singh, D.D., Saikrishnan, K., Kumar, P., Surolia, a, Sekar, K., and Vijayan, M. (2005). 
Unusual sugar specificity of banana lectin from Musa paradisiaca and its probable evolutionary 
origin. Crystallographic and modelling studies. Glycobiology 15, 1025–1032. 
Steinhilber, W., Poensgen, J., Rausch, U., Kern, H.F., and Scheele, G.A. (1988). 
Translational control of anionic trypsinogen and amylase synthesis in rat pancreas in response to 
caerulein stimulation. PNAS 85, 6597–6601. 
Sun, X., and Jiang, X. (2013). Combination of FASP and fully automated 2D-LC-MS/MS 
allows in-depth proteomic characterization of mouse zymogen granules. Biomed. Chromatogr. 27, 
407–408. 
Swaney, D.L., Wenger, C.D., and Coon, J.J. (2010). Value of using multiple proteases for 
large-scale mass spectrometry-based proteomics. J. Proteome Res. 9, 1323–1329. 
Swanson, M.D., Winter, H.C., Goldstein, I.J., and Markovitz, D.M. (2010). A lectin isolated 
from bananas is a potent inhibitor of HIV replication. J. Biol. Chem. 285, 8646–8655. 
Switzar, L., Giera, M., and Niessen, W.M.A. (2013). Protein digestion: an overview of the 
available techniques and recent developments. J. Proteome Res. 12, 1067–1077. 
Szmola, R., and Sahin-Tóth, M. (2007). Chymotrypsin C (caldecrin) promotes degradation 
of human cationic trypsin: identity with Rinderknecht’s enzyme Y. PNAS 104, 11227–11232. 
Takahashi, N., Hayano, T., and Suzuki, M. (1989). Peptidyl-prolyl cis-trans isomerase is the 
cyclosporin A-binding protein cyclophilin. Nature 337, 473–475. 
Tamura, H., Ohtsuka, M., Washiro, M., Kimura, F., Shimizu, H., Yoshidome, H., Kato, A., 
Seki, N., and Miyazaki, M. (2009). Reg IV expression and clinicopathologic features of gallbladder 
carcinoma. Hum. Pathol. 40, 1686–1692. 
Tanaka, K., Waki, H., and Ido, Y. (1988). Protein and Polymer Analyses up to m/z 100 000 
by Laser Ionization Time-of-Flight Mass Spectrometry. Rapid Commun. Mass Spectrom. 2, 151–
153. 
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.L., Hartmann, D., Lüllmann-Rauch, R., 
Janssen, P.M., Blanz, J., von Figura, K., and Saftig, P. (2000). Accumulation of autophagic vacuoles 
and cardiomyopathy in LAMP-2-deficient mice. Nature 406, 902–906. 
Tartakoff, A., Greene, L.J., and Palade, G.E. (1974). Studies on the Guinea Pig Pancreas. J. 
Biol. Chem. 249, 7420–7431. 
Tartakoff, A.M., Jamieson, J.D., Scheele, G.A., and Palade, G.E. (1975). Studies on the 
pancreas of the guinea pig. Parallel processing and discharge of exocrine proteins. J. Biol. Chem. 
250, 2671–2677. 
Tateno, H. (2010). SUEL-related lectins, a lectin family widely distributed throughout 
organisms. Biosci. Biotechnol. Biochem. 74, 1141–1144. 
 Bibliography 
143 
 
Tateno, H., Yabe, R., Sato, T., Shibazaki, A., Shikanai, T., Gonoi, T., Narimatsu, H., and 
Hirabayashi, J. (2012). Human ZG16p recognizes pathogenic fungi through non-self polyvalent 
mannose in the digestive system. Glycobiology 22, 210–220. 
Thévenod, F. (2002). Ion channels in secretory granules of the pancreas and their role in 
exocytosis and release of secretory proteins. Am. J. Physiol. Cell Physiol. 283, C651–C672. 
Thévenod, F., Anderie, I., and Schulz, I. (1994). Monoclonal antibodies against MDR1 P-
glycoprotein inhibit chloride conductance and label a 65-kDa protein in pancreatic zymogen granule 
membranes. J. Biol. Chem. 269, 24410–24417. 
Thorn, P., Lawrie, A.M., Smith, P.M., Gallacher, D. V, and Petersen, O.H. (1993). Local and 
global cytosolic Ca2+ oscillations in exocrine cells evoked by agonists and inositol trisphosphate. 
Cell 74, 661–668. 
Thrower, E.C., Gorelick, F.S., and Husain, S.Z. (2010). Molecular and cellular mechanisms 
of pancreatic injury. Curr. Opin. Gastroenterol. 26, 484–489. 
Tooth, D., Garsed, K., Singh, G., Marciani, L., Lam, C., Fordham, I., Fields, A., Banwait, 
R., Lingaya, M., Layfield, R., et al. (2014). Characterisation of faecal protease activity in irritable 
bowel syndrome with diarrhoea: origin and effect of gut transit. Gut 63, 753–760. 
Tooze, J., Kern, H.F., Fuller, S.D., and Howell, K.E. (1989). Condensation-sorting events in 
the rough endoplasmic reticulum of exocrine pancreatic cells. J. Cell Biol. 109, 35–50. 
Tooze, S.A., Martens, G.J.M., and Huttner, W.B. (2001). Secretory granule biogenesis: 
Rafting to the SNARE. Trends Cell Biol. 11, 116–122. 
Vaccaro, M.I. (2012). Zymophagy: Selective autophagy of secretory granules. Int. J. Cell 
Biol. 2012, 1–7. 
Valentijn, K.M., Gumkowski, F.D., and Jamieson, J.D. (1999). The subapical actin 
cytoskeleton regulates secretion and membrane retrieval in pancreatic acinar cells. J. Cell Sci. 112, 
81–96. 
Vanpouille, C., Denys, A., Carpentier, M., Pakula, R., Mazurier, J., and Allain, F. (2004). 
Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin 
and cell surface heparan sulphate. Biochem. J. 382, 733–740. 
Vasiloudes, P., Paul, N., Tooze, J., and Kern, H.F. (1991). Acceleration of asynchronous 
enzyme transport in the rat exocrine pancreas following hormonal stimulation in vivo. Eur. J. Cell 
Biol. 54, 27–37. 
Violette, S., Festor, E., Pandrea-Vasile, I., Mitchell, V., Adida, C., Dussaulx, E., Lacorte, J.-
M., Chambaz, J., Lacasa, M., and Lesuffleur, T. (2003). Reg IV, a new member of the regenerating 
gene family, is overexpressed in colorectal carcinomas. Int. J. Cancer. 103, 185–193. 
 144 
 
Wagner, A.C., and Williams, J.A. (1994). Pancreatic zymogen granule membrane proteins: 
molecular details begin to emerge. Digestion 55, 191–199. 
Walz, A., Stühler, K., Wattenberg, A., Hawranke, E., Meyer, H.E., Schmalz, G., Blüggel, 
M., and Ruhl, S. (2006). Proteome analysis of glandular parotid and submandibular-sublingual saliva 
in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics 6, 1631–
1639. 
Wang, B.J., and Cui, Z.J. (2007). How does cholecystokinin stimulate exocrine pancreatic 
secretion? From birds, rodents, to humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R666–
R678. 
Wang, P., and Heitman, J. (2005). The cyclophilins. Genome Biol. 6, 226.1–226.6. 
Wasle, B., and Edwardson, J.M. (2002). The regulation of exocytosis in the pancreatic acinar 
cell. Cell. Signal. 14, 191–197. 
Weiss, F.U., Halangk, W., and Lerch, M.M. (2008). New advances in pancreatic cell 
physiology and pathophysiology. Best Pract. Res. Clin. Gastroenterol. 22, 3–15. 
Whitcomb, D.C. (2004). Mechanisms of disease: Advances in understanding the 
mechanisms leading to chronic pancreatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 1, 46–52. 
Whitcomb, D.C., and Beger, H.G. (2008). Definitions of Pancreatic Diseases and their 
Complications. In The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, 
H.G. Beger, A.L. Warshaw, M.W. Büchler, R.A. Kozarek, M.M. Lerch, J.P. Neoptolemos, K. 
Shiratori, D.C. Whitcomb, and B.M. Rau, eds. (Oxford, UK: Blackwell Publishing Ltd), pp. 1–6. 
Wilhelm, M., Schlegl, J., Hahne, H., Moghaddas Gholami, A., Lieberenz, M., Savitski, 
M.M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014). Mass-spectrometry-based draft 
of the human proteome. Nature 509, 582–587. 
Williams, J.A. (2006). Regulation of pancreatic acinar cell function. Curr. Opin. 
Gastroenterol. 22, 498–504. 
Williams, J.A. (2013). Proteomics as a systems approach to pancreatitis. Pancreas 42, 905–
911. 
Xiao, R., Badger, T.M., and Simmen, F.A. (2005). Dietary exposure to soy or whey proteins 
alters colonic global gene expression profiles during rat colon tumorigenesis. Mol. Cancer 4, 1. 
Yoshimori, T., Semba, T., Takemoto, H., Akagi, S., Yamamoto, A., and Tashiro, Y. (1990). 
Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic 
reticulum despite possessing the retention signal. J. Biol. Chem. 265, 15984–15990. 
Yu, S., Michie, S. a, and Lowe, A.W. (2004). Absence of the major zymogen granule 
membrane protein, GP2, does not affect pancreatic morphology or secretion. J. Biol. Chem. 279, 
50274–50279. 
 Bibliography 
145 
 
Zhang, Y., Fonslow, B.R., Shan, B., Baek, M.-C., and Yates III, J.R. (2013). Protein analysis 
by shotgun/bottom-up proteomics. Chem. Rev. 113, 2343–2394. 
Zheng, X., Lu, D., and Sadler, J.E. (1999). Apical sorting of bovine enteropeptidase does not 
involve detergent-resistant association with sphingolipid-cholesterol rafts. J. Biol. Chem. 274, 1596–
1605. 
Zheng, X.L., Kitamoto, Y., and Sadler, J.E. (2009). Enteropeptidase, a type II 
transmembrane serine protease. Front. Biosci. 1, 242–249. 
Zhou, Y.-B., Cao, J.-B., Yang, H.-M., Zhu, H., Xu, Z.-G., Wang, K.-S., Zhang, X., Wang, 
Z.-Q., and Han, Z.-G. (2007). hZG16, a novel human secreted protein expressed in liver, was down-
regulated in hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 355, 679–686.  
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 
 
 
  
  
 
 
 
 149 
 
 
Appendix 
Supplementary Table 1. Identification by mass spectrometry of basic spots from the Wash subfraction after analysis by 2D-PAGE. 
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Localization Function and References 
B1 
LIPR1_RA
T 
Pancreatic lipase 
related protein 1  
52.3 31.7 5.79 317 31% 12 
Zymogen granules 
of the exocrine 
pancreas. 
AB hydrolase superfamily. Lipase family.1 
B2 52.3 34.2 5.79 95.9 20% 8 
B3 52.3 34.0 5.79 290 31% 13 
B7 52.3 34.0 5.79 337 24% 11 
B18 52.3 25.2 5.79 268 34% 10 
B20 52.3 25.6 5.79 184 26% 8 
B21 52.3 25.2 5.79 193 31% 11 
B22 52.3 20.8 5.79 208 36% 10 
B24 52.3 20.8 5.79 171 26% 8 
B32 52.3 16.3 5.79 193 28% 8 
B11 
LIPP_RAT 
Pancreatic 
triacylglycerol 
lipase  
51.4 31.1 6.31 143 30% 11 
Zymogen granules 
of the exocrine 
pancreas. 
Plays an important role in fat metabolism.2  
B12 51.4 31.2 6.31 184 28% 11 
B19 51.4 22.6 6.31 300 43% 15 
B25 51.4 21.6 6.31 295 35% 12 
B34 51.4 16.1 6.31 178 26% 9 
B4 
AMYP_RA
T 
#Pancreatic 
alpha-amylase  
57.1 35.8 8.34 235 38% 13 
Zymogen granules 
of the exocrine 
pancreas. 
Endohydrolysis of 1,4-alpha-D-glucosidic 
linkages in oligosaccharides and 
polysaccharides.3  
B5 57.1 35.8 8.34 185 41% 14 
B6 57.1 35.8 8.34 314 35% 12 
B30 57.1 19.3 8.34 328 40% 14 
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B33 57.1 14.3 8.34 291 40% 14 
B8 
 
CEL_RAT 
 
 
 
 
#Bile salt-
activated lipase 
 
 
66.9 33.6 5.31 191 15% 7 
Zymogen granules 
of the exocrine 
pancreas. Content 
protein, but also  
 
strongly 
membrane 
associated.  
Catalyzes fat and vitamin absorption. Acts 
in concert with pancreatic lipase and 
colipase for the complete digestion of 
dietary triglycerides.4  
B9 66.9 33.6 5.31 219 24% 14 
B10 66.9 33.6 5.31 225 19% 11 
B15 66.9 32.7 5.31 88.2 14% 7 
B23 66.9 20.2 5.31 182 25% 12 
B37 66.9 16.9 5.31 134 15% 7 
B29 66.9 17.5 5.31 126 24% 10 
B28 66.9 18.7 5.31 174 21% 11 
B40 66.9 12.9 5.31 135 18% 7 
B42 66.9 10.9 5.31 55.8 7% 3 
B16 
MCPT1_R
AT 
#Mast cell 
protease I 
(RMCP1) 
(Chymase)  
28.5 27.5 9.54 130 50% 9 
Cytoplasmic 
granules of mast 
cells 
Major secreted protease of mast cells with 
suspected roles in vasoactive peptide 
generation, extracellular matrix 
degradation, and regulation of gland 
secretion.5 
B17 
CELA1_R
AT 
Chymotrypsin-
like elastase 
family member 1 
28.9 28 8.79 60.8 15% 3 
Zymogen granules 
of the exocrine 
pancreas.  
Hydrolysis of proteins, including elastin.6 
B14 VINC_RAT Vinculin  
116.
5 
31 5.77 55.6 28% 17 
Cytoplasm, 
cytoskeleton. Cell 
junction, adherens 
junction. Cell 
membrane; 
Involved in cell adhesion. May be involved 
in the attachment of the actin-based 
microfilaments to the plasma membrane. 
May also play important roles in cell 
morphology and locomotion.7  
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Localization Function and References 
Peripheral 
membrane protein. 
B13 
TRY3_RA
T 
Cationic trypsin-
3 
26.2 25.7 7.45 186 44% 7 
Zymogen granules 
of the exocrine 
pancreas. Content 
protein. 
S1-peptidase, serine protease.8  
B27 
RNS1B_R
AT 
#Ribonuclease 
pancreatic beta-
type 
16.8 16 8.63 136 51% 6 
Zymogen granules 
of the exocrine 
pancreas. Content 
protein. 
Endonuclease that catalyzes the cleavage 
of RNA. Acts on single stranded and 
double stranded RNA.9  
B26 PPIB_RAT 
#Peptidyl-prolyl 
cis-trans 
isomerase B 
(PPIase)  
22.7 22 9.42 55.8 49% 3 
Endoplasmic 
reticulum lumen  
PPIases accelerate the folding of proteins. 
Catalyzes the cis-trans isomerization of 
proline imidic peptide bonds in 
oligopeptides.10  
B31 ZG16_RAT 
#Zymogen 
granule 
membrane 
protein 16 
(Secretory lectin 
ZG16) 
18.2 17.5 9.17 210 72% 9 
Zymogen 
granules, 
peripheral 
membrane protein  
May act as a linker molecule between the 
submembranous matrix on the luminal side 
of zymogen granule membrane (ZGM) and 
aggregated secretory proteins during 
granule formation at the TGN.11  
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Localization Function and References 
B38 
SYCN_RA
T 
#Syncollin 15.9 15.4 8.61 120 29% 7 
Cytoplasmic 
vesicle, secretory 
vesicle membrane; 
Peripheral 
membrane protein. 
Compound exocytosis. Associated with 
lipid rafts in a cholesterol-dependent 
manner. Interacts with GP2.12  
B36 
B2RZA9_R
AT 
Ubiquitin carrier 
protein 
17.8 16.7 8.68 56.8 45% 7   Ubl conjugation pathway 
B35 
LIPR2_RA
T 
Pancreatic lipase-
related protein 2 
52.5 14.1 5.92 88.8 22% 9 
Zymogen granules 
of the exocrine 
pancreas. 
Lipid degradation.13  
B41   Not identified           
B45   Not identified           
B39 
COL_RAT Colipase  
12.2 11.8 8.04 57 36% 4 Zymogen granules 
of the exocrine 
pancreas. Content 
protein. 
Cofactor of pancreatic lipase. Allows the 
lipase to anchor itself to the lipid-water 
interface.14  
B44 12.2 9.6 8.04 125 43% 5 
B43 12.2 9.2 8.04 85.3 64% 7 
B46 
Q9EQZ8_R
AT 
Chymopasin 28.1 27.3 8.56 51 40% 7 
Zymogen granules 
of the exocrine 
pancreas. 
S1-peptidase, serine protease.15 
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Supplementary Table 2. Proteins identified by mass spectrometry from the enterokinase samples  
Rank 
Accession 
Number 
(Expasy) 
Protein Name Species 
Total 
Ion 
Score 
Accession 
Number 
Protein 
MW 
Protein 
PI 
Peptide 
Count 
Total 
Ion 
Score 
C.I. 
% 
Best 
Ion 
Score 
C.I. % 
1 P00689 
Pancreatic alpha-
amylase 
Rattus 
norvegicus 
495,51 AMYP_RAT 57141 8,34 21 100 98,972 
2 P07338 Chymotrypsinogen B 
Rattus 
norvegicus 
251,56 
CTRB1_RA
T 
27831 4,9 9 100 99,98 
3 P19223 Carboxypeptidase B 
Rattus 
norvegicus 
172,43 CBPB1_RAT 47485 5,44 5 100 97,529 
4 P54316 
Pancreatic lipase 
related protein 1 
Rattus 
norvegicus 
154,4 LIP1_RAT 52345 5,79 4 100 99,869 
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Rank 
Accession 
Number 
(Expasy) 
Protein Name Species 
Total 
Ion 
Score 
Accession 
Number 
Protein 
MW 
Protein 
PI 
Peptide 
Count 
Total 
Ion 
Score 
C.I. 
% 
Best 
Ion 
Score 
C.I. % 
5 P00731 Carboxypeptidase A1 
Rattus 
norvegicus 
113,85 
CBPA1_RA
T 
47168 5,45 4 100 96,831 
6 P19222 Carboxypeptidase A2 
Rattus 
norvegicus 
99,076 
CBPA2_RA
T 
46883 5,17 4 100 94,656 
7 P27657 
Pancreatic 
triacylglycerol lipase 
Rattus 
norvegicus 
91,454 LIPP_RAT 51407 6,31 2 100 99,352 
8 P08426 Cationic trypsin III 
Rattus 
norvegicus 
72,57 TRY3_RAT 26252 7,45 1 
99,98
2 
99,99 
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Supplementary Table 3. Distribution (%) of ZG proteins to different ZG subfractions 
Protein ZGC ZGM ZGMcarb Wash 
Amylase 86.5 ± 3.8 13.5 ± 3.8 24.3 ± 4.0 75.7 ± 4.0 
GP2 2.2 ± 1.3 97.8 ± 1.3 86.0 ± 5.3 14.0 ± 5.3 
ZG16p 1.8 ± 2.4 98.3 ± 2.4 21.8 ± 3.3 78.3 ± 3.3 
Chymase 2.8 ± 1.0 97.2 ± 1.0 11.0 ± 3.6 89.0 ± 3.6 
PpiB 1.2 ± 1.3 98.8 ± 1.3 15.0 ± 4.4 85.0 ± 4.4 
CEL 21.0 ± 4.0 79.0 ± 3.6 71.0 ± 3.6 29.0 ± 3.6 
RNase 61.3 ± 6.5 38.7 ± 6.5 17.3 ± 2.5 82.7 ± 2.5 
Distribution to ZGC and ZGM (% of total ZGC + ZGM) and distribution to ZGMcarb and 
Wash (% of total ZGM). Data are from at least three independent experiments and are 
expressed as means ± standard deviation. 
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Supplementary Figure 1. Restriction map of the vector pDsRed2-ER (A) and ER-Myc-
ZG16p (B). The DsRed2 and KDEL (ER retention signal) sequences were replaced by Myc-
ZG16p. The red boxes indicate the restriction enzymes used for cloning.  
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Supplementary Figure 2. Prediction of the potential cleavage sites for trypsin in ZG16p 
given by the ExPASy PeptideCutter tool. 
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